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“… Human beings are like that. We want to live by each other’s 
happiness - not by each other’s misery. We don’t want to hate and 
despise one another. In this world there is room for everyone. And the 
good earth is rich and can provide for everyone. The way of life can be 
free and beautiful, but we have lost the way. 
Greed has poisoned men’s souls, has barricaded the world with hate 
and has goose-stepped us into misery and bloodshed. We have developed 
speed, but we have shut ourselves in. Machinery that gives abundance 
has left us in want. Our knowledge has made us cynical, our cleverness 
hard and unkind. We think too much and feel too little. More than 
machinery we need humanity. More than cleverness we need kindness 
and gentleness. Without these qualities, life will be violent and all will be 
lost.... 
… Let us fight for a world of reason, a world where science and 
progress will lead to all men’s happiness….” 
 
     -The Great Dictator – Charlie Chaplin, 1940 
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SUMMARY 
 
Pollen project 
Asthma accounts for one of the many forms of chronic pulmonary diseases. Rather than a 
single disease, asthma is a term that can include a multitude of clinical symptoms related to gas 
exchange limitation, airway hyper-responsiveness resulting in wheezing and coughing, and 
airway inflammation. This variety of symptoms depicts very well the complexity of asthma and 
suggests the involvement of a multitude of triggers, biological pathways, and molecular 
mechanisms, which can be related to an allergic or non-allergic asthma outcome. 
On one side, the allergic asthma is characterized by the inflammation of the airway tissue in 
response to a load of allergic triggers. The inflammatory process is induced by the over-reaction 
of the immune system, and causes airways swelling and mucus over-production. Besides 
inflammation, pro-inflammatory cytokines like interleukins (IL-1β), tumor necrosis factor (TNF), 
and interferon-gamma (IFN-γ) are involved in the smooth muscle contraction. On the other side, 
the non-allergic asthma is mediated by non-inflammatory processes. Non-allergic triggers are 
organic and inorganic airway irritants, which modulate neuro-muscular macromolecular targets 
(receptors, channels) generating airways hyper-responsiveness and smooth muscle contraction.  
The Transient Receptor Potential cation channel A1 (TRPA1) is a ubiquitous Ca2+-selective 
protein highly expressed on somatosensory neurons and is activated by environmental irritants 
inducing pain, cold and itchiness. Its expression on afferent neurons in the airways makes this 
channel a target for small chemical irritants, resulting in airway hyper-responsiveness to 
contractile stimuli. Differently, the type I PhosphatidylInositol 4-Phosphate 5-Kinase (PIP5K) 
gamma isoform is a lipid kinase involved in the regulation of intracellular Ca2+ in smooth muscle 
cells. PIP5Kγ produces phosphatidylinositol 4,5-biphosphate (PIP2), a substrate necessary for 
phospholipase C β (PLCβ)-mediated inositol triphosphate (IP3) production. Finally, IP3 induces 
the release of Ca2+ from the sarcoplasmic reticulum with consequent myosin phosphorylation and 
smooth muscle contraction. The polyamines spermidine and spermine are crucial cofactors for 
PIP5Kγ activation.  
The aim of this work was to investigate the potential role of plant pollen secondary metabolites in 
the non-allergic exacerbation of asthma symptoms. We performed the phytochemical study of 
pollen from 30 plant species, including the highly allergenic Ambrosia artemisiifolia and 
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Ambrosia psilostachya from the family Asteraceae, and the highly allergic Betula pendula and 
Corylus avellana from the non-Asteraceae.  
The spectrophotometric quantification of electrophiles in extracts revealed a surprisingly low 
concentration in Ambrosia artemisiifolia, a high concentration in Ambrosia psilostachya, and an 
electrophiles concentration in non-Asteraceae that was comparable to some species from 
Ambrosia, Artemisia, and other genera from the Asteraceae family. Furthermore, we observed the 
presence of polyamines in their conjugated form, which were exclusively present in the 
Asteraceae pollen. Finally, extracts and pure compounds were tested in murine afferent neurons 
for their effect on Ca2+ influx measured via calcium imaging, and for constriction of murine 
tracheal rings in organ bath experiments. 
A. psilostachya THF extract and the STLs mixture coronopilin (13) and parthenin (14) induced 
similar Ca2+ influx results inducing Ca2+ influx in 32% (n = 207) and 37% (n = 372) (p < 0.05) of 
cinnamaldehyde positive (CA+) neurons, respectively. A. artemisiifolia induced Ca2+ influx in 
only 15% (n = 144) of CA+ neurons (statistically not significant). Tracheal tone in naïve and 
metacholine (MCh) pre-constricted tracheal rings was recorded in response to vehicle (0.5% 
DMSO), extract, and compounds. In naïve tracheal rings A. psilostachya extract and conjugated 
polyamines had no significant effect on tracheal tone. In contrast, 13/14 induced significant 
tracheal relaxation (p = 0.017). After washing, the tracheal rings were treated with MCh, a 
muscarinic receptor agonist known to induce a strong tracheal constriction. Interestingly, the 
magnitude of constriction in the 13/14 pre-treated tracheal rings was significantly lower 
compared to control (p < 0.05). MCh-constricted tracheal rings were treated with either A. 
psilostachya extract, 13/14, or conjugated polyamines. Conjugated polyamines had no effect on 
MCh-constricted tracheal rings, while A. psilostachya extract and 13/14 both caused significant 
relaxation (p < 0.05). 
 
Ziziphus project 
Glycosylated triterpenes are organic molecules belonging to the secondary metabolism of 
plants and other organisms such as marine invertebrates. The genus Zizyphus (Rhamnaceae) 
comprises a variety of spiny shrubs and small trees, which leaves are commonly used in the 
oriental and Middle-East folk medicine for the treatment of various diseases but also to produce 
natural detergents and shampoos. Phytochemical characterization of glycosylated triterpenes in 
the hydroalcoholic extract from Ziziphus spina-christi leaves resulted in the identification of ten 
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saponins, of which three were found to be novel dammarane-type aglycones. Their structures 
were elucidated by a combination of powerful analytical methods such as HPLC-PDA-TOF-MS 
and highly sensitive microprobe NMR. 
 
ACD/Labs project 
The technological development of LC-MS instrumentation has led to significant 
improvements in automation, performance, and sensitivity. Complex samples, such as plant 
extracts can now be analyzed routinely and in high-throughput mode. Software tools allow 
efficient deconvolution of LC-MS chromatograms to obtain comprehensive information on single 
constituents. However, the systematic and unbiased comparison of large numbers of complex 
LC-MS chromatograms remains a challenge. Existing software tools for comparative processing 
are widely used in scientific fields like systems biology, including disciplines like genomics, 
proteomic, and metabolomics. Nevertheless, still little application is observed in phytochemistry 
and drug discovery research. The reasons for this are diverse and include insufficient user 
friendliness and the method-oriented (MS or NMR) configuration of the large majority of the 
available metabolomics platforms. In our opinion, a valid alternative to the existing 
computational tools could be found in the implementation of automated data processing and 
statistical analysis in software packages designed for modern drug discovery. ACD/Labs 
(Advanced Chemistry Development, Inc., Toronto, Canada) is a commercial analytical platform 
integrated with a wide range of analytical and predictive functionalities such as LC-MS and 
NMR data processing and analysis (ACD/Spectrus®), metabolite identification 
(ACD/MetaSense®) and in silico drug likeliness predictions (ACD/Percepta®). 
In this work we focused on creating a two-step protocol comprising a parallel comparative 
processing integrated in ACD/Labs, and a web platform developed in R language designed for 
clustering and visualization of chromatographic data. Initially, all relevant chromatographic and 
spectroscopic data (retention time, molecular ions with the respective ion abundance, and sample 
names) are automatically extracted and assembled in an Excel spreadsheet. Afterwards, the file is 
loaded into an online web application equipped with various statistical algorithms where the user 
can compare and visualize the results in intuitive 2D heat maps.  
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ZUSAMMENFASSUNG 
 
Asthma Projekt 
Das Asthma gehört zu einer Form der chronischen Lungenkrankheiten. Lieber als eine 
Krankheit, Asthma wird als ein Begriff bezeichnet welcher eine Vielzahl von klinischen 
Symptomen in Bezug zu Gasaustausch Beschränkungen, Atemwege Überempfindlichkeit, und 
Atemwege Entzündung einbezieht.  Diese Vielseitigkeit von Symptomen wiedergibt sehr wohl 
die Asthma Komplexität und hinweist auf die Beteiligung von mehreren Auslösern, biologischen 
Signalwege, und molekulare Mechanismen, welche mit einem allergischen oder nicht-
allergischen Asthma zusammenhängen.  
Zu einer Seite, das allergische Asthma ist charakterisiert bei einer Atemwegeentzündung als 
Rückantwort zur Last von allergischen Auslösern. Der inflammatorische Prozess ist verursacht 
durch eine Überreaktion des Immunsystem, und führt zu Atemwege Anschwellung begleitet 
durch Schleim Überproduktion. Ausser Entzündung, die pro-inflammatorische Cytokinen wie 
Interleukine (IL-1β), Tumornekrosefaktor (TNF), und Interferon-gamma (IFN-γ) sind auch 
beteiligt in der Konstriktion der glatten Muskulatur. Auf der anderen Seite, das nicht-allergische 
Asthma wird durch nicht-inflammatorischen Prozessen vermittelt. Zu den nicht-allergischen 
Auslösern gehören organische und anorganische Reizstoffe der Atemwege, welche die 
neuromuskulären makromolekularen Targets (Rezeptoren, Kanälen) modulieren und somit die 
Atemwege Überempfindlichkeit und Konstriktion verursachen.  
Der TRPA1 (auf Englisch Transient Receptor Potential cation channel A1) ist ein ubiquitäres 
Ca2+-selektives Protein das auf somatosensorischen Neuronen überexprimiert ist, welches durch 
umweltbedingte Reizstoffe aktiviert wird. Ihre Expression auf den somatosensorischen Neuronen 
in den Atemwegen macht den TRPA1 Kanal ein beliebtes Target für chemische Reizstoffe, was 
zu Kontraktion-Überempfindlichkeit der Atemwege führt.  Die PIP5K-gamma Isoform Lipid 
Kinase (auf Englisch type I PhosphatidylInositol 4-Phosphate 5-Kinase (PIP5K) gamma isoform) 
ist verbunden mit der Regulation der intrazelluläre Ca2+ Konzentration in die Zellen der glatten 
Muskulatur. PIP5Kγ erzeugt phosphatidylinositol 4,5-biphosphat (PIP2), ein Substrat für die 
Phospholipase C (PLC)-vermittelte Produktion von Inositoltriphosphat (IP3). IP3 bewirkt über 
die Bindung an seinen spezifischen Rezeptor, den IP3-Rezeptor, die Freisetzung von Calcium-
Ionen aus dem sarkoplasmatischen Retikulum. Dies hat zur Folge, dass Myosin durch die 
Miosyn-leichte-Ketten-Kinase phosphoryliert wird und zur Kontraktion der glatten Muskulatur 
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führt. Die Polyaminen Spermidin und Spermin sind entscheidende Kofaktoren für die 
Aktivierung der PIP5Kγ. 
Der Zweck dieser Arbeit war die Ermittlung der potentiellen Rolle von Pollen 
Sekundärmetaboliten in der Exacerbation von nicht-allergischen Asthma Symptome. Wir führten 
die phytochemische Studie von Pollen aus 30 Pflanzenspezies vor, inklusive die hoch-allergische 
Ambrosia artemisiifolia und Ambrosia psilostachya aus der Familie Asteraceae, als auch die 
hoch-allergische Betula pendula und Corylus avellana aus den nich-Asteraceae. Die 
spektrophotometrische Quantifizierung von elektrophilen Stoffen in Extrakten zeigte eine 
überraschend tiefe Konzentration in Ambrosia artemisiifolia, eine hohe Konzentration in 
Ambrosia psilostachya, und eine Konzentration in nicht-Asteraceae die vergleichbar mit einigen 
Spezies aus Ambrosia, Artemisia, und anderen Genera aus der Familie Asteraceae war. 
Weiterhin, könnten wir die Anwesenheit von Polyaminen in deren konjugierte Form beobachten, 
und ihre Verteilung nur in Asteraceae Pollen beschliessen. Schlussendlich, wurden ausgewählte 
Extrakten und Reinstoffe in afferenten Mausneuronen für ihren Effekt auf der intrazelluläre Ca2+ 
Erhöhung mittels Calcium Imaging und auf Einschränkung von trachealen Mausringen in Organ 
Bad Experimenten getestet. 
A. psilostachya THF Extrakt und die Mischung an STL Coronopilin (13) und Parthenin (14) 
zeigten ähnliche Ergebnissen und induzierten Ca2+ Influx in beziehungsweise 32% (n = 207) und 
37% (n = 372) (p < 0.05) von Cinnamaldehyd-positive (CA+) Neuronen. A. artemisiifolia 
induzierte Ca2+ Influx in nur 15% (n = 144) von CA+ Neuronen (statistisch insignifikantes 
Ergebnis). Die Erregungsantwort des trachealen Tonus in naive und Metacholin (MCh) 
voreingeschränkte trachealen Ringen wurde nach Zugabe von Kontrolle (0.5% DMSO), Extrakt, 
und 13/14 gemessen. In den naiven trachealen Ringen zeigten A. psilostachya Extrakt und die 
konjugierten Polyamine kein signifikanter Effekt. Im Gegensatz dazu, 13/14 induzierte eine 
signifikante tracheale Relaxation (p = 0.017). Nach dem Abspülen, wurden die trachealen Ringen 
mit MCh (ein muskarinisches Rezeptor Agonist) eingeschränkt. Interessanterweise, die maximale 
MCh-vermittelte Einschränkung war deutlich tiefer in 13/14 vorbehandelten trachealen Ringen, 
im Vergleich zur Kontrolle (p < 0.05). MCh voreingeschränkte trachealen Ringen wurden mit 
entweder A. psilostachya Extrakt, konjugierten Polyaminen oder 13/14 behandelt. Die 
konjugierten Polyamine zeigten keinen Effekt, während A. psilostachya Extrakt und 13/14 
bewirkten eine signifikante Relaxation (p < 0.05). 
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Ziziphus Projekt 
Glykosylierte Triterpene sind organische Moleküle, die zum Sekundärstoffwechsel von 
Pflanzen sowie anderen Organismen wie marinen Invertebraten gehören. Zur Ziziphus Gattung 
(Rhamnaceae) gehören verschiedene Arten von dornigen Sträuchern und Büschen, deren Blätter 
in der Volksmedizin sowie zur Herstellung von natürlichen Reinigungsmitteln und Shampoo 
verwendet werden. Die phytochemische Charakterisierung von glykosylierten Triterpenen im 
hydroalkoholischen Extrakt aus Ziziphus spina-christi Blättern führte zur Identifizierung von 
zehn Saponinen, von denen drei ein neuartiges Dammaran-Typ Aglykon besitzen. Ihre 
Strukturaufklärung wurde mittels Kombination von leistungsstarken analytischen Verfahren wie 
HPLC-PDA-TOF-MS und hochsensibler Mikro NMR durchgeführt. 
 
ACD Projekt 
 Die technologische Entwicklung von LC-MS Instrumenten führte zu signifikanten 
Verbesserungen in Automation, Leistung, und Empfindlichkeit. Komplexe Proben, wie 
Pflanzenextrakten können jetzt routinemässig und in Hochdurchsatz analysiert werden. Die 
Softwares erlauben effiziente Dekonvolution von hunderte Metaboliten in einem LC-MS 
Chromatogramm, und helfen somit die Informationen über den einzelnen Konstituenten zu 
enthalten. Jedoch, das systematische und unverfälschte Vergleich von grossen Zahlen von 
komplexen LC-MS Chromatogrammen bleibt eine Herausforderung. Die bestehenden 
Computerprogramme für komparatives Processing sind weitgehend in wissenschaftlichen 
Gebieten wie Systembiologie. Trotzdem, ein immer noch zu geringer Einsatz ist zu beobachten in 
Phytochemie und Drug Discovery. Die Gründe dafür sind unterschiedliche und könnten an eine 
ungenügende Benutzerfreundlichkeit oder eine methodenorientierte (MS oder NMR) 
Konfiguration der Mehrheit der verfügbaren metabolomischen Plattformen ansprechen werden. 
Unserer Meinung nach, eine zulässige Alternative zu den existierenden Computerprogrammen 
könnte man in der Implementierung von automatisierter Datenprozessierung und statistischen 
Analysen in Programmpaketen für moderne Drug Discovery suchen. ACD/Labs (Advanced 
Chemistry Development, Inc., Toronto, Canada) ist eine kommerzielle analytische Plattform die 
mit einer breiten Auswahl an Spektralanalysen und prädiktiven Funktionen, wie LC-MS Data-
Prozessierung (ACD/Spectrus®), Metaboliten Identifizierung (ACD/MetaSense®), und in-silico 
Voraussage der pharmakologischen Eigenschaften von Stoffen (ACD/Percepta®) integriert ist. In 
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Kollaboration mit ACD/Labs haben wir ein automatisiertes LC-ESIMS Prozessierung Tool 
entwickelt, und somit die schon stark polyedrische analytische Ausstattung von ACD/Labs weiter 
verbessert. Ausserdem, haben wir eine externe, kostenfreie, on-line Clustering-Plattform in R 
entwickelt, um bei der Darstellung von großen und komplexen Datensätze zu helfen, aber auch, 
um die Cluster-Identifizierung und die Analyse der Metaboliten Verteilung zwischen den Proben 
zu erleichtern. 
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1. AIM OF THE WORK 
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Asthma project 
Asthma exacerbations are acute events characterized by severe respiratory symptoms. Even 
though, diagnosis and treatment of such acute attacks are well managed, their causes are still 
poorly understood. Existing recognized causalities are mostly focused on inflammatory 
processes, though often it is still difficult to correlate inflammation with exacerbation events. The 
physiological regulation of airway constriction and relaxation is driven by the autonomous 
nervous system, somatosensory, and smooth muscular activities and some of the proteins 
involved are the TRPA1 channel and the lipid kinase PIP5Kγ. TRPA1 is located on 
somatosensory neurons and responsible for pain, cold, and itching sensations. Its expression on 
afferent neurons in airways makes TRPA1 an extremely important target for small chemical 
irritants with or without electrophilic character, responsible for airway hyper reactivity to 
contractile stimuli. On the other hand, PIP5Kγ is present in the smooth muscle cells where it 
produces PIP2, a substrate for PLCβ-mediated IP3 production, which induces the release of Ca2+ 
from the sarcoplasmic reticulum, and consequently the smooth muscle contraction. Polyamines 
spermidine and spermine are crucial cofactors for the PIP5Kγ activation, regulated by the co-
localization of the polyamine-catabolizing enzyme spermidine/spermine N1-acetyltransferase. 
Our hypothesis is that plant pollen secondary metabolites could be involved in the non-allergic 
asthma exacerbation process by triggering specific targets in airways, and leading to airways 
constriction. To explore the biological effect of pollen secondary metabolites on airways we 
conducted a comprehensive phytochemical study on pollen originating from thirty different plant 
species, and tested selected pollen extracts and pure compounds on murine dorsal root ganglia 
neurons and on the murine tracheal preparations. 
 
Ziziphus Project 
Saponins are naturally occurring chemical compounds originating from various plant species. 
The chemical peculiarity of this class of plant metabolites resides in the molecular structure 
characterized by an aliphatic (lipophilic) and a polar (hydrophilic) moiety. The resulting 
amphiphilic character of saponins makes them valuable, naturally occurring surfactants and this 
physico-chemical property is employed in pharmaceutical technology, for example to enhance 
the cell membrane penetration of macromolecules, or in cosmetics due to their detersive 
properties. Ziziphus spina-christi (Rhamnaceae) is an evergreen tree, which leaves extract is used 
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in North Africa, the Middle East, and Asia for the preparation of body-care preparations like 
shampoos. Considering the surprisingly little scientific literature about the saponin content in the 
leaves of Z. spina-christi, and its socio-cultural importance in Middle East regions, we performed 
an in-depth phytochemical profiling of saponins by means of HPLC coupled to PDA-ESIMS-
ELSD and microprobe NMR on the hydro-alcoholic extract from Z. spina-christi leaves. 
 
ACD/Labs Project 
Our lab is focused on the discovery of new leads from natural products. This early stage of 
drug discovery comprises extraction and fractionation of crude extracts, and purification of active 
metabolites, which then undergo biological and pharmacological studies for bioactivity 
characterization and evaluation of drug-like properties. This implies the acquisition of analytical 
(e.g. LC-PDA-MS, NMR) and biological (e.g. bioactivity, ADME-Tox) data, for rationalization 
of lead structure with its bioactivity. This multi-step interdisciplinary process is furthermore 
streamlined through consolidated use of computational platforms, like ACD/Labs, integrated with 
a wide range of analytical and predictive functionalities for LC-MS and NMR data, metabolite 
identification, and in silico drug likeliness prediction tools. ACD/Spectrus Processor is a multi-
technique data processing and chemical characterization tool, which besides other functionalities 
allows efficient deconvolution of LC-MS chromatograms to obtain comprehensive information 
on single constituents. Nevertheless, in the current configuration the user is still faced with the 
time-consuming processing and comparison of multiple chromatograms, and representation of 
results in complex tables with a difficult read-out. 
In this project, we developed a two-step protocol consisting of an automated LC-ESIMS batch 
processing tool integrated in ACD/MS Workbook Suite, and a web platform designed for 
clustering and visualization of chromatographic results. The two-step protocol was meant for 
enabling user to perform automated processing and comparison of multiple LC-MS 
chromatograms in a systematic, comprehensive, and unbiased way. This solution is meant to 
represent a valid alternative to existing metabolic platforms like XCMS and MZmine. 
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2. INTRODUCTION 
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2.1 Origin and uses of natural products 
Natural products are very diverse in chemical structure and biological origin. Their biological 
source is wide and belongs to organisms living in marine, freshwater, and terrestrial ecosystems. 
Besides plants, it includes other eukaryotic organisms such as fungi and animals, as well as 
prokaryotic bacteria and archaea. The nature is an important source of low molecular weight 
organic molecules originating from metabolic processes involved in the growth, adaptation, and 
defense of the living organisms. Their synthesis is orchestrated by a plethora of metabolic 
enzymes, regulators of complex biosynthetic pathways, and is able to produce compounds with 
great structural diversity and complexity [1]. 
Since ancient times, plants represent the most important source of natural products to humans in 
form of nutrition but are also an integral part of human culture and health. During the millennia 
of the evolutionary process and still now-a-days, humans have been using natural products from 
eukaryotic fungi, animal, and plant sources but also from prokaryotic bacteria. The 19th Century 
was characterized by great historical changes worldwide at the political, economic, and scientific 
levels. This was also the time when we started to discovering and understanding the rationale 
behind the natural products chemistry and biological activity. The increasing knowledge of 
chemistry and related sciences, led to the duplication, modification, inspiration, and de novo 
synthesis of organic molecules, which were then used and studied for therapeutic uses. Examples 
are penicillin, tetracycline, or streptomycin antibiotics [2], statins like mevastatin from 
Penicillium citrinum, and immunosuppressant drugs from fungi [3], anti-hypertensive and anti-
platelet drugs from animal tissues or venoms [4], and many others. On the other hand, the 
nutritive and health beneficial properties of traditional edible plants are catching an increasing 
interest gained by the scientific community, and are retrieving the people’s perception regarding 
their benefits, especially when originating from wild sources [5]. From ancient times until today, 
besides providing pharmacological and nutritive benefits to humans, plants have played an 
important role in cosmetic preparations varying from skin care to perfumery. Perfumes 
originating from essential oils, skin and anti-aging creams obtained from vegetal oils (e.g. olive 
oil), and shampoos prepared with naturally occurring surfactants are only some examples. 
Nevertheless, the increasing demand for safety and quality of cosmetic products from natural 
sources is pushing the research and development to be constantly up to date with scientific 
knowledge and technologies. Cosmetic products based on natural sources are mostly prepared 
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with extracts, that might be obtained from different biologic origins. The application of extracts 
can result beneficial for a synergistic effect of contained natural products on biologic systems but, 
at the same time, the quality and safety of the preparation cannot be addressed to a specific active 
ingredient. For this reason, appropriate analytical tools are needed [6] in order to determine the 
quality and safety of applied extracts by discriminating the beneficial from deleterious 
metabolites. 
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2.2 Strategies in analysis and discovery of natural products  
The main goal in the natural products research is the identification of molecular entities 
originating from an organism. The purpose of studying the natural products can be very diverse, 
and comprises the discovery of new leads; study of environmental effects on the organism 
metabolome; identification of beneficial or toxic agents in food products; characterization of 
cosmetic products based on natural sources; ect. Depending on the goal of the study, different 
approaches can be undertaken. 
Progress from targeted to comprehensive profiling approach 
Targeted profiling of crude extracts is a holistic approach consisting in a concept of separating 
and identifying specific classes of low molecular weight entities. In the past, this approach was 
based on the extraction, fractionation, and purification of molecules with the final structure 
elucidation performed by nuclear magnetic resonance (NMR) spectroscopy. The monitoring and 
partial identification of metabolites during the fractionation and purification process was 
performed by thin layer chromatography (TLC), where the detection was based on UV light and 
visible light after treatment with visualization reagents, respectively [1-3]. This classical 
approach was appropriate for identifying major phytochemicals belonging to a specific class of 
metabolites. The relatively high limit of detection and the high material loss rate between each 
purification step was demanding relatively large amounts of starting material and was of limited 
applicability for the identification of minor compounds. In fact, the relatively poor separation 
capabilities of gravitational or low pressure chromatography columns, the low sample recovery, 
as well as low detection sensitivity were limiting factors to perform an exhaustive phytochemical 
study. Now-a-days, the cost-extensive and time-consuming targeted approach got relieved in the 
process by modern and powerful analytical technologies. These include chromatographic 
techniques like high performance liquid chromatography (HPLC) or ultra-high performance 
liquid chromatography (UHPLC), which are coupled to photodiode array (PDA), evaporative 
light scattering (ELSD), mass spectrometry (MS), high resolution-mass spectrometry (HR-MS), 
and tandem mass spectrometry (MSn) detectors. HPLC/UPLC-PDA-ESI-ELSD is used as state of 
the art methodology for metabolic studies in extracts originating from edible [4] or medicinal [5] 
plants. The application of sensitive and selective detectors like mass spectrometers brings up the 
detection of a broad variety of analytes present in traces. Besides that, the MS detection enables 
16 
 
the discrimination of co-eluting compounds via deconvolution, a computational process, which 
creates pure spectra for each component. This enables scientist to detect and differentiate 
hundreds of peaks in one chromatogram. The high separation performance and the 
chromatographic reproducibility of liquid chromatographers coupled with different detectors 
significantly accelerated the compound identification process. This led to a new approach in the 
natural products discovery, named as comprehensive metabolic profiling. It enabled the scientists 
the detection and identification of molecular entities characterized by a broad structural variety, 
and the differentiation of metabolites with subtle structural variations. The comprehensive 
metabolite profiling with the aid of computational support went one step further and led to the 
creation of a new concept in the natural product science: the metabolome fingerprinting. This 
approach rather than being used for the identification of metabolites was implemented for the 
comparison of metabolic profiles within or among biologic systems, and with the final goal of 
identifying metabolome patterns. Few more important aspects regarding the metabolic 
fingerprinting approach are described in chapter 2.3. 
HPLC-based activity profiling 
Alternatively to the comprehensive phytochemical study, the HPLC-based activity profiling 
approach is a strategy used in the identification and structural characterization of specific peaks 
in plant extracts or fractions. This is a miniaturized approach to accelerate dereplication and thus 
the discovery of new bioactive compounds in crude extracts. HPLC hyphenated to bioassays 
results in the most widespread method for separation and tracking of natural products bioactivity. 
However, HPLC separation conditions or the bioassay complexity are limiting factors for such 
fully on-line strategies. This can result in a non-applicable method or in a slowed-down process 
caused by the extensive bioassay measurements or bioassays non-applicable at microscales (e.g. 
calcium imaging). Recently, alternative MS-based methods based on detection of ligands binding 
to a specific immobilized target, NMR-based methods revealing ligand interaction with soluble 
proteins, and investigations on a microchip format such as in vitro or in vivo gene expression 
profiling on microarrays have been developed in order to track activity [6].  
Mass spectrometry (MS) 
For an accurate elucidation of molecular structures the molecular weight, molecular formula, and 
structure fragmentation patterns are some of the most important information that can be obtained 
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from the mass spectrometry (MS). The basic principle of the MS method is to provide analytes 
with a charge, make them move through an electrostatic field, and finally measure their 
molecular weight. Nevertheless, depending on the instrument used, this general working principle 
can strongly vary at the technical level of the instrument. Different ionization techniques and 
mass analyzers can provide more or less accurate mass values of the analyte. Some examples of 
ionization techniques are: electron ionization (EI) - the analytes ionization can be obtained 
through an electron beam, which causes the loss of an electron to the analyte producing a cation 
(M + e− =  M+• + 2e−); chemical ionization (CI) – the ionization is obtained by adding a 
charged element obtained from a reagent gas, in this case methane, into the analyte instead of 
knocking out an electron from it (M + CH5
+ =  [M + H]+ + CH4) [7]; electrospray ionization 
(ESI) - the ionization takes place in a nebulizing voltage capillary, which produces a fine spray of 
(multiple) charged solvent droplets containing the analytes [8] (Figure 1A). The charged droplets 
are driven by an electrostatic field towards the cone where the high temperature and an inert 
nebulizing gas continuously reduce the droplets size by solvent evaporation (desolvation). The 
final outcome is the transfer of the charge from the droplet to the analyte, which results in 
creation of ions in a gaseous phase with consequent acceleration towards the mass analyzer [8, 9]. 
The solvent and the neutral molecules are removed from the system by vacuum. Differently from 
the ESI ionization, the atmospheric pressure chemical ionization (APCI) doesn’t produce charged 
droplets (Figure 1B). The nebulization originates from a non-voltage heating capillary at 
atmospheric pressure. The heat induces desolvation of droplets containing neutral analytes until 
transformation of solvent molecules and analytes in the gas-phase. At this point, uncharged 
analyte and solvent molecules enter the region of corona discharge. The much more abundant 
solvent molecules get ionized and some of them transfer the charge to the analyte.  
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Figure 1: Graphical representation of ESI (A) and APCI (B) ionization sources. The red dots represent the charged 
solvent molecules, which after transferring the charge to the analyte become neutral (light blue) (B). 
Depending on the information needed about an analyte, different mass analyzers can be used. 
Triple quadrupole (TQ) systems are suitable for classical metabolites profiling (scan mode) as 
well as analyte quantification and structural studies (selected/multiple reaction monitoring – 
SRM/MRM). In the scan mode all ions are directed to the Q3 where the detector is located and 
the result is shown in a mass chromatogram (Figure 2A). In the SRM mode, the focus is given on 
detection and characterization of one specific analyte. After ionization, the ion of interest gets 
filtered from other ions in the first quadrupole unit (Q1). In the collision cell the selected ion gets 
partially or totally fragmented depending on the strength of the applied collision energy. The so 
obtained fragments can be separated in the Q3 based on their m/z, and finally detected and 
quantified (Figure 2B).  
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Figure 2: Schematic representation of a triple quadrupole (TQ). Full scan analysis allows the analyst to detect all 
ionized molecules carrying a m/z situated within the selected m/z range. This method is useful to detect a wide range 
of analytes with different masses. A possible limiting factor of the full scan detection is the lower detection 
sensitivity, which is indirectly proportional to the m/z scan range if assuming a constant event time (A). SRM 
analysis consists in the detection of a specific m/z, thus enabling a highly specific and sensitive analysis (B).  
 
Differently from the triple quadrupole, ion trap systems are suitable for MSn (tandem mass 
spectrometry) experiments, which are able to produce fragments of fragments and therefore 
provide information on the intramolecular atom connectivity [10]. Time-of-flight (TOF) and 
quantitative time-of-flight (Q-TOF) mass analyzers are instruments designed to deliver accuracy 
in milli mass units range providing accurate masses to calculate the molecular formula of a 
compound. UV spectroscopic data, the accurate mass, and the molecular formula of the analyte 
are fundamental information for a correct interpretation of nuclear magnetic resonance (NMR) 
spectra and for the correct structure assignment of organic compounds.  
Nuclear magnetic resonance (NMR) 
The NMR technique is based on the evaluation of the magnetic properties of atomic nuclei. Since 
organic molecules are principally composed of hydrogen and carbon atoms, only the proton 
NMR (1H NMR) and the carbon NMR (13C NMR) are going to be discussed here. Both 1H NMR 
and the 13C NMR work on same physical principles. Elemental isotopes 1H and 13C are 
characterized by a spin (I) of 1/2. Assuming that the atomic nuclei are spherical, we can imagine 
them spinning around their axis and thus generate a magnetic dipole. By applying an external 
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magnetic field (B0) two spin states are established. The +1/2 represents the magnetic moment of 
the lower energy state and is aligned with the external field, whereas the -1/2 (higher energy spin) 
is opposed to the external field. The energy difference (ΔE) between two spin states is 
proportional to the applied B0 (Figure 3) [11]. Unfortunately, the nuclei are characterized by a 
very low ΔE between the upper (β) and the lower (α) spin state, due to an almost homogenous 
population of spin states (ΔE1, Figure 3A). To detect the net magnetization, namely the 
minuscule difference in population number between the upper and the lower spin states, it is 
necessary to apply stronger B0 (Figure 4B)  Thus, the application of higher external magnetic 
fields results in higher signal-to-noise ratios in the spectrum and consequently in higher 
sensitivity. 
 
 
Figure 3: Distribution of spin state populations between upper (β) and lower (α) energy spin. ΔE0 is observed when 
hypothetically the number of high energy spin states equals the low energy spin states. The increasing difference in 
population number between the upper and the lower spin states results in a higher energy difference (ΔE1 < ΔE2), 
assuming a constant external magnetic field  (A). Energy difference between two neighboring spin states increases in 
a linear manner with an increasing B0 (A) (adapted from [11]).  
Since the discovery of one dimensional NMR spectroscopy by Bloch and Purcell in 1946 (Nobel 
Prize in Physics, 1952) [11], great technical advances have been made in the optimization and the 
increase of sensitivity of this technique. The application of higher magnetic fields together with 
the implementation of Pulse Fourier Transform (PFT) spectroscopy and the optimization of the 
probe performance, made it possible to increase the sensitivity of NMR instruments in order to 
detect naturally less occurring nuclei like 13C and 15N. These technical advances allowed a higher 
sample throughput and smaller quantities of samples needed.  
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For the structural elucidation of the molecule, a wide option of NMR experiments is available, 
depending on the nature of the analyte. The NMR experiments are classified into one-
dimensional 1H NMR and 13C NMR experiments, two-dimensional mononuclear 1H, 1H-
correlation spectroscopy (COSY) (Figure 4A), and heteronuclear 1H, 13C correlation experiments 
like heteronuclear multiple-bond correlation spectroscopy HMBC and heteronuclear single-
quantum correlation spectroscopy (HSQC) (Figure 4B).  
 
 
Figure 4: Examples of detected correlations for COSY (A), and HSQC/HMBC (B). 
 
The correlation spectroscopy (COSY) is a two-dimensional experiment for detection of 
homonuclear correlations in coupled spins (Figure 4A). HMBC and HSQC are standard 
experiments in determining the covalent structure of the compound. HMBC detects heteronuclear 
correlations over longer ranges of about 2 to 4 bonds, whereas HSQC detects correlations 
between nuclei of two different types separated by one bond (Figure 4B). In case of more 
complex structures (e.g. glycosides, aliphatic chains, aliphatic rings), the presence of coupling 
systems results in overlapping signals. To accredit the right scalar coupling between nuclei, 
additional experiments like (1H, 1H)-total correlation spectroscopy TOCSY or (1H,13C)-HSQC-
TOCSY are necessary. At the end, the stereo chemical information of the analyte is provided by 
through-space correlation methods. The nuclear Overhauser effect (NOE) is a transfer of nuclear 
spin polarization through space between two atoms that are in a close spatial proximity, 
independently from the bond connectivity.  
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Figure 5: Diagram showing correlation between the molecular size and the relative increase/decrease of NOE. 
Figure adapted from [12]. 
 
The nuclear Overhauser effect spectroscopy (NOESY) provides a similar spectrum to COSY 
spectrum. However, rather than shoving nuclei that are coupled through-bond, NOESY correlates 
nuclei that are spatially close to each other. For molecules with a molecular weight of around 
1000 Da, the NOE is proximal to zero and therefore non detectable. In this case, measurement of 
rotating-frame nuclear Overhauser effect correlation spectroscopy (ROESY) experiment is a 
valid alternative (Figure 5). 
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2.3 Profiling, comprehensive data analysis, and visualization of mass 
spectrometry data 
 
The term metabolomics describes a systematic study of exclusive metabolite fingerprints in 
biological systems, and is supported by analytical methods like gas and liquid chromatography 
coupled to mass spectrometry (GC/LC-MS), and/or nuclear magnetic resonance spectroscopy [1, 
2]. The American biochemist Roger John Williams (1893 - 1988) formulated for the first time the 
term “metabolic patterns” in the book “Individual metabolic patterns and human disease: an 
exploratory study utilizing predominantly paper chromatographic methods” (1951) [4]. Williams 
and co-authors discussed the correlation of metabolic patterns in saliva and urine samples using 
paper chromatography, and represented the differences in metabolic composition and intensities 
between different samples using vector diagrams (Figure 6).  
 
 
Figure 1: Correlations between salivary constituents and taste sensitivity to sodium chloride (adapted from [4]). 
 
 
Figure 2: GC-MS profile of urinary samples performed by Horning and Horning (adapted from [5]). 
 
The second half of the 20th century was a period where new technologies in the analytical 
chemistry were developed. The following commercialization of new analytical techniques such 
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as gas chromatography coupled to MS in the 1960’s [6] enabled analysis of organic samples with 
higher selectivity, sensitivity, and peak resolution. The following development and modernization 
of GC-MS and other analytical techniques such as LC-MS and NMR expanded their use in the 
analysis of complex organic samples. The evolution of computational tools for analysis of 
chromatographic and spectroscopic data went in parallel with the improvement of analytical 
hardwares. One of the most important achievements in GC/LC-MS data processing was the 
creation in 1999 of AMDIS (Automated Mass Spectrometry Deconvolution and Identification 
System) algorithm, which enabled the automated identification of co-eluting components [7, 8], 
and a consequent discrimination of hundreds of peaks in a single chromatogram. The growing 
need for metabolic studies in complex biological systems demanded for further development of 
computer-assisted strategies in processing and comparison of multiple samples capable of 
accelerating the identification of metabolic differences between samples [9, 10]. This process 
finally evolved in modern free-access and commercial metabolomics platforms like XCMS, 
MetaboAnalyst, and MZmine integrated with multivariate statistics and designed for GC/LC-MS 
data processing, comparison, and visualization. The advanced computational tools gave the 
researchers the possibility to develop modern metabolomics studies in systems biology, like those 
pioneered by Prof. Jeremy Nicholson [11-13]. 
 
 
Figure 3. Example of computational functions in XCMS Metabolomics platform. It includes automatic peak 
detection, nonlinear alignment of chromatograms, peak grouping, and statistical analysis [14].  
 
The most advanced achievements in the metabolomics have been published in 2015 by Sauer and 
Zamboni, and consist in a simultaneous and real-time analysis of hundreds of compounds in cells 
or organisms, skipping the chromatographic separation process [3].  
 
26 
 
References 
1. Karpievitch, Y. V.; et al. Liquid chromatography mass spectrometry-based proteomics: biological and 
technological aspects. Ann. Appl. Stat. 2010, 4, 1797-1823. 
2. Zhou, B.; et al. LC-MS-based metabolomics. Mol. Biosyst. 2012, 8, 470-481. 
3. Link, H.; et al. Real-time metabolome profiling of the metabolic switch between starvation and growth. Nat. 
Methods 2015, 12, 1091-1097. 
4. Individual metabolic patterns and human disease : an exploratory study utilizing predominantly paper 
chromatographic methods. Austin: The University of Texas Publication, 1951. University of Texas Library. 
Web. 27 Apr. 2017. https://repositories.lib.utexas.edu/handle/2152/7023. 
5. Horning, E. C.; Horning, M. G. Metabolic profiles: gas-phase methods for analysis of metabolites. Clin. 
Chem. 1971, 17, 802-809. 
6. Hites, R. A. Development of gas chromatographic mass spectrometry. Anal. Chem. 2016, 88, 6955-6961. 
7. Colby, B. N. Spectral deconvolution for overlapping GC/MS components. J. Am. Soc. Mass Spectrom. 
1992, 3, 558-562. 
8. Stein, S. E. An integrated method for spectrum extraction and compound identification from gas 
chromatography/mass spectrometry data. J. Am. Soc. Mass Spectrom. 1999, 10, 770-781. 
9. Jonsson, P.; et al. A strategy for identifying differences in large series of metabolomic samples analyzed by 
GC/MS. Anal. Chem. 2004, 76, 1738-1745. 
10. Wolfender, J. L.; et al. Plant metabolomics: from holistic data to relevant biomarkers. Curr. Med. Chem. 
2013, 20, 1056-1090. 
11. Nicholson, J. K.; Lindon, J.C. Systems biology: metabonomics. Nature 2008, 455, 1054-1056. 
12. Holmes, E.; et al. Metabolic phenotyping in health and disease. Cell 2008, 134, 714-717. 
13. Nicholson, J. K.; et al. Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. 
Drug Discov. 2002, 1, 153-161. 
14. Johnson, C. H.; et al. Bioinformatics: the next frontier of metabolomics. Anal. Chem. 2014, 87. 
 
 
 
 
 
 
 
 
 
 
 
27 
 
2.4 Saponins as natural products with biological activity and detersive 
properties 
 
Saponins (latin sapo meaning soap) are organic molecules deriving from plants and marine 
invertebrate secondary metabolism [1]. Their molecular structure consists of an apolar agylcon of 
triterpenic (C30), steroidal (C27), or alkaloid nature (e.g. solanine) [2, 3], substituted by 
monoglycosides (monodesmosidic) or glycosidic chains (Figure 1). The name saponin derives 
from the characteristic soap-foaming effect of these organic molecules when strongly shaken in 
water, a phenomenon related to their amphiphilic character.  
 
 
Figure 1. Saponin structure and its amphiphilic character. Compound adapted from [4]. 
 
Saponins are very abundant in plant families like Hippocastanaceae (Aesculus hyppocastanum), 
Araliaceae (Hedera helix, Panax ginseng), Asparagaceae (Ruscus aculeatus), Quillajaceae 
(Quillaja saponaria), and Caryophyllaceae (Saponaria officinalis) [5]. In the past, soap plants 
like Saponaria officinalis (soapwort), were used as a source of natural soaps or detergents for 
laundry and personal hygiene. The use of soap plants for washing purposes goes back to the 
ancient times, and an example worth of consideration is the treatment of the Holy Shroud of 
Tourin with extracts derived from the Saponaria officinalis (Figure 2). The reasons for its 
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extraordinary conservation are still debated, and the delicateness and antifungal properties of the 
characteristic triterpenoid saponins are considered as valid arguments [6].  
 
Figure 2. Shroud of Turin, a piece of cloth bearing the image of the Jesus of Nazareth [7]. 
 
Biosynthesis of saponins 
The isoprene isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate 
(DMAPP) are precursors for the biosynthesis of terpenoids, which constitute one of the largest 
families of natural products derived from plants [8]. Saponins are metabolites biogenetically 
originating from terpenoids, and their structure is characterized by an apolar triterpene derivative 
skeleton conjugated to a polar glycosidic moiety. The IPP/DMAPP biosynthesis follows two 
distinct pathways, namely the mevalonate pathway and the non-mevalonate pathway (Figure 3). 
In higher plants, both biogenetic pathways use the glycolysis-derived pyruvate as precursor for 
the IPP/DMAPP synthesis, although being active in two different cellular compartments. The 
mevalonate pathway operates in the cellular cytosol, whereas the non-mevalonate pathway takes 
part in the chloroplasts [9]. In the mevalonate pathway, the pyruvate is transformed into acetyl-
CoA, which is subject to a series of condensation and reduction steps until forming the mevalonic 
acid. Consequent phosphorylation and decarboxylation steps transform the mevalonate 
(phosphorylated mevalonic acid) into IPP/DMAPP [10]. Differently, the non-mevalonate 
pathway, also called 1-deoxy-D-xylulose-5-phosphate (DOXP) pathway, starts with the 
condensation of pyruvate and glyceraldehyde 3-phosphate resulting in the DOXP-synthase 
(DXS)-mediated formation of DOXP. Additional enzymatically-orchestrated reactions lead to the 
formation of the isoprene IPP/DMAPP [11] (Figure 4), which follow a reductive condensation 
and cyclisation to finally form cyclic triterpenes and steroids. The so formed cyclic hydrocarbons 
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are then functionalized by Cytochrome P450–mediated oxygenation of the scaffold, which finally 
results in a target for type 1 glycosyltransferases responsible for their glycosylation [12].  
 
Figure 3. Biosynthesis of plant natural products with anti-microbial activity [13]. The mevalonate and the non-
mevalonate (DOXP) biosynthetic pathways are described as biogenetic sources of isoprenoids IPP/DMAPP, building 
blocks for the synthesis of terpenes. 
 
Besides being present in higher plants, the DOXP pathway is also operating in other organisms 
like eubacteria, algae, and cyanobacteria. On one hand, the absence of DOPX in mammals made 
the enzymes involved in this pathway interesting pharmacological targets for treatment of 
diseases such as malaria or cryptosporidiosis [14]. On the other hand, other organisms like 
cyanobacteria and E. coli have been characterized as highly performing hosts for the 
heterologous overexpression of specific enzymes [15], or for the engineered biosynthesis of 
natural products, like lycopene and terpenoids [16, 17]. 
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Figure 4. Non-mevalonate biosynthetic pathway of isoprene IPP and DMAPP, precursors in the terpene biosynthesis 
(adapted from [11]). 
 
Bioactivity of saponins  
Saponins are characteristic natural products in foods like beans, potatoes, quinoa, asparagus, and 
blackberries, and comprise a broad range of structurally diverse amphiphilic molecules. Besides 
their soap-like properties they were studied for their biological and pharmacological activities 
like anti-inflammatory [18] and venotonic properties [19]. Anti-microbial and anti-fungal 
properties were also reported, along with anti-tumor [20], and in vitro immunomodulation [21]. 
Another important feature of saponins is attributed to their effects on cell membranes where they 
can strongly affect the membrane integrity by different mechanisms depending on their chemical 
structure. This ability of saponins to modify membrane permeability can be used to facilitate the 
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passage of drug molecules or other natural products through the cell membrane [22], but can also 
result in undesired toxic hemolytic activity [23, 24].  
Although saponins are known to be involved in vital morphological and biochemical processes in 
plants, still very little is known regarding the biological mechanisms controlled by these 
secondary metabolites [25]. On the other side, saponins have gained a lot of attention for their 
therapeutic potential, but also for valuable properties as cosmetic ingredients by increasing the 
function of microvasculature (e.g. Aesculus hippocastanum), and for their detersive properties 
[26]. This wide range of potential applications makes saponins highly interesting secondary 
metabolites, on which still a lot of research is needed for better understanding their biological 
contribution. 
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2.5 Asthma  
Historical aspects of asthma 
The term asthma is known since remote times in ancient Egyptians, Chinese, Japanese, and Greek 
civilities. Asthma as a medical term was already described in the classical period by the Greek 
physician and philosopher Hippocrates (460 – 370 BC) in the Corpus Hyppocraticum, an 
important collection of medical works. The first clinical descriptions of asthma were provided by 
the ancient Greek master clinician Aretaeus of Cappadocia [1, 2]. In the 12th century, Treatise of 
Asthma written by Maimonides (1135-1204 AD) were first documents describing environmental 
factors such as low temperature and air moisture, causing negative effects on asthmatics [3]. 
Further findings about asthma were published in the 17th century by the Belgium physician and 
pneumatic chemist Jean Baptiste Van Helmont (1579-1644 AD). In his posthumous work Ortus 
Medicinae, he described the pipes of the lungs as the anatomical origin of asthma [4]. These 
findings were followed by Bernardino Ramazzini (1633-1714 AD) in De Morbis Artificum 
Diatriba, a work focused on the occupational medicine, where he described the negative 
influence of organic dust on asthma [5]. All these findings were of great importance in order to 
understand the anatomical localization of the disease and its triggers. In parallel, other works 
were conducted on medical observations that were originally not linked to the asthma, such as the 
immune system and its functionality. For the future understanding of asthma pathophysiology, 
important contribution was given by the Viennese pediatrician Clemens von Pirquet Freiher 
(1874–1929), who coined the term allergy as a protective and/or harmful immune system reaction 
[6] and by Prausnitz and Küstner in early 1920’s by discovering the protein reagin [7], an 
antibody found in the blood of individuals that have a genetic predisposition to allergies. These 
were key findings that permitted Johansson and Ishizaka to discover the antibody IgE, and finally 
observe the causality of the serum IgE and asthma. Nowadays, asthma is recognized as a 
syndrome driven by “asthma susceptibility genes” expressed in the epithelium and innate 
immune pathways [8], and characterized by airway inflammation and airway hyper-
responsiveness, where coughing, wheezing, and chest tightness are recognized as common 
symptoms [9]. 
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Pathophysiology of asthma 
The airway in humans is divided in upper and lower respiratory tract and is covered with a 
continuous sheet of epithelial cells. The upper respiratory tract is defined between the larynx and 
the nasal cavity, whereas the lower respiratory tract starts below the larynx and comprises 
trachea, bronchi, and bronchioles. The mucociliary apparatus consists of ciliated and secretory 
cells localized in the lower respiratory tract, and is part of the mechanical defense of the airways 
against inhaled pathogens and allergens. Beside the mucus, the airway epithelium itself 
represents a physical barrier protecting the tissue from the external environment. In this context, 
the airway epithelial tight junctions were revealed to play an integral role with the mucociliary 
apparatus in blocking the passage of allergens and thus mechanically blocking the passage of 
asthma-inducing factors [10]. Nevertheless, the function of the epithelial barrier can be 
compromised by the proteolytic character of many allergens [11] as well as chemicals present in 
the tobacco smoke [10], thus increasing the susceptibility of individuals to asthma. 
Asthma is considered as a heterogeneous disease characterized by different symptoms [12], often 
correlated with the genetic predisposition of individuals and their exposure to environmental 
conditions as well as therapeutic adherence [9]. It results in airway morphological changes as a 
response to tissue injury caused by pathogens, allergens, but also inflammatory mediators 
generated by the immune response. These changes are known as “airway remodeling” and 
include a wide variety of changes at the tissue morphology and cellular function levels including 
(i) epithelial disruption caused by infiltration of inflammatory cells (lymphocytes, eosinophils, 
and mast cells) [13]; (ii) smooth muscle hypertrophy with consequent airway lumen reduction; 
(iii) tissue with excess interstitial fluid (edematous); (iv) blood vessel dilatation, and angiogenesis 
with endothelial swelling; (v) mucus gland hypertrophy with consequent mucus overproduction 
[14]. The past few decades have been characterized by a general decrease in the number of 
hospitalizations of patients suffering from asthma due to advanced sensitization and therapeutic 
programs [15]. Nevertheless, the hospitalization frequency due to an acute exacerbation of 
asthma remains still high [16]. The etiology of acute asthma exacerbations is attributed to 
infections of viral or bacterial origin, allergens, pollutants, and drugs. All this leads to typical 
symptoms such as airway hyper responsiveness and breathing difficulties [17]. Generally, asthma 
is characterized by an immunologic reaction to allergens of different nature. 
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Figure 1. Images of pollen grains (Corylus betulus, up and Ambrosia artemisiifolia, down) recorded by electron 
microscopy at the Zentrum für Mikroskopie (ZMB), University of Basel. 
Plant pollen (Figure 1) are known to induce respiratory allergy and consequent asthma via proteic 
allergens present in the grain. Nicotinamide adenine dinucleotide phosphate (reduced) oxidases, 
bioactive lipid mediators, and other irritants are defined as pollen allergens and are contained in 
pollen fragments able to penetrate lower airways inducing an immune-modulated asthmatic 
response [18]. The pollen characterized with the highest number of allergens belong to families 
of Poaceae, Cupressaceae, Asteraceae, Oleaceae, and Betulaceae, and are restricted to 29 protein 
families (out of 157 characterized pollen proteins, 18%) [19]. The key factor to initiate an 
allergenic response is constituted by the highly affine interaction between the allergen and the 
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host antibody. The presentation of an allergen by antigen-presenting cells induces the release of 
the cytokine IL-4 from the TH2 cell. The interaction between the TH2 and the B cells induces the 
transformation of B cells into plasma cells, which under stimulation of IL-4 secretes the antibody 
IgE. IgE consequently binds to FcεRI receptors present on the surface of basophils and mast 
cells, which results in the cells sensitization to the specific allergen (Figure 2). A later exposure 
to the same allergen followed by its cross-binding to the IgE, will induce mast cell degranulation 
and release of inflammatory mediators such as histamine, cytokines, and prostaglandins. Specific 
structural regions in the protein defined as epitopes are responsible for the recognition of an 
allergen by the antibody. In case of IgE antibodies, responsible for the type 1 hypersensitivity 
[20], high affinity is shown towards conformational epitopes [21]. Besides the allergen-antibody 
affinity, the immunologic reaction can be modulated by other mechanisms. Regulatory T-cells 
(Tregs) are important regulators of the immune response. Namely, Tregs downregulate the 
proliferation of effector T-cells inducing an immunosuppressive reaction [22], and therefore 
maintain a healthy immune response.  
 
 
Figure 2. Allergenic reaction pathway. Early stage type 1 reaction and sensitization process [23].  
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The great multitude of cells and pathways involved in the immunologic and inflammatory 
reaction emphasizes the complexity of an allergy response. Furthermore, the individual genetic 
predisposition for the production of specific antibodies and receptors involved in the 
immunologic cascade makes it hard to predict the final clinical outcome.  
Causes of increased prevalence of asthma and allergy in Western countries 
Based on data presented in the World Health Organization asthma fact sheet (N° 307), last 
updated in 2013, asthma is a non-communicable disease which affects more than 200 million 
people worldwide. These numbers gain more importance if correlated with the worldwide uneven 
distribution of the asthma in single countries. The Global Initiative for Asthma (GINA) program 
performed a worldwide study on the burden of asthma based on literature published in the 
International Study of Asthma and Allergies in Childhood (ISAAC) and the European 
Community Respiratory Health Survey (ECHRS) [24]. These studies revealed a highest asthma 
prevalence in industrialized countries, and were correlated with the so called “westernized 
lifestyle” defined in four points: (1) “paradox of modern housing”. It ascribes the modern housing 
environment (warm and humid) favorable for the proliferation of strong allergens such as house 
dust mite [25]; (2) the “hygiene hypothesis” is being largely discussed and it supports the direct 
correlation of the lower microbial pressure, especially in the early childhood, with a higher 
prevalence of asthma [26, 27]; (3) lot of studies have been performed to understand how the 
sedentary lifestyle and the consequent obesity can be correlated to asthma [28]. Recently, Baffi 
and coworkers [29, 30] tried to give a rationale between asthma and obesity. On the mechanistic 
aspect, they pointed out the increasing accumulation of fat tissue around the chest wall and 
abdomen as a direct cause for losing lung volume capacity. Furthermore, they highlighted the bi-
directional relationship between asthma and obesity (low physical activity leads to obesity, and 
obesity leads to low physical activity); (4) the westernized lifestyle is characterized by an 
increasing consumption of processed food. The “dietary hypothesis” proposes the changes of 
specific nutrients content like antioxidants, lipids, and oligo elements – caused by extensive food 
processing and storage – as contribution to the increase in prevalence of asthma and allergy [31]. 
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2.6 Neuro-muscular pathways regulating airway mechanics 
 
Airway smooth muscle contraction is a result of cyclic cross-bridging of actin and smooth muscle 
myosin, which is regulated by the myosin phosphorylation state. The reversible phosphorylation 
of the myosin is simultaneously coordinated on one side by the myosin light chain kinase 
(MLCK), and on the other side by the myosin light chain phosphatase (MLCP). Increase in 
cytosolic calcium (Ca2+), by modulation of regulatory proteins (e.g. lipid kinase PIP5Kγ) [1], 
induces the messenger protein calmodulin (CaM)-mediated activation of the myosin light chain 
kinase (MLCK), responsible for phosphorylation of the myosin filament. In parallel, RhoA 
directly activates Rho-associated coiled-coil protein kinase (ROCK), which phosphorylates and 
thereby inactivates the myosin light chain phosphatase (MLCP) responsible for myosin de-
phosphorylation, thus dilatation [2]. Besides a direct control of airway smooth muscle contraction 
by activation of regulatory mechanisms in the myocytes, an indirect modulation through the 
sympathetic and para-sympathetic nervous systems also plays a central role. Muscarinic and 
adrenergic receptor subunits are coupled to different G protein subunits, and lead to constriction 
or dilatation of airway. For example, the sympathetic α1 adrenoceptor coupled to the G protein 
subunit Gaq/11 in efferent neurons leads to a phospholipase C (PLC)-mediated increase of 
cytosolic Ca2+ in airway smooth muscle (ASM). Differently, the adrenergic β2 receptor activates 
the subunit Gs resulting in cyclic adenosine monophosphate (cAMP)-mediated decrease of Ca
2+, 
and thus inducing dilatation [3]. The muscarinic receptors (subtypes M1-M5) are also involved in 
the contraction of the ASM, but regulating different pathways. Namely, the stimulation of M1, 
M3, and M5 subtypes promotes the PLC-driven production of inositol triphosphate, which has as 
consequence the increase of cytosolic Ca2+, released from the sarcoplasmic reticulum [4]. On the 
other side, the muscarinic subtypes M2 and M4 are indirectly involved in the ASM contraction 
through the inhibition of the adenylate cyclase, responsible to produce cAMP [1]. Tachykinin 
peptides are neuropeptides involved in many biological processes including neurogenic 
inflammation, mediated by the substance P, and the bronchoconstriction induced by neurokinin A 
[5].  
Furthermore, the ASM contractility was also shown to be remote controlled at the endogenous 
level by many mediators released from organs (Figure 1) [6]. For example, epinephrine (or 
adrenaline) released from the adrenal glands induces a β2-agonist mediated ASM dilatation, 
whereas glucocorticoids showed effects on gene expression of ASM associated with an 
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improvement in airway hyper responsiveness [7]. Leptin, a hormone released from adipose tissue, 
debilitates the parasympathetic constricting effect on ASM through M3 muscarinic receptor [8]. 
On the other hand, the blood factor fibrin has been correlated with an increased Airway Hyper 
Responsiveness in asthma (AHR), caused by a decrease in alveolar surface tension [6]. Guanylin, 
and in a smaller extent uroguanylin, were characterized by relaxing effects on ASM due to 
increased cGMP production [9], whereas insulin, the pancreatic hormone responsible for the 
regulation of blood glucose levels, has been characterized as a mediator in the ASM regulation by 
coordinating the availability of glucose, as energy source for ASM contraction [6]. Besides the 
adrenergic and muscarinic receptors, the voltage-gated ion channels and Transient Receptor 
Potential (TRP) ion channels were characterized as important proteins in the regulation of the 
airway smooth muscle tone. 
 
 
Figure 1. Endogenous mediators contribute to the direct or indirect regulation of airway smooth muscle relaxation or 
contraction. It can result in a direct regulation by contracting or relaxing the airway smooth muscle (ASM), or an 
indirect regulation by modulating the ASM responsiveness to spasmogens and bronchodilators. Mediators like 
estrogen, testosterone, adiponectin, and leptin indirectly control the ASM responsiveness via the parasympathetic 
nervous system [6].  
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Transient receptor potential cation channel, member A1 (TRPA1) 
In 1995 Wes and colleagues characterized for the first time the transient receptor potential 
channel-related protein 1 (TRPC1), a human homolog of trp and with 40% similarity to 
Drosophila TRP [10]. Today, the transient receptor potential (TRP) family of ion channels 
represents an ensemble of 30+ cation channels divided in seven main families, based on sequence 
homology: the TRPC (Canonical), the TRPV (Vanilloid), the TRPM (Melastatin), the TRPP 
(Polycystin), the TRPML (Mucolipin), the TRPA (Ankyrin), and the TRPN (NOMPC - no 
mechanoreceptor potential C) family [11]. The human TRPA1 is expressed in hair cells [12], 
dorsal root ganglia and trigeminal ganglia neurons [13], and was first described as ANKTM1 by 
Story and colleagues in 2003 [14]. TRPA1 is a transmembrane 120-130 kDa protein encoded by 
the trpa1 gene and functions as a homotetramer (four units of TRPA1 protein) (Figure 2) [15]. It 
is a Ca2+ permeable non-selective cation channel and belongs to the large TRP family of ion 
channels, characterized as sensory proteins, and involved in important homeostatic functions. 
TRPA1 is expressed on somatosensory neurons but recently was also found on non-neuronal cells 
like vascular smooth muscle, keratinocytes, and endothelium cells [16]. Both covalent binding of 
electrophiles to nucleophilic cysteine residues, and lock-and-key interaction through non-
covalent intermolecular forces belong to TRPA1 activation mechanisms [17] (Chart 1, Chart 2). 
Each TRPA1 unit of the channel contains 31 cysteines, most of them present on the intracellular 
fragment and all potentially involved in the covalent binding. Nevertheless, only Cys415, 
Cys422, and Cys622 have been shown to be involved in the channel activation in humans (Figure 
3). On the other hand, the murine TRPA1 activation was shown to be modulated by cysteines 
located in regions of the Ankyrin repeat domain different from those in humans [18], sometimes 
showing species-specific biological effects [19]. 
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Figure 2. Human TRPA1 3D density map with side, top, and bottom view [15]. 
 
Figure 3. Schematic representation of TRPA1 dimer with all 31 cysteines present in the protein structure (blue 
circles) [18]. 
 
 
 
 
 
 
 
45 
 
Electrophiles and non-electrophiles with TRPA1 modulation properties 
 
 
Chart 1. Electrophiles from various origins as TRPA1 activators via covalent binding to cysteine and/or lysine 
residues [6]. 
 
 
Chart 2. Non-electrophiles as TRPA1 activators via lock-and-key mechanism [6]. Paracetamol is a non-electrophilic 
compound, which in case of overdose induces depletion of glutathione and undergoes metabolic transformation to 
the electrophilic N-acetyl-p-benzo-quinone imine (NAPQI). 
 
Type I PhosphatidylInositol 4-Phosphate 5-Kinase gamma (PIP5Kγ) 
PhosphatidylInositols (PtdIns) are important secondary messengers in eukaryotic cells involved 
in the regulation of a plethora of cellular functions like cellular metabolism, protein synthesis, 
and vesicle trafficking. The signaling specificity of PtdIns is attributed to the different positions 
and extent of phosphorylation of the inositol ring, which is regulated by phosphatases and 
phosphoinositide lipid kinases (PIKs). PIKs are diversified in three major families: PtIns 3-
kinases (PI3Ks), PtdIns 4-kinases (PI4Ks), and PtdIns-P (PIP) kinases (PIP5Ks and PIP4Ks). 
Type I PIP5K is one of the three PIP kinases and PIP5Kγ (PIP5K1C) is one of them [20]. The 
lipid kinase PIP5Kγ is the most important regulator of intracellular Ca2+ in smooth muscle cells. 
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PIP5Kγ produces phosphatidylinositol 4,5-biphosphate (PIP2), substrate for PLC beta1 mediated 
IP3 production, which induces the release of Ca2+ from the sarcoplasmic reticulum with 
consequent induction of smooth muscle contraction. Spermidine and spermine are crucial 
cofactors for PIP5Kγ and its activation is regulated by co-localization of the polyamine-
catabolizing enzyme spermidine/spermine N1-acetyltransferase (SSAT) (Figure 4) [1]. 
 
 
Figure 4. Schematic representation of lipid kinase PIP5Kγ-mediated Ca2+ release from sarcoplasmic reticulum into 
cytosol. Polyamines spermidine and spermine are co-factors regulating the activity of the PIP5Kγ (A). Ca2+-mediated 
smooth muscle contraction (B) [1]. 
 
In vitro bioassay for assessing intracellular Ca2+ influx 
Calcium is an important biologic messenger regulating many cellular processes with complex 
spatial (cellular compartments) and temporal forms and coordinates the function of multicellular 
systems [21]. The Ca2+ homeostasis is regulated by calcium-regulating hormones [22]. The 
perturbation of the Ca2+ homeostatic state has been in focus of lot of studies and it was suggested 
to be the major cause in neurodegenerative diseases like Alzheimer [23-26] and Parkinson [27], 
and was correlated with the modulation of blood pressure and obesity [28]. The extraordinary 
importance of Ca2+ in many physiological processes led to the development of sophisticated 
strategies to monitor the Ca2+ physiologic dynamics at all levels, from cellular to intact organisms 
[29]. Calcium imaging method implies the cell loading with chemical or genetically encoded 
indicators [30, 31]. By the selection of the appropriate indicator, different aspects must be taken 
into consideration. For example, the binding affinity of the Ca2+ to the indicator is a very 
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important parameter. In fact, depending on the compartmental Ca2+ concentrations an indicator 
with a convenient dissociation constant must be chosen. The different spectral properties of 
different indicators can also significantly influence the final read-out. Single wavelength 
indicators are characterized by changing fluorescent intensities at a stable excitation and emission 
wavelengths, whereas ratiometric indicators have the advantage of shifting their excitation or 
emission curve upon binding. Ca2+ indicators are present in different forms. Salts and dextran 
conjugates both require invasive introduction in the cell, but the dextran conjugates were shown 
to not compartmentalize and thus permitting the cytosolic Ca2+ measurement over a long period 
of time. Acetoxymethyl esters (AM) are a form of indicators that permit an easy cellular loading 
due to their increased lipophilicity [32]. Fura-2AM is a membrane-permeable AM ester 
derivative of aminopolycarboxylic acid (Fura-2). In the cytosol, Fura-2AM gets metabolized by 
esterases to Fura-2, an active calcium-binding ratiometric dye, which is characterized by an 
emission shift after binding to calcium (Figure 5). The intensity ratio is calculated at 
340free/380bound nm, corresponding to wavelengths where difference of fluorescence between 
bound and free indicator is maximum. Recording of intensities and the calculation of ratios is 
performed by sophisticated digital microscopy coupled to advanced computing technologies for 
final data analysis. 
 
 
Figure 5. Molecular structure and chelation mechanism of Fura-2 [32]. 
 
For the in vitro bioassays we used the laboratory mouse strain C57BL/6. This is one of the most used 
mouse strains, from which good models of human diseases can be developed.  
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Isolation and preparation of murine afferent neurons for Ca2+ imaging 
 
 
Figure 6. Schematic workflow for isolation of jugular/nodose neurons from male and female C57BL/6 mice (age 
range: 10 to 16 weeks) After mechanical isolation of dorsal root ganglia and their enzymatic lysis, dissociated 
jugular/nodose neurons are fixed on collagen-coated coverslips and incubated with Fura-2 AM for 24 h. For more 
details, see Bozicevic et al., JNP. 
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In vitro bioassay for assessing tracheal tone modulation 
The murine tracheal rings preparations are being widely used for exploring the physiological and 
pathophysiological mechanisms in airways. In vitro organ bath experiments with wild-type and 
knock-out mice models largely contributed to the functional characterization of Transient 
Receptor Potential (TRP) ion channels [33], muscarinic receptors [34], and for the evaluation of 
different asthmatic phenotypes [35]. The organ bath experiments are performed with specific 
equipment consisting of a tissue bath, force transducer, and an analog to digital converter (A/D). 
The tissue bath is a 10-15 mL flask provided with water jacket for circulating a warming solution 
(37°C), a fritted glass inlet to bubble oxygen (95%/5% O2/CO2 mixture), and inlet and outlet 
ports for changing solutions. The isometric tension of the tracheal ring preparations is measured 
with two stainless steel rods (one fixed and one connected to the force transducer) with an L-
shaped end threaded in the inner part of the ring. Contraction of the trachea creates tension on the 
force transducer, which is converted to a voltage signal at the preamplifier (Figure 7). The 
relaxation can be also measured in this configuration because the tracheal rings are maintained at 
a constant tension of 0.5 grams. Finally, the A/D converter transforms the signal from analog to 
digital, which is then transferred to acquisition software.  
 
 
Figure 7. adapted from [36]. 
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Phytochemical proﬁling of Ziziphus spina-christi leaves led to the characterization of 10 dammarane-type
saponins and 12 phenolic compounds. Isolation was achieved by gel chromatography on Sephadex LH20,
open column chromatography on silica gel, and semi-preparative HPLC with PDA and ELSD detectors.
Structural characterization was performed by extensive 1D and 2D NMR, mass spectrometry, and by GC-
MS of sugar derivatives. A biosynthetic pathway leading to three previously undescribed sapogenins is
proposed. The saponin proﬁles in Z. spina-christi leaves of four different origins were compared by means
of HPLC-ESIMS.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
Ziziphus species (Rhamnaceae) occur in warm-temperate and
sub-tropical regions around the world, and are commonly used in
folk medicine for the treatment of various diseases, such as diges-
tive disorders, weakness, liver complaints, obesity, urinary prob-
lems, diabetes, skin infections, fever, diarrhea, and insomnia
(Abdel-Zaher et al., 2005). Ziziphus spina-christi (L.) Desf. (Christ's
Thorn Jujube, Sedr in Farsi, and Konar in Arabic) is a wild evergreen
tree characterized by spiny branches and small orange fruits that is
native of subtropical eastern Africa, the Middle East, and the Indian
subcontinent, but also widespread in northwestern Africa. In some
countries of the Middle East, leaves of Z. spina-christi are harvested
from the wild or from cultures to be mainly sold on local markets.
The Iranian province of Khuzestan is known for the extensive
cultivation of Z. spina-christi, and leaves are used in Iran as a natural
detergent and shampoo due to the saponin content. Surprisingly,
the phytochemistry of Z. spina-christi leaves is poorly studied, and
only a limited number of polyphenols (Nawwar et al., 1984) and
jujubogenin glycosides have been reported up to now (Mahran
et al., 1996). More information is available regarding theBozicevic), maria.demieri@
nibas.ch (A. Di Benedetto),phytochemical composition of Z. spina-christi and Z. jujuba fruits.
Pawlowska et al. (2009) identiﬁed numerous ﬂavonoids in both
species, and various phenolics, triterpenoids, sterols, cyclopeptide
alkaloids, and amino acids have been reported from Z. jujuba (Gao
et al., 2013). In viewof a possible use of Z. spina-christi leaf extract as
a cosmetic ingredient due to its surfactant properties, a phyto-
chemical analysis of the leaves was performedwith an emphasis on
saponins. Finally, the saponin proﬁles in Z. spina-christi leaf samples
of four different origins were compared by means of HPLC-ESIMS,
in order to assess the variability of saponin patterns.
2. Results and discussion
Leaves of Z. spina-christiwere submitted to sequential extraction
with EtOAc and 35% (v/v) ethanol. After evaporation of the hydro-
alcoholic extract, the residue was suspended in water and parti-
tioned with n-BuOH to remove sugars and other highly polar
compounds. The n-BuOH layer was separated by gel ﬁltration on
Sephadex LH20, open column chromatography on silica gel, and
semi-preparative HPLC to afford ten triterpene saponins 1e10. Of
these, compounds 8e10 contained new dammarane type aglycons.
In addition, eleven phenolic compounds (11e21) were identiﬁed,
including the new quercetin glycoside 11. The HPLC proﬁle of the n-
BuOH layer, and peaks corresponding to compounds 1e21 are
shown in Fig. 1.
Structure elucidation was achieved by means of extensive 1D
and 2D NMR analysis and HRESIMS. In addition, sugar moieties in
Fig. 1. HPLC proﬁle of the n-BuOH layer of Ziziphus spina-christi leaf extract recorded with PDA (254 nm), ELSD, and ESIMS (positive and negative ion mode). Peak numbers
designate saponins 1e10 and polyphenols 11e21.
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after acid hydrolysis followed by derivatization with L-cystein
methyl ester and subsequent silylation, and comparison with
derivatized reference sugars. In case of minor saponins 2e5, 7, 8
and 10, we did not perform a hydrolysis due to the limited amount
of material. We here assume the same absolute conﬁguration of
sugars as found in saponins 1, 6, and 9, given the same nature of
individual sugars, and the relatedness of sugars chains to those in 1,
6 and 9.
Saponins 1 and 2 were identiﬁed as jujuboside B1 (Matsuda
et al., 1999) and christinin A (Mahran et al., 1996) which had
been previously reported from leaves of Z. jujuba and Z. spina-
christi, respectively (Fig. 2).
The negative ion HRESIMS spectrum of 3 showed a signal atm/z
969.5150 [M-H]- corresponding to amolecular formula of C49H78O19
(calcd for C49H77O19: 969.5137). 1D and 2D NMR spectra of 3 were
virtually superimposable to those of 2. The only differences were in
the presence of an oxygenated methine (dH 4.51, br s) in 3 vs a
methylene in 2, and of an acetylmoiety (dH2.05, s; dC 169.5) in 3. The
location of the oxygenated methine at C-22 was inferred from its
COSY correlation with H-23, and corroborated through HMBC cor-
relations with C-17, C-20, and C-21 (Fig. 3). An HMBC correlation of
H-22 with the carboxyl group at d 169.5 established the location of
the acetyl moiety. The relative conﬁguration of the triterpene skel-
eton corresponded to that reported for christinin A (Fig. 2). The
ROESY contact of H-23/H-15a (Fig. 3) indicated a b-orientation of H-
23, while the a-orientation of the 22-acetoxy moiety was inferred
from the small JHH coupling of H-22/H-23 (br s), and corroborated by
the absence of ROESY contacts of H-22/H-17. Thus, the structure of 3
was established as 22a-acetoxy christinin A (Fig. 2).
Saponins 4 and 5 were obtained as an inseparable mixture.
Molecular formula of C49H78O18 and C50H78O20 were deduced from
ions at m/z 953.5161 [M-H]-, (calcd for C49H77O18: 953.5188) and
997.5072 [M-H]-, (calcd for C50H77O20: 997.5086) in the HRESIMS
spectra of 4 and 5, respectively. Inspection of the NMR data
revealed the presence of jujubogenin as aglycon in both saponins,
and of a trisaccharidic moiety that closely resembled that of 2.Additional signals were detected in the mixture of 4 and 5, namely
of a methylene group (dH 3.50, dC 70.7), a methyl group (dH 1.99, dC
21.6) (Fig. S8), and signals attributable to carboxylic groups in the
DEPTq spectrum (d 167.8 and d 168.7) (Fig. S9). Hence, saponins
were esteriﬁed with an acetyl and malonyl moiety, respectively.
The signals corresponding to the CH2-6 of the glucose moiety (dH
4.31 and 4.09/dC 64.7) appeared downﬁeld compared to those in 2
(dH 3.65 and 3.45/dC 61.0), and thereby indicated attachment of the
acyl moieties at this position. The saponins were thus identiﬁed as
jujubogenin 3-b-O-(6-O-acetyl)-b-D-glucopyranosyl-(1/3)-[a-D-
fucopyranosyl-(1 / 2)]-a-L-arabinopyranoside (4) and jujuboge-
nin 3-b-O-(6-O-malonyl)-b-D-glucopyranosyl-(1 / 3)-[a-D-fuco-
pyranosyl-(1/ 2)]-a-L-arabinopyranoside (5), and were named as
christinin A1 and A2, respectively (Fig. 2).
Compound 6 had a molecular formula of C48H80O18, as deduced
from the signal at m/z 943.5363 (calcd for C48H79O18: 943.5345) in
the negative ion HRESIMS spectrum. 1H and 13C NMR spectra
showed the presence of six methyl singlets in the high ﬁeld region
(d 0.74, 0.80, 0.83, 0.93, 1.02, and 1.15), of a 3-methyl-2-butenyl
group (d 1.58 and 1.65, H3-26 and 27; d 5.15, H-24; d 2.13, H2-23),
and of two oxygenated quaternary carbons (d 109.5, C-16; and
d 76.5, C-20). The NMR data of the aglyconwere in good accordwith
those of lotogenin (Renault et al., 1997). In addition, three anomeric
protons were detected in the 1H NMR spectrum at d 4.24 (d,
J ¼ 7.4 Hz), d 5.34 (br s), and d 5.03 (br s), with 13C resonances of
their corresponding carbon atoms at d 104.0, d 98.9, and d 101.0. By
1H-1H-COSY, 1D selective TOCSY, and 2D HSQC-TOCSY experiments
the three sugars spin systems were assigned to one b-glucose and
two units of a-rhamnose, respectively (Table 3). b-Glucose was
identiﬁed by the J values of H-10 to H-50 that showed all-trans
diaxial interactions. The a-rhamnose units were identiﬁed by the
small J values of H-200/H-2000 and their vicinal protons (dd, 3JH-2/H-
3 ¼ 3.6 Hz, and 3JH-2/H-1 ¼ br s) (same for compound 11), while the
13C-NMR shifts of C-30 0/C-3000 (d 71.2 and 70.9) and C-50 0/C-5000 (d 65.9
and 68.8) conﬁrmed the a conﬁguration at the anomeric carbons.
Long range 3JHC HMBC correlations of H-1000 (d 5.03) of Rha II and C-
40 0 (d 78.4) of Rha I, and H-10 0 (d 5.34) of Rha I with C-20 (d 75.0) of
Fig. 2. Structures of saponins 1e10 and ﬂavonoid 11.
A. Bozicevic et al. / Phytochemistry 138 (2017) 134e144136Glc established the trisaccharide chain. ROESY contacts of H-1000 (d
5.03) and H-400 (d 3.33), H-100 (d 5.34) and H-20 (d 3.28) (Fig. 3)
supported this assignment. Attachment of the trisaccharide moiety
at C-3 of the aglycon via a b-oriented glycosidic linkage was infer-
red from the 3JHCHMBC correlation between H-10 (d 4.24) and C-3 (d
88.3) of the aglycon, and by the JHH coupling of H-3 (d 3.03, dd,
J ¼ 11.4, and 4.0 Hz) which was indicative of its axial disposition in
the chair-like conformation. The relative conﬁguration of theaglyconwas identical to that reported for lotogenin, as indicated by
key ROESY correlations (Fig. 3). The absolute conﬁgurations of
glucose and rhamnose were determined as described for com-
pound 1, 6, and 9. Thus, compound 6 was established as lotogenin
3-b-O-a-L-rhamnopyranosyl-(1 / 4)-a-L-rhamnopyranosyl-
(1 / 2)-b-D-glucopyranoside, and was named as lotoside III
(Fig. 2).
A molecular formula of C44H72O15 was assigned to compound 7
Fig. 3. Key 1H-1H ROESY and HMBC correlations in compounds 3e10.
A. Bozicevic et al. / Phytochemistry 138 (2017) 134e144 137on the basis of a molecular ion at m/z 839.4849 in the negative ion
HRESIMS spectrum (calcd for C44H71O15: 839.4871). Inspection of
the NMR data indicated lotogenin as aglycon, and the presence of
an acetyl moiety (dH, 1.98, s; dC 21.6, C-32; dC 169.9, C-31). Attach-
ment of the acetyl group at C-15 was established by an HMBC
correlation of H-15 (d 5.06) to C-31 (d 169.9), and conﬁrmed by the
downﬁeld shift of H-15 compared to H-15 in 6 (d 3.73). The two
sugars moieties in 7 were identiﬁed by COSY and 1D selective
TOCSYexperiments as b-glucopyranoside and a-rhamnopyranoside
(Figs. S18 and S22). Key HMBC correlations of H-100 (d 5.24) and C-20
(d 76.6), H-10 (d 4.23) and C-3 (d 87.8) established the inter-
glycosidic linkage and the attachment of the disaccharide to C-3
of lotogenin (Renault et al., 1997) (Fig. 3). Hence, the structure of 7
was established as 15-acetoxy-lotogenin 3-b-O-a-L-rhamnopyr-
anosyl-(1 / 2)-b-D-glucopyranoside, and the compound was
named as 15-acetoxy lotoside IV (Fig. 2).
Saponin 8 showed a molecular ion at m/z 943.5339 in the
negative ion HRESIMS spectrum, corresponding to a molecular
formula of C48H80O18 (calcd for C48H79O18: 943.5345). Chemical
shifts of three anomeric protons at d 4.25 (d, J¼ 7.4 Hz), d 5.34 (br s),
and d 5.06 (br s) with corresponding carbons at d 103.5, 98.7, and
100.5were identical to those of the sugarmoiety in 6. Analysis of key
HMBC and ROESY correlations conﬁrmed the trisaccharide moiety
as a-rhamnopyranosyl-(1 / 4)-a-rhamnopyranosyl-(1 / 2)-b-glucopyranoside (Fig. 3). Additional resonances detected in the
HSQC and HMBC spectra were eight methyls, seven methylenes,
eight methines, and seven quaternary carbons including a carbonyl
(d 216.1) indicating a lotogenin-like aglycon (Renault et al., 1997).
Compared to lotogenin, compound 8 lacked of the quaternary car-
bon attached to a hemiacetal group (d 109.5). This was replaced by a
carbonyl (d 216.1), as conﬁrmed by HMBC correlations of H-17/C-16
andH-15/C-16 (Fig. 3). Consequently, C-20 andC-22were located on
a side chain, and the spin system was identiﬁed as shown in Fig. 2.
The relative conﬁguration of the triterpene skeleton was corrobo-
rated by key ROESY correlations of H-17/H3-30 and H-13/H-15
(Fig. 3), which established the relative conﬁguration at C-17 and C-
15. However, the relative conﬁguration at C-20 could not be estab-
lished due to the free rotation of the side chain, and limited amounts
of material precluded derivatization. The aglycon was identiﬁed as
3b,15a,20,25-tetraol-dammar-23(24)-ene-16-one, and this new
dammarane-type triterpenoid was named sidrigenin. Thus, com-
pound 8 was sidrigenin 3-O-a-L-rhamnopyranosyl-(1 / 4)-a-L-
rhamnopyranosyl-(1/ 2)-b-D-glucopyranoside (Fig. 2).
Compound 9 showed a molecular ion of m/z 929.5563 in the
negative HRESIMS spectrum corresponding to a molecular formula
of C48H82O17 (calcd for C48H81O17: 929.5552). The sugar moiety was
identical to that of 8, but the aglycon portion was slightly different.
By means of COSY, HSQC, and HMBC experiments C-16 was
A. Bozicevic et al. / Phytochemistry 138 (2017) 134e144138identiﬁed as amethylene (dH 1.82 and 1.24), while themethylene C-
22 in compound 8 (dC 42.3) was replaced by a hydroxylated
methine (dC 75.3). The signal of the only oleﬁnic proton in 9 (d 5.21,
br t, J ¼ 7.0 Hz; H-24) was coupled with a methylene group (d 2.08,
ddd, J ¼ 13.0, 7.0, 3.0 Hz; H-23a; d 1.80, m; H-23b) due to the
presence of a double bond at positions 24 and 25 (Table 2). The
relative conﬁguration of the tetracyclic portion of the aglycon was
established by analysis of J couplings, and conﬁrmed by ROESY data
(Fig. 3). However, the relative conﬁguration at the stereogenic
carbons C-21 and C-22 could not be established by NMR due to the
ﬂexibility of the side chain. Formation of an acetonide (2,2-
dimethoxypropane and catalytic amount of p-toluenesulfonic acid
in dry acetone at r.t. for 2 h) (Ihre et al., 1998) was attempted with
the aglycon after acid hydrolysis, but failed due to decomposition of
the aglycon during the reaction. The aglycon was thus established
as 3b,15a,20,22-tetraol-dammar-24(25)-ene and was named as
konarigenin. Hence, 9 was konarigenin 3-O-a-L-rhamnopyranosyl-Table 1
1H and 13C spectroscopic data for the aglycon moieties of 3e6 (DMSO-d6) (d in ppm, J in
No. 3 4
dH
a dC
b, type dHa dCb, type
1 1.58
0.88, m
38.1, CH2 1.58
0.88, m
38.1, CH2
2 1.71, m
1.54
25.5, CH2 1.71, m
1.54
25.5, CH2
3 3.03,
dd (12.0, 4.0)
86.9, CH 3.03,
dd (12.0, 4.0)
86.9, CH
4 e 39.3, C e 39.3, C
5 0.71 55.1, CH 0.71 55.1, CH
6 1.46
1.39
17.2, CH2 1.46
1.39
17.2, CH2
7 1.47
1.37
35.1, CH2 1.47
1.37
35.1, CH2
8 e 36.5, C e 36.5, C
9 0.83,
br d (12.0)
51.7, CH 0.83,
br d (12.0)
51.7, CH
10 e 36.4, C e 36.4, C
11 1.51
1.34
20.7, CH2 1.51
1.34
20.7, CH2
12 1.69
1.59
27.3, CH2 1.69
1.59
27.3, CH2
13 2.44, m 35.2, CH 2.44, m 35.2, CH
14 e 52.9, C e 52.9, C
15a
15b
1.94, d (8.2)
1.05
35.4, CH 1.94, d (8.2)
1.05
35.4, CH2
16 e 108.5, C e 109.4, C
17 1.10,
br d (6.2)
48.3, CH 0.84 52.8, CH
18 1.03, s 18.0, CH3 1.03, s 18.0, CH3
19 0.79, s 15.7, CH3 0.79, s 15.7, CH3
20 e 68.8, C e 68.8, C
21 0.96, s 24.5, CH3 1.03, s 29.3, CH3
22 4.51, br s 73.3, CH 1.37
1.24
44.2, CH2
23 4.73,
br d (8.0)
67.8,CH 4.59 67.2,CH
24 4.99,
d (8.0)
121.0,CH 5.08, br d (8.0) 125.9,CH
25 e 135.2, C e 133.5, C
26 1.61, s 17.9, CH3 1.61, s 17.9, CH3
27 1.65, s 25.0, CH3 1.65, s 25.0, CH3
28 0.91, s 26.7, CH3 0.91, s 27.6, CH3
29 0.70, s 15.5, CH3 0.70, s 16.0, CH3
30a
30b
3.88
3.78, d (7.2)
64.2, CH2 3.88 d (7.2)
3.78, d (7.2)
64.2, CH2
31 e 169.5, C e e
32 2.05, s 20.3, CH3 e e
a Overlapped 1H-NMR signals are reported without multiplicities.
b 13C shifts were extracted from HSQC and HMBC data.(1 / 4)-a-L-rhamnopyranosyl-(1 / 2)-b-D-glucopyranoside
(Fig. 2).
Compound 10 had a molecular formula of C48H78O18 (m/z
941.5167 in the negative HRESIMS; calcd for C48H77O18: 941.5188).
1H and 13C-NMR chemical shifts of the trisaccharide moiety were
superimposable to those of 6, 8, and 9 (Table 3, Table 4). The aglycon
of 10 showed close similarity to lotogenin, but with differences in
the fragment of C23-C27. The oleﬁnic methine at C-24 of lotogenin
was replaced in 10 by an oxygenated sp3 methine (d 3.95, br s), and
the 2-methylpropenyl in lotogenin was replaced in 10 by an iso-
propylene residue (d 4.89, br s, and 4.71, br s; H-27a and H-27b; and
d 1.66, s, H3-26). Furthermore, an epoxy bridge between C-20 and
C-24 was in accord with the molecular formula and required de-
grees of hydrogen deﬁciency. The relative conﬁguration was
determined by ROESY experiments (Fig. 3). Key ROESY contacts of
H3-21 with H-17 and H-22 established the cofacial orientation of
these groups. Due to the close chemical shifts of H-22 and H-24Hz).
5 6
dH
a dC
b, type dHa dC, type
1.58
0.88, m
38.1, CH2 1.58
0.88, m
39.0, CH2
1.71, m
1.54
25.5, CH2 1.90
1.50
26.1, CH2
3.03,
dd (12.0, 4.0)
86.9, CH 3.03,
dd (11.4, 4.0)
88.3, CH
e 39.3, C e 38.8, C
0.71 55.1, CH 0.68,
br d (12.0)
56.1, CH
1.46
1.39
17.2, CH2 1.41
1.34
17.6, CH2
1.47
1.37
35.1, CH2 1.47
1.35
35.5, CH2
e 36.5, C e 40.6, C
0.83,
br d (12.0)
51.7, CH 1.22, m 50.5, CH
e 36.4, C e 36.5, C
1.51
1.34
20.7, CH2 1.40
1.14
20.6, CH2
1.69
1.59
27.3, CH2 1.68
1.14
25.6, CH2
2.44, m 35.2, CH 1.93, m 34.9, CH
e 52.9, C e 52.2, C
1.94,
d (8.2)
1.05
35.4, CH2 3.73
e
75.6, CH
e 109.4, C e 109.5, C
0.84 52.8, CH 1.69, d (11.4) 61.9, CH
1.03, s 18.0, CH3 1.02, s 16.0, CH3
0.79, s 15.7, CH3 0.80, s 16.6, CH3
e 68.8, C e 76.5, C
1.03, s 29.3, CH3 1.15, s 26.9, CH3
1.37
1.24
44.2, CH2 3.66 87.5, CH
4.59 67.2,CH 2.13, m 27.2, CH2
5.08,
br d (8.0)
125.9,CH 5.15, br t (7.0) 122.5,CH
e 133.5, C e 131.1, C
1.61, s 17.9, CH3 1.58, br s 17.8, CH3
1.65, s 25.0, CH3 1.65, br s 25.7, CH3
0.91, s 27.6, CH3 0.93, s 27.4, CH3
0.70, s 16.0, CH3 0.74, s 15.8, CH3
3.88 d (7.2)
3.78, d (7.2)
64.2, CH2 0.83, s
e
9.5, CH3
e e e e
e e e e
Table 2
1H and 13C spectroscopic data for the aglycon moieties of 7e10 (DMSO-d6) (d in ppm, J in Hz).
No. 7 8 9 10
dH
a dC, type dHa dCb, type dHa dCb, type dHa dCb, type
1 1.57
0.89
38.8, CH2 1.58
0.94
38.5, CH2 1.57
0.92
38.9,CH2 1.58
0.94
39.0, CH2
2 1.89
1.50
26.0, CH2 1.93, m
1.53
25.5, CH2 1.91
1.52
25.6, CH2 1.91
1.52
25.6, CH2
3 3.01, dd (11.4, 4.0) 87.8, CH 3.03. dd (11.5, 4.0) 87.8, CH 3.02, dd (11.5, 4.0) 87.9, CH 3.05, dd (11.4, 4.0) 87.8, CH
4 e 40.6, C e 38.5, C e 38.0, C e 39.3, C
5 0.68, br d (12.0) 55.6, CH 0.73 55.7, CH 0.70, m 55.5, CH 0.71, br d (11.5) 56.1, CH
6 1.37
1.32
17.6, CH2 1.44
1.39
17.0, CH2 1.42
1.33
17.2, CH2 1.45
1.38
17.1, CH2
7 1.42
0.98
34.6, CH2 1.55
1.35
35.0, CH2 1.59
1.40
35.0, CH2 1.44
1.25
35.4, CH2
8 e 40.6, C e 39.6, C e 39.3, C e 40.2, C
9 1.22, m 50.3, CH 1.37, m 50.6, CH 1.25, m 50.6, CH 1.28, m 50.2, CH
10 e 36.5, C e 36.7, C e 36.4, C e 37.5, C
11 1.40
1.13
20.7, CH2 1.51
1.28
20.6, CH2 1.41
1.10
21.0, CH2 1.44
1.16
20.5, CH2
12 1.67
1.18
25.2, CH2 1.81, m
1.30
26.3, CH2 1.74
1.21
27.0, CH2 1.75
1.26
24.8, CH2
13 2.02, m 34.9, CH 2.24, ddd (11.0, 10.3, 3.5) 34.1, CH 1.69, m 39.2, CH 2.07, m 37.5, CH
14 e 52.4, C e 46.6, C e 49.4, C e 53.1, C
15 5.06, br s 76.7, CH 3.95 80.0, CH 3.86, dd (8.5, 8.5) 71.2, CH 4.16, br s 82.0, CH
16 e 109.9, C e 216.1, C 1.82
1.24
32.9, CH2 e 118.7, C
17 1.75, d (11.4) 62.5, CH 1.70, d (10.3) 53.5, CH 1.67 42.9, CH 1.94, d (12.0) 61.0, CH
18 1.02, s 15.9, CH3 1.11, s 15.2, CH3 0.96, s 14.9, CH3 1.00, s 15.9, CH3
19 0.82, s 16.4, CH3 0.85, s 15.9, CH3 0.80, s 16.0, CH3 0.81, s 16.3, CH3
20 e 76.3, C e 72.3, C e 75.3, C e 76.1, C
21 1.15, s 27.2, CH3 1.06, s 15.8, CH3 0.94, s 20.1, CH3 1.18, s 26.9, CH3
22a
22b
3.70
e
87.6, CH 2.32, dd (13.3, 8.0)
2.15, dd (13.3, 6.0)
42.3, CH2 3.20
e
75.3, CH 3.99
e
86.1, CH
23a
23b
2.16, m
e
27.1, CH2 5.49, ddd (15.7, 8.0, 6.0)
e
121.1,CH 2.08, ddd (13.0, 7.0, 3.0)
1.80, m
30.0, CH2 1.60, m
1.50
34.6, CH2
24 5.15, br t (7.0) 122.3,CH 5.56, d (15.7) 142.0,CH 5.21, br t (7.0) 122.6,CH 3.95, br s 70.6,CH
25 e 131.4, C e 68.2, C e 129.8, C e 148.9, C
26 1.58, br s 17.8, CH3 1.14, s 29.8, CH3 1.54, s 17.4, CH3 1.66, s 17.7, CH3
27a
27b
1.65, br s
e
25.6, CH3 1.14, s
e
29.8, CH3 1.65, s
e
25.1, CH3 4.89, br s
4.71, br s
109.0, CH2
28 0.93, s 27.2, CH3 0.94, s 26.8, CH3 0.93, s 27.0, CH3 0.94, s 27.1, CH3
29 0.75, s 16.0, CH3 0.75, s 15.1, CH3 0.73, s 15.3, CH3 0.74, s 15.4, CH3
30 1.00, s 10.1, CH3 0.69, s 9.2, CH3 0.82, s 9.4, CH3 0.81, s 8.7, CH3
31 e 169.9, C e e e e e e
32 1.98, s 21.6, CH3 e e e e e e
a Overlapped 1H-NMR signals are reported without multiplicities.
b 13C shifts were extracted from HSQC and HMBC data.
A. Bozicevic et al. / Phytochemistry 138 (2017) 134e144 139resonances, the relative conﬁguration at C-24 could not be deter-
mined by a ROESY spectrum. Spatial proximity of H3-21 and H3-26
was inferred from a selective ROESY experiment (Fig. S40) that
indicated an a-orientation of the isopropylene group. The new
aglycon of 10 was thus established as (3b,15a,16a,22R,24S)-3,15,16-
triol-16,22:20,24-diepoxy-dammar-25(27)-ene, and named sico-
nigenin. Hence, saponin 10 was identiﬁed as siconigenin 3-O-a-L-
rhamnopyranosyl-(1 / 4)-a-L-rhamnopyranosyl-(1 / 2)-b-D-
glucopyranoside (Fig. 2).
From a biogenetic perspective, the aglycon of 10 can be ratio-
nalized as being formed from aglycons of 8 and 9 via 20,22-
dihydroxy,16-keto-dammar-24,25-ene (a) as a putative intermedi-
ate (Fig. 4). This intermediate would then undergo cyclization to a
hemiketal, and subsequent nucleophilic attack of the C-22 hydroxy
function onto the 24,25 oleﬁn, followed by oxidation/reduction
steps would lead to the aglycon of 10.
Saponin proﬁles of Z. spina-christi leaves of different geograph-
ical origin were compared in order to evaluate possible qualitative
and semi-quantitative differences that might occur. HPLC-ESIMS
chromatograms of the n-BuOH portion of hydroalcoholic extracts
of four samples are shown in Fig. S67. Besides the sample from
Dezful (Iran) that was used in the phytochemical characterization,samples from Caesarea (Israel), Nurabad (Iran), and a commercial
sample purchased in a bazar in Tehran (Iran) were analyzed (Fig. 5).
Jujubogenin glycosides 1e4 were the major saponins in samples
from Caesarea and Nurabad, as compared to glycosides of lotoge-
nin, sidragenin, konarigenin, and siconigenin (compounds 6e10).
The sample purchased at the bazar contained the lowest concen-
tration as well as diversity of triterpene glycosides. Jujubogenin
glycoside 5was a major saponin in the sample fromDezful, but was
not found in the other three samples. Lotogenin glycosides 6 and 7
were absent in the sample from the bazar. Sidrigenin and siconi-
genin glycosides 8 and 10 were present in all samples in compa-
rable concentrations, whereas konarigenin glycoside 9 was
detected only in the samples from Dezful and Nurabad (Fig. 5).
The structure of the previously undescribed ﬂavonol glycoside
11 (Fig. 2) was established as follows. A molecular ionwas observed
atm/z 901.2469 [M-H]- in the HRESIMS spectrum corresponding to
a molecular formula of C42H46O22 (calcd for C42H45O22: 901.2481).
The UV spectrum was typical of a ﬂavonol, with UV absorption
maxima at 273 and 312 nm. The 1H-NMR and 13C-NMR data
(Table 5) showed characteristic signals of quercetin, with three
proton resonances at d 7.62 (dd, J ¼ 8.5 and 2.0 Hz), 7.50 (d,
J ¼ 2.0 Hz), and 6.80 (d, J ¼ 8.5 Hz), and two meta-coupled
Table 3
1H and 13C spectroscopic data for the sugar moieties of 3e6 (DMSO-d6) (d in ppm, J in Hz).
Sugar No 3 4 5 6
dH
e dC
f, type dHe dCf, type dHe dCf, type dHe dC, type
Glca 10 4.33, d (7.7) 102.8, CH 4.33, d (7.7) 102.8,CH 4.33, d (7.7) 102.8,CH 4.24, d (7.4) 104.0,CH
20 3.06, dd (8.5, 7.7) 73.2, CH 3.06, dd (8.5, 7.7) 73.2, CH 3.06, dd (8.5, 7.7) 73.2, CH 3.28, dd (9.0, 7.4) 75.0, CH
30 3.17, dd (9.0, 8.5) 76.6, CH 3.17, dd (9.0, 8.5) 76.6, CH 3.17, dd (9.0, 8.5) 76.6, CH 3.34, dd (9.0, 9.0) 78.3, CH
40 3.11, dd (9.0, 9.0) 69.3, CH 3.11, dd (9.0, 9.0) 69.3, CH 3.11, dd (9.0, 9.0) 69.3, CH 3.09 70.4, CH
50 3.14,
ddd (9.0, 5.0, 2.0)
76.6, CH 3.14,
ddd (9.0, 5.0, 2.0)
76.6, CH 3.14,
ddd (9.0, 5.0, 2.0)
76.6, CH 3.09 76.6, CH
6a0 3.65, br d (11.2, 2.0) 60.8, CH2 4.31 (11.2, 2.0) 64.7, CH2 4.31 (11.2, 2.0) 64.7, CH2 3.65, br d (11.0, 2.0) 61.1, CH2
6b0 3.44, dd (11.2, 5.0) 4.09 (11.2, 5.0) 4.09 (11.2, 5.0) 3.45, dd (11.0, 5.0)
31 e e e 167.8,g C e 168.7,g C e e
32 e e 1.99, s 21.6, CH3 3.50 70.7, CH2 e e
33 e e e e e 168.7,g C e e
Rha Ib 100 e e e 5.34, br s 98.9, CH
200 e e e 3.63, br d (3.6) 70.7, CH
300 e e e 3.68, dd (9.0, 3.6) 71.2, CH
400 e e e 3.33, dd (9.0, 9.0) 78.4, CH
500 e e e 3.97, dq (9.0, 6.0) 65.9, CH
600 e e e 1.11, d (6.0) 18.3, CH3
Rha IIb 1000 e e e 5.03, br s 101.0,CH
2000 e e e 3.71, br d (3.6) 70.7, CH
3000 e e e 3.37 70.9, CH
4000 e e e 3.19, dd (9.0, 9.0) 72.0, CH
5000 e e e 3.49, dd (9.0, 6.0) 68.8, CH
6000 e e e 1.10, d (6.0) 17.8, CH3
Arac 100 4.29, d (6.2) 103.6,CH 4.29, d (6.2) 103.6,CH 4.29, d (6.2) 103.6,CH e
200 3.73, dd (8.5, 6.2) 71.9, CH 3.73, dd (8.5, 6.2) 71.9, CH 3.73, dd (8.5, 6.2) 71.9, CH e
300 3.70, dd (8.5, 3.0) 81.6, CH 3.70, dd (8.5, 3.0) 81.6, CH 3.70, dd (8.5, 3.0) 81.6, CH e
400 3.87, m 66.6, CH 3.87, m 66.4, CH 3.87, m 66.4, CH e
5a0 0 3.68 64.3, CH2 3.68 64.3, CH2 3.68 64.3, CH2 e
5b0 0 3.39 3.39 3.39
Fucd 1000 5.31, br s 100.0,CH 5.31, br s 100.0,CH 5.31, br s 100.0,CH e
2000 3.63, br d (6.0) 70.1, CH 3.63, br d (6.0) 70.1, CH 3.63, br d (6.0) 70.1, CH e
3000 3.60, m 65.0, CH 3.60, m 65.0, CH 3.60, m 65.0, CH e
4000 3.56, m 72.1, CH 3.56, m 72.1, CH 3.56, m 72.1, CH e
5000 4.11, br q (6.2) 66.0, CH 4.11, br q (6.2) 66.0, CH 4.11, br q (6.2) 66.0, CH e
6000 1.07, d (6.2) 16.5, CH3 1.07, d (6.2) 16.0, CH3 1.07, d (6.2) 16.0, CH3 e
a Glc ¼ b-D-glucopyranosyl.
b Rha ¼ a-L-rhamnopyranosyl.
c Ara ¼ a-L-arabinopyranosyl.
d Fuc ¼ b-D-fucopyranosyl.
e Overlapped 1H-NMR signals are reported without multiplicities.
f 13C shifts were extracted from HSQC and HMBC data.
g Interchangeable spin systems of sugars were resolved by 1D selective TOCSY and 2D HSQC-TOCSY.
A. Bozicevic et al. / Phytochemistry 138 (2017) 134e144140resonances at d 6.37 (br s) and 6.19 (br s) attributable to rings B and
A, respectively. Three anomeric protons at d 5.53 (d, J¼ 7.8 Hz), 5.12
(br s), and 4.40 (br s) indicated the presence of 3 sugars. By 1H-1H-
COSY, 1D selective TOCSY, and 2D HSQC-TOCSY experiments the
three sugars spin systems were assigned to one b-galactose and
two a-rhamnose units (Table 5). The b-galactosyl residue was
characterized by J values of H-100 (d 5.53, d, JH-1/H-2 ¼ 7.8 Hz) and H-
300 (d 3.62, dd, JH-3/H-2 ¼ 9.0 Hz, JH-3/H-4 ¼ 3.5 Hz). The two rham-
nosyl residues were identiﬁed from the vicinal coupling constants
of H-2000/H-200 00 (dd, 3JH-2/H-3 ¼ 3.2 Hz, 3JH-2/H-1 ¼ br s), and the a
conﬁguration was established on the basis of the 13C-NMR shifts of
C-3000/C-30 000 (d 68.0 and 70.5) and C-5000/C-50 00 0 (d 65.5 and 67.8)
(Agrawal et al., 1985). The linkage position of sugar residues was
established by HMBC and 2D ROESY data (Figs. S41 and S45). HMBC
correlations between H-10 0 (d 5.53) and C-3 (d 135.0) indicated that
the galactose unit was attached to the hydroxyl group at C-3 of the
ﬂavonoid. Likewise, the HMBC correlation between H-1000 (d 5.12)
and C-20 0 (d 75.1) established the fragment of a-rhamnopyranosyl-
(1/ 2)-b-galactopyranoside. The downﬁeld shift of H-4000 (d 4.83)
and its HMBC correlation with a carboxyl carbon (d 165.7) revealed
that the Rha I unit was esteriﬁed at C-4000 by a trans-p-coumaroyl
moiety. The attachment of the second a-rhamnose was established
by a NOESY contact between the methylenic proton of CH2-6b00 of
Gal (d 3.25, m) and H-10 000 (d 4.40, br s) of Rha II. Hence, compound11 was identiﬁed as quercetin 3-O-(4-O-trans-p-coumaroyl)-a-L-
rhamnopyranosyl-(1 / 2)-[a-L-rhamnopyranosyl-(1 / 6)]-b-D-
galactopyranoside.
Phenolic compounds 12e21 were identiﬁed on the basis of UV,
ESIMS, and NMR data comparison as: 30,50-di-C-b-glucosylphlor-
etine (12) (Ogawa et al., 2001), quercetin 3-O-b-xylopyranosyl-(1/
2)-a-rhamnopyranoside 40-O-a-rhamnopyranoside (13) (Nawwar
et al., 1984), epigallocatechin (14) (Liao et al., 2014), gallocatechin
(15) (Nomizu et al., 2008), quercetin 3-O-a-rhamnopyranosyl-
(1 / 6)-a-rhamnopyranosyl-(1 / 2)-b-galactopyranoside (16)
(Yasukawa et al., 1989), prodelphinidin (17) (Fujii et al., 2013),
quercetin (18) (Shul'ts et al., 2012), kaempferol 3-O-robinobioside
(19) (Pawlowska et al., 2009), kaempferol 3-O-rutinoside (20)
(Kazuma et al., 2003), quercetin 3-O-a-arabinosyl-(1 / 2)-a-
rhamnoside (21) (Nielsen et al., 2005).
3. Conclusions
A phytochemical proﬁling of Z. spina-christi leaves led to the
characterization of 10 dammarane-type saponins and 12 known
polyphenols. Eight saponins (3e10) are reported here for the ﬁrst
time. For the three previously undescribed aglycons in saponins
8e10, a possible biosynthetic pathway leading from 8 and 9 to the
unprecedented bis-tetrahydrofurane moiety in 10 is proposed.
Table 4
1H and 13C spectroscopic data for the sugar moieties of 7e10 (DMSO-d6) (d in ppm, J in Hz).
Sugar No 7 8 9 10
dH
c dC, type dHc dCd, type dHc dCd, type dHc dCd, type
Glca 10 4.23, d (7.4) 103.9,CH 4.25, d (7.4) 103.5,CH 4.25, d (7.7) 103.3,CH 4.25, d (7.4) 103.5,CH
20 3.24, dd (9.0, 7.4) 76.6, CH 3.28, dd (9.0, 7.4) 75.0, CH 3.27, dd (9.0, 7.7) 74.9, CH 3.28, dd (9.0, 7.4) 75.0, CH
30 3.31, dd (9.0, 9.0) 78.2, CH 3.34, dd (9.5, 9.0) 77.9, CH 3.33, dd (9.5, 9.0) 78.0, CH 3.34, dd (9.0, 9.0) 78.3, CH
40 3.09 70.5, CH 3.09 70.2, CH 3.09 70.1, CH 3.07 70.2, CH
50 3.09 76.1, CH 3.09 76.2, CH 3.09 76.0, CH 3.09 76.2, CH
6a0 3.64, br d (11.0) 61.1, CH2 3.65, br d (11.0) 60.8, CH2 3.65, br d (11.0) 60.5, CH2 3.66, br d (11.0) 61.1, CH2
6b0 3.47, dd (11.0, 5.0) 3.44, dd (11.0, 5.0) 3.45, dd (11.0, 5.0) 3.45, dd (11.0, 5.0)
RhaIb 100 5.24, br s 99.8, CH 5.34, br s 98.7, CH 5.33, brs 98.4, CH 5.33, br s 98.7, CH
200 3.73, br d (3.6) 70.7, CH 3.62, br d (3.6) 70.5, CH 3.64, dd (3.6) 70.3, CH 3.63, br d (3.6) 70.7, CH
300 3.49, dd (9.0, 3.6) 71.2, CH 3.68, dd (9.0, 3.6) 70.7, CH 3.68, dd (9.0, 3.6) 70.6, CH 3.68, dd (9.0, 3.6) 71.1, CH
400 3.19, dd (9.0, 9.0) 78.4, CH 3.34, dd (9.0, 9.0) 78.0, CH 3.33, dd (9.0, 9.0) 78.0, CH 3.34, dd (9.0, 9.0) 78.2, CH
500 3.81, dq (9.0, 6.0) 65.9, CH 3.97, dq (9.0, 6.0) 65.6, CH 3.96, dq (9.0, 6.0) 65.5, CH 3.98, dq (9.0, 6.0) 65.9, CH
600 1.07, d (6.0) 17.9, CH3 1.11, d (6.0) 17.7, CH3 1.10, d (6.0) 17.8, CH3 1.10, d (6.0) 17.6, CH3
RhaIIb 1000 e 5.06, br s 100.5,CH 5.06, br s 100.4,CH 5.06, br s 100.8,CH
2000 e 3.69, br d (3.5) 70.4, CH 3.71, br d (3.5) 70.3, CH 3.71, br d (3.5) 70.6, CH
3000 e 3.39, dd (9.0, 3.5) 70.4, CH 3.38, dd (9.0, 3.5) 70.4, CH 3.38, dd (9.0, 3.5) 70.5, CH
4000 e 3.19, dd (9.0, 9.0) 71.9, CH 3.19, dd (9.0, 9.0) 71.6, CH 3.19, dd (9.0, 9.0) 72.0, CH
5000 e 3.49, dq (9.0, 6.0) 68.3, CH 3.48, dq (9.0, 6.0) 68.2, CH 3.49, dq (9.0, 6.0) 68.8, CH
6000 e 1.11, d (6.0) 17.3, CH3 1.10, d (6.0) 17.4, CH3 1.10, d (6.0) 17.6, CH3
Spin systems of sugars were resolved by 1D selective TOCSY and 2D HSQC-TOCSY.
a Glc ¼ b-D-glucopyranosyl.
b Rha ¼ a-L-rhamnopyranosyl.
c Overlapped 1H-NMR signals are reported without multiplicities.
d 13C shifts were extracted from HSQC and HMBC data.
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distinct leaf samples showed that lotogenin glycosides were the
major saponins and occurred in all samples analyzed, while gly-
cosides of the other aglycons were more restricted in occurrence.
4. Experimental section
4.1. Solvents and chemicals
For extraction and column chromatography technical grade
solvents (Scharlau, Spain) were used after distillation, and HPLC
grade solvents (Macron, Norway) were used for HPLC. HPLC grade
water was obtained from an EASY-pure II water puriﬁcation system.
DMSO was from Scharlau (Spain). Deuterated solvents were pur-
chased from Armar Chemicals (Switzerland). Sephadex LH-20 was
purchased from GE Healthcare. Silica gel 60 (40e63 mm, 70e230
mesh ASTM) was from Merck (Germany).
4.2. Plant material
Z. spina-christi leaves were originating from the province of
Khuzestan, Dezful County, Iran. Leaves were collected in February
2014 by Mr. Hamid Ranjbar, and identiﬁed by Dr. Ali Sonboli,
Department of Biology, Medicinal Plants and Drugs Research
Institute, Shahid Beheshti University, Tehran, Iran. A voucher
specimen (MPH-2409) has been deposited at the Herbarium of the
Medicinal Plants and Drugs Research Institute, Shahid Beheshti
University, Tehran. The samples originating from Caesarea (Israel),
Nurabad (Iran), and a sample purchased from a bazar in Tehran
(Iran) were provided by Mibelle AG, Buchs, Switzerland.
4.3. NMR spectroscopy
NMR spectra were recorded on a 500 MHz Avance III™ spec-
trometer (Bruker BioSpin) equipped with a 1 mm TXI microprobe
(1H-NMR) or a 5 mm BBO probe (13C-NMR) at 18.0 and 23.0 C,
respectively. Standard pulse sequences of the software package
Topspin 3.0 were used.4.4. HPLC analysis
HPLC proﬁling of extracts was carried out on a HPLC system
(Shimadzu, USA) (system 1) consisting of a degasser, binary high
pressure mixing pump, column thermostat, PDA detector (SDP-
M20A) with thermostatted UV cell, and a triple quadrupole MS
with ESI interface (ESIMS) (LCMS-8030) coupled via T split. Both
positive and negative ion HPLC-ESIMS spectra were simultaneously
recorded in the range of m/z 160 to 1500; capillary voltage: 4.5 V;
scan speed: 6000 u/sec; event time: 0.150 s. The second line of the
T-splitter was connected to an Alltech 3300 evaporative light
scattering detector. ELSD conditions were as follows: nitrogen ﬂow:
2.5 l/min, temperature: 55 C, detector gain: 8. Data acquisition and
analysis were performed with LabSolutions software (Shimadzu,
USA).
High-resolution spectrawere recordedwith amicrOTOF (Bruker
Daltonic, Germany) mass spectrometer with ESI interface (Bruker)
connected to an 1100 series HPLC (Agilent, USA) (system 2). Spectra
were recorded in both positive and negative mode in the range of
m/z 160 to 1500; capillary voltage: 4.0 V in positive and 3.0 V in
negative mode. For calibration, a reference solution of sodium
formate 0.1% (m/v) in iso-PrOH/H2O (1:1) containing 5 mM NaOH
was used. Data acquisition and processing were performed using
HyStar 3.0 software (Bruker).
The n-BuOH fraction was dissolved in MeOH at a concentration
of 10 mg/ml and ﬁltered. Separation conditions for the n-BuOH
fraction were: SunFire C18 column (3.5 mm, 150  3.0 mm I.D.)
(Waters, Ireland) equipped with a guard column (20.0  3.0 mm
I.D.); mobile phase A: H2Owith 0.1% (v/v) formic acid, mobile phase
B: MeCN with 0.1% (v/v) formic acid; gradient proﬁle: 15% B iso-
cratic for 2 min, 15e70% B in 18 min, 100% B in 5 min; ﬂow rate:
0.4 ml/min; column temperature: 25.0 C; sample injection vol-
ume: 6 ml.4.5. Extraction and isolation
Dried leaves of Z. spina-christi (900 g) were ground with a RLB
mill (Rotor AG, Switzerland) and extracted by maceration with
Fig. 4. Proposed biosynthesis of aglycon in saponin 10.
Fig. 5. 2D heat map representing semi-quantitative distribution of saponins 1e10 in
leaf samples of four different origins.
A. Bozicevic et al. / Phytochemistry 138 (2017) 134e144142EtOAc (2  2 l), followed by 35% EtOH v/v (3  4 l). After evapo-
ration 30 g of EtOAc and 119 g of 35% ethanolic extracts were ob-
tained. For the ethanolic extract, ﬁfteen aliquots of 7 g each weresuspended in distilled water (600 ml), ultrasonicated for 15 min,
and partitionedwith n-BuOH (3 200ml). After evaporation a total
of 64 g of aqueous and 24 g of n-BuOH fraction were obtained
(Fig. S68).
A portion of the n-BuOH fraction (12 g) was separated on a
Sephadex LH-20 column (100  7 cm, I.D.) eluted with MeOH at a
ﬂow rate of 1.5 ml/min using the B-688 pump (Büchi, Switzerland).
Fractions were collected with a SuperFrac fraction collector (Phar-
macia Biotech, Sweden). A total of 11 fractions (A-K) were com-
bined on the basis of TLC patterns. The saponin containing fraction
A (2.9 g) was further separated on an open column (75 4 cm, I.D.)
packed with silica gel 60 (40e63 mm, 300 g). Separation was per-
formed with a step gradient of CHCl3-MeOH-H2O 80:20:2 (1 l),
75:30:3 (1 l), and 65:35:3.5 (1 l) at a ﬂow rate of 5 ml/min. The
eluate was combined in fractions A1-A13 based on TLC pattern.
Fractions A2 (15.7mg), A3 (44.1mg), A5 (38.4 mg), A6 (23.3mg), A7
(98.2 mg), A9 (72.8 mg) A11 (59.7 mg), A12 (45.5 mg) were selected
for ﬁnal puriﬁcation of compounds. This step was achieved by HPLC
utilizing an Alliance 2690 instrument (Waters, USA) coupled via a
T-splitter to an Alltech 2000ES (USA) evaporative light scattering
detector (system 3). Separations were carried out at 25 C on a
SunFire C18 column (5 mm, 150  10 mm, I.D.) (Waters, Ireland)
equipped with a pre-column (10  10 mm, I.D.). Gradients of H2O/
MeCN were used. The ﬂow-rate was 4 ml/min. Finally, we obtained
compound 1 (3.2 mg) and compound 2 (5.1 mg) from A3; com-
pound 3 (2.8 mg) from A2; compounds 4e5 (2.1 mg) from A6;
compound 6 (2.2 mg) from A7; compound 7 (2.8 mg) from A5;
compound 8 (1.7mg) fromA9; compound 9 (1.7 mg) fromA11-A12;
compound 10 (1.3 mg) from A11. Sephadex fractions B-K contained
polyphenolic compounds. Compound 11 (4.7 mg) from fraction D
(300.1 mg), 12 (4.3 mg) and 13 (6.2 mg) from fraction E (273.4 mg),
and 14 (14.8 mg) and 15 (12.7 mg) from fraction H (283.6 mg) were
isolated by means of semi-preparative HPLC. Compounds 16e22
were identiﬁed in fractions B-C, F-G, I-K comparing their UV spectra
and MS spectroscopic data with those available in literature.
4.5.1. 22a-Acetoxy-christinin A (3)
Amorphous white solid; [a]25Na -27.9 (c 0.05, MeOH); for 13C
NMR and 1H NMR spectroscopic data, see Table 1 and Table 3;
(-)-ESIMS m/z 969; (-)-HRESIMS m/z 969.5150 [M-H]- (calcd for
C49H77O19: 969.5137).
4.5.2. Christinin A1 (4); christinin A2 (5)
Amorphous white solid; for 13C NMR and 1H NMR spectroscopic
data, see Tables 1 and 3; (-)-ESIMS m/z 953; (-)-HRESIMS m/z
953.5161 [M-H]- (calcd for C49H77O18: 953.5188) (4). ESIMS m/z
997; (-)-HRESIMS m/z 997.5072 [M-H]- (calcd for C50H77O20:
997.5086) (5).
4.5.3. Lotoside III (6)
Amorphous white solid; [a]25Na -50.4 (c 0.12, MeOH); for 13C
NMR and 1H NMR spectroscopic data, see Tables 1 and 3; (-)-ESIMS
m/z 943; (-)-HRESIMS m/z 943.5363 [M-H]- (calcd for C48H79O18:
943.5345).
4.5.4. 15-Acetoxy-lotoside IV (7)
Amorphous white solid; [a]25Na -36.2 (c 0.31, MeOH); for 13C
NMR and 1H NMR spectroscopic data, see Tables 2 and 4; (-)-ESIMS
m/z 839; (-)-HRESIMS m/z 839.4849 [M-H]- (calcd for C44H71O15:
839.4871).
4.5.5. Sidrigenin 3-O-a-L-rhamnopyranosyl-(1/4)-a-L-
rhamnopyranosyl-(1/ 2)-b-D-glucopyranoside (8)
Amorphous white solid; [a]25Na -76.8 (c 0.14, MeOH); for 13C
NMR and 1H NMR spectroscopic data, see Tables 2 and 4; (-)-ESIMS
Table 5
1H and 13C spectroscopic data of 11 (DMSO-d6) (d in ppm, J in Hz).
No. aglycon sugars
dH dC
c, type dHe dCc, type
2 e 156.1, C Gala 100 5.53, d (7.8) 99.1, CH
3 e 135.0, C 200 3.86, dd (9.0, 7.5) 75.1, CH
4 e d 300 3.62, dd (9.0, 3.5) 73.5, CH
5 e d 400 3.62, d (3.7) 68.3, CH
6 e d 500 3.57 73.1, CH
7 6.19, br s 98.7, CH 6a0 0 3.59 65.0, CH2
8 e 165.0, C 6b0 0 3.25
9 6.37, br s 93.4, CH
10 e 100.5, C Rha Ib 1000 5.12, br s 100.0,CH
10 e d 2000 3.85, dd (3.2, br s) 70.7, CH
20 7.50, d (2.0) 115.5, CH 3000 3.87, dd (9.0, 3.2) 68.0, CH
30 e 145.4, C 4000 4.83, dd (9.0, 9.0) 73.6, CH
40 e 147.8, C 5000 4.14, dq (9.0, 6.0) 65.5, CH
50 6.80, d (8.5) 115.0, CH 6000 0.73, d (6.0) 16.5, CH3
60 7.62, dd (8.5, 2.0) 121.2, CH
10 0 0 0 0 e 125.5, C Rha IIb 10 0 0 0 4.40, br s 99.8, CH
20 0 0 0 0 7.36, d (8.0) 130.0, CH 20 0 0 0 3.42, dd (3.2, br s) 70.1, CH
30 0 0 0 0 6.79, d (8.0) 115.3, CH 30 0 0 0 3.32, dd (9.0, 3.2) 70.5, CH
40 0 0 0 0 e 159.5, C 40 0 0 0 3.10, dd (9.0, 9.0) 71.5, CH
50 0 0 0 0 6.79, d (8.0) 115.3, CH 50 0 0 0 3.37, dq (9.0, 6.0) 67.8, CH
60 0 0 0 0 7.36, d (8.0) 130.0, CH 60 0 0 0 1.06, d (6.0) 17.5, CH3
70 0 0 0 0 7.35, d (16.0) 143.8, CH
80 0 0 0 0 6.23, d (16.0) 114.0, CH
90 0 0 0 0 e 165.7, C
Spin systems of sugars were resolved by 1D selective TOCSY and 2D HSQC-TOCSY.
a Gal ¼ b-D-galactopyranosyl.
b Rha ¼ a-L-rhamnopyranosyl.
c 13C shifts were extracted from HSQC and HMBC data.
d Not detected.
e Overlapped 1H-NMR signals are reported without multiplicities.
A. Bozicevic et al. / Phytochemistry 138 (2017) 134e144 143m/z 943; (-)-HRESIMS m/z 943.5339 [M-H]- (calcd for C48H79O18:
943.5345).
4.5.6. Konarigenin 3-O-a-L-rhamnopyranosyl-(1/4)-a-L-
rhamnopyranosyl-(1/ 2)-b-D-glucopyranoside (9)
Amorphous white solid; [a]25Na -30.4 (c 0.16, MeOH); for 13C
NMR and 1H NMR spectroscopic data, see Tables 2 and 4; (-)-ESIMS
m/z 929; (-)-HRESIMS m/z 929.5563 [M-H]- (calcd for C48H81O17:
929.5552).
4.5.7. Siconigenin 3-O-a-L-rhamnopyranosyl-(1/ 4)-a-L-
rhamnopyranosyl-(1/ 2)-b-D-glucopyranoside (10)
Amorphous white solid; [a]25Na -30.7 (c 0.26, MeOH); for 13C
NMR and 1H NMR spectroscopic data, see Tables 2 and 4; (-)-ESIMS
m/z 941; (-)-HRESIMS m/z 941.5167 [M-H]- (calcd for C48H77O18:
941.5188).
4.5.8. Quercetin 3-O-(4-O-trans-p-coumaroyl)-a-L-
rhamnopyranosyl-(1/ 2)-[a-L-rhamnopyranosyl-(1/ 6)]-b-D-
galactopyranoside (11)
Amorphous yellow solid; [a]25Na -57.2 (c 0.12, MeOH); UV
(MeOH) lmax (log ε) 273 (2.95), 312 (4.01) nm; 1HNMR and 13C NMR
data, see Table 5; (-)-ESIMSm/z 901; (-)-HRESIMSm/z 901.2469 [M-
H]- (calcd for C42H45O22: 901.2481).
4.6. Acid hydrolysis and sugar analysis
Hydrolysis of sugars and GC-MS analysis of derivatives was
performed according to Abbet et al. (2011). Compounds 1 (0.8 mg),
6 (1.5 mg), 9 (1.7 mg), and 11 (1.2 mg) were hydrolyzed separately.
After heating at 100 C for 1 h in 2 M TFA (1 ml), the mixture was
extracted with CH2Cl2 (3  1.0 ml). The aq. phase was freeze-dried,
and re-dissolved in dry pyridine (200 ml) containing 5 mg/ml L-cysteine methyl ester hydrochloride. The reaction mixture was
heated at 60 C for 1 h, followed by silylation with hexamethyldi-
silazane and chlorotrimethylsilane (Fluka) in pyridine (3:1:10,
300 ml) at 60 C for 30 min (Chai et al., 2007). After silylation,
pyridine was evaporated, and the solid residue extracted with n-
hexane. GC-MS analysis was performed on a 5890 Series II gas
chromatograph coupled to a HP 5971A mass detector (Hewlett
Packard, USA). The separation was carried out on a DB-225 MS
column (30 m  0.25 mm, I.D., Waters, USA); column temp. 150 C
for 2 min, then gradient of 58 C/min to 210 C, then 10 C/min to
240 C. Comparison of the retention times of derivatized reference
sugars with those obtained from samples resulted in L-arabinose
(Rt 24.48 min), D-glucose (Rt 28.64 min). D-xylose (Rt 24.47 min),
and D-fucose (Rt 25.96 min) in compound 1, and D-glucose (Rt
28.64 min) and L-rhamnose (Rt 25.66 min) in compound 6. Sugars
in 9 and 11were analyzed at a different time and were identiﬁed as
D-glucose and Lerhamnose (9), and L-rhamnose (24.49 min) and
D-galactose (26.04 min) (11). Derivatives of L-arabinose (Rt
24.48 min) and D-xylose (Rt 24.47 min) had very similar retention
times resulting in peak overlapping. Conﬁrmation of L-arabinose
and D-xylose in 1was obtained in a subsequent spiking experiment
with derivatized reference sugars leading to unambiguous sepa-
ration (D-arabinose, Rt 24.92 min); L-xylose, Rt 24.84 min)
(Figs. S47eS66).Acknowledgements
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Figure S1: 1H-NMR spectrum of compound 3 (500 MHz, DMSO-d6). 
 
 
Figure S2: 1H-1H COSY spectrum of compound 3 (500 MHz, DMSO-d6). 
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Figure S3: Overlay of HSQC (green-blue) and HMBC (red) spectra of compound 3 (500 and 125 MHz, DMSO-d6). 
 
 
Figure S4: Overlay of HSQC and TOCSY spectra of compound 3 (500 and 125 MHz, DMSO-d6). 
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Figure S5: 2D 1H-1H ROESY spectrum of compound 3 (500 and 125 MHz, DMSO-d6). 
 
Figure S6: Selective 1D TOCSY spectrum of compound 3 (500 MHz, DMSO-d6). 
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Figure S7: 1H-NMR spectrum of compounds 4-5 (500 MHz, DMSO-d6). 
 
Figure S8: Overlay of HSQC (green-blue) and HMBC (red) spectra of compound 4-5 (500 and 125 MHz, DMSO-
d6). 
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Figure S9: DEPTq spectrum of compounds 4-5 (500 MHz, DMSO-d6). 
 
Figure S10: 1H-NMR spectrum of compound 6 (500 MHz, DMSO-d6). 
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Figure S11: 1H-1H COSY spectrum of compound 6 (500 MHz, DMSO-d6). 
 
Figure S12: Overlay of HSQC (green-blue) and HMBC (red) spectra of compound 6 (500 and 125 MHz, DMSO-
d6). 
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Figure S13: 2D 1H-1H ROESY spectrum of compound 6 (500 MHz, DMSO-d6). 
 
 
Figure S14: Overlay of HSQC and TOCSY spectra of compound 6 (500 and 125 MHz, DMSO-d6). 
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Figure S15: Selective 1D TOCSY spectrum of compound 6 (500 MHz, DMSO-d6). 
 
Figure S16: DEPTq spectrum of compound 6 (125 MHz, DMSO-d6). 
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Figure S17: 1H-NMR spectrum of compound 7 (500 MHz, DMSO-d6). 
 
Figure S18: 1H-1H COSY spectrum of compound 7 (500 MHz, DMSO-d6). 
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Figure S19: Overlay of HSQC (green-blue) and HMBC (red) spectra of compound 7 (500 and 125 MHz, DMSO-
d6). 
 
Figure S20: 2D 1H-1H ROESY spectrum of compound 7 (500 MHz, DMSO-d6). 
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Figure S21: Overlay of HSQC and TOCSY spectra of compound 7 (500 and 125 MHz, DMSO-d6). 
 
 
Figure S22: Selective 1D TOCSY spectrum of compound 7 (500 MHz, DMSO-d6). 
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Figure S23: DEPTq spectrum of compound 7 (500 MHz, DMSO-d6). 
 
Figure S24: 1H-NMR spectrum of compound 8 (500 MHz, DMSO-d6). 
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Figure S25: 1H-1H COSY spectrum of compound 8 (500 MHz, DMSO-d6). 
 
Figure S26: Overlay of HSQC (green-blue) and HMBC (red) spectra of compound 8 (500 and 125 MHz, DMSO-
d6). 
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Figure S27: 2D 1H-1H ROESY spectrum of compound 8 (500 MHz, DMSO-d6). 
 
 
Figure S28: Overlay of HSQC and TOCSY spectra of compound 8 (500 and 125 MHz, DMSO-d6). 
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Figure S29: 1H-NMR spectrum of compound 9 (500 MHz, DMSO-d6). 
 
Figure S30: 1H-1H COSY spectrum of compound 9 (500 MHz, DMSO-d6). 
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Figure S31: Overlay of HSQC (green-blue) and HMBC (red) spectra of compound 9 (500 and 125 MHz, DMSO-
d6). 
 
Figure S32: 2D 1H-1H ROESY spectrum of compound 9 (500 MHz, DMSO-d6). 
 
S21 
 
 
Figure S33: Overlay of HSQC and TOCSY spectra of compound 9 (500 and 125 MHz, DMSO-d6). 
 
Figure S34: Selective 1D TOCSY spectrum of compound 9 (500 MHz, DMSO-d6). 
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Figure S35: 1H-NMR spectrum of compound 10 (500 MHz, DMSO-d6). 
 
 
Figure S36: 1H-1H COSY spectrum of compound 10 (500 MHz, DMSO-d6). 
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Figure S37: Overlay of HSQC (green-blue) and HMBC (red) spectra of compound 10 (500 and 125 MHz, DMSO-
d6). 
 
Figure S38: 2D 1H-1H ROESY spectrum of compound 10 (500 MHz, DMSO-d6). 
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Figure S39: Overlay of HSQC and TOCSY spectra of compound 10 (500 and 125 MHz, DMSO-d6). 
 
 
Figure S40: 1D selective ROESY compound 10 (500 MHz, DMSO-d6).  
 
S25 
 
 
 
Figure S41: Key 1H-1H ROESY and HMBC correlations of compound 11. 
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Figure S42: 1H-NMR spectrum of compound 11 (500 MHz, DMSO-d6). 
 
Figure S43: 1H-1H COSY spectrum of compound 11 (500 MHz, DMSO-d6). 
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Figure S44: Overlay of HSQC (green-blue) and HMBC (red) spectra of compound 11 (500 and 125 MHz, DMSO-
d6). 
 
Figure S45: 2D 1H-1H ROESY spectrum of compound 11 (500 MHz, DMSO-d6). 
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Figure S46: Selective 1D TOCSY spectrum of compound 11 (500 MHz, DMSO-d6). 
 
Figure S47: GC-MS chromatogram of hydrolyzed sugars from compound 1.  
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Figure S48: GC-MS chromatogram of hydrolyzed sugars from compound 6. 
 
Figure S49: GC-MS chromatogram of derivatized D-arabinose.  
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Figure S50: GC-MS chromatogram of derivatized D-fucose. 
 
Figure S51: GC-MS chromatogram of derivatized D-glucose. 
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Figure S52: GC-MS chromatogram of derivatized D-rhamnose. 
 
 
Figure S53: GC-MS chromatogram of derivatized D-xylose. 
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Figure S54: GC-MS chromatogram of derivatized L-arabinose. 
 
Figure S55: GC-MS chromatogram of derivatized L-fucose. 
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Figure S56: GC-MS chromatogram of derivatized L-glucose. 
 
Figure S57: GC-MS chromatogram of derivatized L-rhamnose. 
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Figure S58: GC-MS chromatogram of derivatized L-xylose. 
 
Figure S59: GC-MS chromatogram of hydrolyzed sugars from compound 9. Sugar retention times in compounds 3 
and 6 differ from those in 9 and 11 because have been measured on columns with different length. 
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Figure S60: GC-MS chromatogram of hydrolyzed sugars from compound 11. 
 
Figure S61: GC-MS chromatogram of derivatized D-glucose.  
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Figure S62: GC-MS chromatogram of derivatized D-galactose. 
 
Figure S63: GC-MS chromatogram of derivatized D-rhamnose. 
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Figure S64: GC-MS chromatogram of derivatized L-glucose. 
 
Figure S65: GC-MS chromatogram of derivatized L-galactose. 
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Figure S66: GC-MS chromatogram of derivatized L-rhamnose. 
 
Figure S67: HPLC-ESIMS traces recorded in positive and negative ion mode of Ziziphus spina-christi of four 
different origins. Peak numbering designates compounds 1-21. 
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Figure S68: 1H-NMR spectrum of water and n-BuOH phases (500 MHz, DMSO-d6). 
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A two-steps protocol comprising a comparative metabolite profiling tool integrated in ACD/Labs, 
and a web platform FreeClust designed for clustering and visualization of the results in 2D 
heatmaps was developed. This versatile two-steps data mining workflow provides valuable add-
in processing options applicable in different research fields such as natural products and early 
drug discovery research. 
 
Preparation of honey samples (solid phase extraction on C18 EC cartridges), HPLC profiling, 
and preparation of the figures were my contribution. Writing of the manuscript draft was my 
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ACD/MS Workbook Suite was performed by Hans De Bie and colleagues with the contribution of 
Eliane Garo and mine. The development of the on-line clustering platform FreeClust was done by 
Maciej Dobrzynski. Eliane Garo and I participated in decision making regarding the 
implementation of statistical functions and design of FreeClust. 
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ABSTRACT: The technological development of LC-MS
instrumentation has led to signiﬁcant improvements of
performance and sensitivity, enabling high-throughput analysis
of complex samples, such as plant extracts. Most software
suites allow preprocessing of LC-MS chromatograms to obtain
comprehensive information on single constituents. However,
more advanced processing needs, such as the systematic and
unbiased comparative metabolite proﬁling of large numbers of
complex LC-MS chromatograms remains a challenge. Currently, users have to rely on diﬀerent tools to perform such data
analyses. We developed a two-step protocol comprising a comparative metabolite proﬁling tool integrated in ACD/MS
Workbook Suite, and a web platform developed in R language designed for clustering and visualization of chromatographic data.
Initially, all relevant chromatographic and spectroscopic data (retention time, molecular ions with the respective ion abundance,
and sample names) are automatically extracted and assembled in an Excel spreadsheet. The ﬁle is then loaded into an online web
application that includes various statistical algorithms and provides the user with tools to compare and visualize the results in
intuitive 2D heatmaps. We applied this workﬂow to LC-ESIMS proﬁles obtained from 69 honey samples. Within few hours of
calculation with a standard PC, honey samples were preprocessed and organized in clusters based on their metabolite proﬁle
similarities, thereby highlighting the common metabolite patterns and distributions among samples. Implementation in the
ACD/Laboratories software package enables ulterior integration of other analytical data, and in silico prediction tools for modern
drug discovery.
High performance and ultrahigh performance liquidchromatography coupled to mass spectrometry
(HPLC/UHPLC-MS/HRMS) are widely used for the analysis
of diﬀerent kinds of complex samples, such as foods,
environmental samples, biological ﬂuids, and natural product
extracts. LC-MS is a higly highly versatile and powerful
analytical tool, because it enables analysis of trace components,
qualitative and quantitative analyses of single compounds in
complex mixtures, as well as metabolite ﬁngerprinting.1,2
Signiﬁcant advances in LC-MS hardware have been achieved
over the past 25 years with respect to sensitivity, robustness,
reliability, automation, and speed of data acquisition. Large sets
of complex samples are measured nowadays routinely by LC-
MS, thereby producing large data sets in a relatively short
period of time.3−5
In recent years eﬀorts have been made in the development of
software algorithms and tools to eﬃciently mine data from the
wealth of data generated by LC-MS.6 Diﬀerent software suites
are used for the preprocessing of raw chromatograms, which
typically includes peak picking and chromatogram deconvolu-
tion.7,8 Most instrument vendors provide software enabling
data acquisition and processing in one place. However, data
processing is limited to their proprietary data format. Free
softwares suites, such as XCMS and MZmine 2, are powerful
alternatives for expert users who do not need major technical
support. Platforms such as ACD/Spectrus oﬀer a ﬂexible
interface which accepts most ﬁle formats and is appropriate for
users working with diﬀerent analytical techniques (i.e., NMR,
IR, LC/UV/MS) and instruments from diﬀerent vendors.
However, most of these software suites only support part of the
processing workﬂow, and users have to rely on diﬀerent tools
and algorithms to perform more advanced tasks, such as peak
identiﬁcation and dereplication, or comparison of diﬀerent LC-
MS proﬁles, clustering, and data visualization.
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Peak identiﬁcation and dereplication is a major challenge,
especially in the ﬁeld of natural product research. Hence, a
number of dereplication workﬂows have been developed to
address this important issue.7−9 The Global Natural Product
Social Molecular Network (GNPS), a free platform used by
more than 10 000 users, is probably one of the most successful
examples, as it streamlines the dereplication eﬀort through a
common leverage of raw and processed MS/MS data.10 The
ACD/Laboratories platform also provides interesting tools for
dereplication via in-house and commercial MS and NMR
spectral database searches.
Comparative processing of large groups of LC-MS data sets
for the purpose of pattern identiﬁcation and sample
classiﬁcation remains another major challenge in the
ﬁeld.11−16 Such types of advanced interrogation of large data
sets require (i) additional cross-comparison of individual
chromatograms and (ii) the identiﬁcation of metabolite
patterns and subsequent data clustering. The free metabolomics
platforms such as XCMS17 and MZmine 2,18 used for
preprocessing, oﬀer some basic postprocessing tools, such as
PCA, and could be used for comparative analyses. They are
creating so-called mapped metabolic networks, used to identify
biomarkers to support the diagnostic and monitoring of various
diseases.19−21 They were also used to highlight gene-to-
metabolite networks in plants and allowed the elucidation of
a speciﬁc natural product biosynthesis pathway.22,23 Similar
metabolic mapping approaches have been recently developed
for planar chromatography using rTLC.24 The web server
MetaboAnalyst 3.0 supports an extensive range of tools for data
analysis and can be used for more advanced statistical
evaluations.25 However, it is more appropriate for expert
users. Because of the diversity of the processing algorithms and
tools, the user often has to implement diﬀerent software suites
in his workﬂow. This can be a major bottleneck for users,
especially for nonexperts in the ﬁeld of metabolomics.
We implemented ACD/Spectrus in our natural product
discovery setting, because this software suite provides an
optimal platform for processing and evaluation of all our
diﬀerent analytical data in a single environment. We here
propose a two step data mining approach for the comparative
processing of large groups of LC-MS data. In an attempt to
develop a workﬂow that is straightforward and user-friendly, a
ﬁrst processing step consists of a customized add-in tool
developed within the ACD/Spectrus platform. The second
processing step includes a new open access web-based
application clustering tool called FreeClust. FreeClust was
developed in the R programming language, and its interactive
design allows for various modes of visualization to facilitate data
interpretation. This two step data mining approach was then
tested with a set of HPLC-ESIMS chromatograms originating
from 69 honey samples.
■ EXPERIMENTAL SECTION
LC-MS Separation. LC-MS analysis was performed on a
Shimadzu Prominence HPLC system composed of a LC-20 AD
binary pump, CTO-20AC column thermostat, SDP-M20A
PDA detector, CBM-20A system controller, and coupled to an
LCMS-8030 Triple Quadrupole Mass spectrometer equipped
with an electrospray ionization source (ESI). Conditions were
as follows: capillary voltage, 4.5 V; desolvation line temper-
ature, 250 °C; heat block temperature, 500 °C; drying gas
(nitrogen) ﬂow, 15 L min−1; nebulizing gas (nitrogen) ﬂow, 3 L
min−1. For data acquisition in both positive and negative
ionization modes, full-scan (160−1500) was carried out with
6000 u/sec scan speed and 0.150 s per event time. LC
separation was carried out on a C18 SunFire column (3.5 μm, 3
× 150 mm i.d., Waters) equipped with a guard column (3 × 20
mm i.d.). HPLC solvents were kept in Teﬂon FEP bottles
(Nalgene, ThermoFisher) with 5 μm PTFE in-line ﬁlters (Vici).
The mobile phase consisted of water (A) and acetonitrile (B),
Figure 1. Schematic representation of the proposed two steps in the LC-ESIMS data mining workﬂow. Step 1: LC-ESIMS chromatograms are
loaded into the add-in tool that is using the IntelliXtract (IX) and IntelliTarget (ITA) algorithms. Results are presented as a matrix table (table of
components). The processed chromatograms are saved as separate Spectrus ﬁles and are accessible in ACD/MS Workbook Suite for additional
processing, databasing, and reporting. Step 2: Matrix table is loaded into the FreeClust web application for clustering and graphical representation.
Results are displayed as heatmap for clustering. Bayesian, hierarchical, and sparse hierarchical clustering algorithms are available.
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both containing formic acid (0.1%, v/v), and the ﬂow rate was
set to 0.5 mL min−1. The injection volume was 2 μL. The
following gradient was used: 0−2 min 5% B; 2−27 min 5−
100% B; 27−32 min 100% B. The equilibration time between
each injection was 7.0 min. Data acquisition was performed
with LabSolutions software (Shimadzu). Data were processed
and analyzed with ACD/Spectrus Processor (ACD/Laborato-
ries) on an Intel Core i7, 2600 CPU at 3.40 GHz personal
computer. For the add-in tool, the main parameters used were:
Peak Number, 5; tR Threshold, 0.5. For IntelliXtract (IX)
Options: 12C/13C error (%), value 10; CODA, True; Peak S/N
Threshold, 6; fwhm (scans), 0.1; Convert Proﬁle to Centroid;
Data Analysis Region, Start tR 6 min and End tR 20 min; For
IntelliTarget (ITA) Options: Peak S/N Threshold, 200; Peak
Area Threshold (counts), 500. Tables S-2 and S-3 provide the
entire list of parameters used.
Preparation of Honey Samples. Honey (3.0 g) was
dissolved in 20 mL of distilled water (Millipore, Merck) at
room temperature (Table S-1). The C18 ec cartridges
(Chromabond, 3 mL/500 mg) were eluted with the aid of a
SPE vacuum manifold (Visiprep). Samples were loaded onto
water preconditioned cartridges, and dried on the vacuum
manifold. Cartridges were ﬁrst rinsed with 3 × 5 mL distilled
water to remove sugars, then eluted with 4 mL HPLC grade
methanol (Macron) to obtain a sugar-free fraction. Solvent was
removed using a GeneVac EZ-2 plus centrifugal evaporator, and
dried residues redissolved in extra pure dimethyl sulfoxide
(Scharlau) at a ﬁnal concentration of 5 mg mL−1.
■ RESULTS AND DISCUSSION
The two-step data mining workﬂow was developed for
comparative metabolite proﬁling of large groups of LC-
ESIMS chromatograms (step 1), and data clustering and
visualization (step 2) (Figure 1). The comparative metabolite
proﬁling is a preprocessing step using a customized add-in tool
developed in the ACD/MS Workbook Suite software. The tool
manages ACD/IntelliXtract (ACD/IX) and ACD/IntelliTarget
(ACD/ITA) modules in sequence to process the loaded
chromatograms. ACD/IX uses a generic component ﬁnding
algorithm called COmponent Detection Algorithm (CODA)26
to reduce noise and background signals in mass spectra, and
thereby streamlines the interpretation of data. Chromatograms
are deconvoluted in a comprehensive way to enable the
identiﬁcation of trace components and coeluting peaks. Single
peaks in a chromatogram are deﬁned by their retention time
(RT) and ion mass (m/z), and treated as input values (RT-m/
z). Peak recognition in the ACD/IX module takes into account
ESI traces recorded in both positive and negative ionization
mode, if available. All relevant information for spectral
interpretation, such as isotopes, 12C/13C ratios, adduct ions,
multimers, neutral losses, fragment ions, and [M + H]+ or [M
− H]− ion assignments are extracted by ACD/IX and added to
the input values. This provides then a so-called input list for
each individual chromatogram. The comparative metabolite
proﬁling add-in tool is then used to compare features
(metabolites) between samples and combine them into one
major input list. Peaks with same RT-m/z values are considered
as duplicates and are, therefore, eliminated at this step. The
ACD/ITA module uses this list to check the presence of each
individual compound in all data sets. A table of components is
then generated with the abundance, expressed as area under the
curve (AUC), of detected compounds in all chromatograms.
The open access web-based application FreeClust was
designed for clustering and visualization of the results obtained
in step 1. The Excel spreadsheet obtained from step 1 is loaded
into the FreeClust application which allows for data
presentation utilizing hierarchical, sparse hierarchical, and
Bayesian clustering methods. Outliers are identiﬁed in a
histogram to help the user in deﬁning the optimal clustering
method. In addition, the importance score factor of each
metabolite within the group of data sets is calculated to indicate
its weight in the clustering. A color-code is used to show ion
abundance in each sample. FreeClust is freely accessible at
http://bioz-lcms-chromclust.bioz.unibas.ch:3838/shiny-
freeclust/.
Data Acquisition. Chromatographic data acquired on
HPLC-ESIMS and UHPLC-ESIMS systems are opened in
ACD/MS Workbook Suite. Various ﬁle formats, such as “.lcd”,
“.d”, “.raw”, and “.spectrus” are supported, thus enabling data
import from instruments of major manufacturers. Functions for
automated baseline subtraction and MS signal normalization
were not implemented in the present version of the
comparative batch processing tool. These steps were performed
manually.
Comparative Metabolite Proﬁling (Data Mining Step
1). The customized tool developed in ACD/MS Workbook
Suite is managed through a pop-up form which allows users to
load multiple ﬁles to be processed (Figure S-1). This add-in
tool is using ACD/IX and ACD/ITA algorithms. Parameters in
ACD/IX, ACD/ITA, as well as in the customized pop-up form
can be optimized. ACD/IX and ACD/ITA include settings
such as detection of adduct ions, peak picking (S/N, peak
minimal height, peak area count), or peak recognition
parameters (Table S-2, S-3). Furthermore, the following
parameters can be selected in the pop-up form for an optimal
processing:
• ESI+/ESI− deﬁnes the ion polarity to be used in the data
mining workﬂow.
• tR Threshold deﬁnes the resolution of retention time.
Two peaks with the same m/z will be considered as the
same input if their RT diﬀerence is within the RT
threshold.
• no. peaks (number of peaks) designates the maximal
number of most abundant peaks per sample to be
processed.
If the no. peaks entered is bigger than the total number of
peaks identiﬁed based on S/N value (ACD/IX option), the
latter value will be considered for analysis. The optimal no.
peaks is selected empirically and may vary depending on the
batch composition. Use of this parameter is illustrated by two
theoretical examples (Figure 2). The relative abundance of
molecular ions present in each sample is represented by
diﬀerent shades of blue. The batch in the ﬁrst example
comprises two samples which contain four and ﬁve peaks,
respectively (Figure 2A). Compounds identiﬁed in each sample
are all diﬀerent which results in a total of 9 peaks in the batch. If
no. peaks is set to 2, the total number of peaks found in the
batch would be 4 (peaks A2, A3, B5, and B9). The remaining 5
peaks would not be integrated. If no. peaks is set to 4, all peaks
in sample A and peaks B5 and B7−B9 would be integrated.
Peak B6 would not be considered although being more
abundant than peak A1.
The batch in the second example contains six samples with a
total of ten diﬀerent peaks, and varying numbers of peaks per
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sample (between 2 and 4 per sample) (Figure 2B). Only peak 1
is speciﬁc to sample C, while all other peaks occur in several
samples. If no. peaks is set to 2, peaks A2, A3, B9, B10, C3, C8,
D3, D4, E8, E10, F4, and F6 would be integrated. Thus, peaks 1
and 7 would not be considered for data mining. If the no. peaks
is increased to 3, all peaks would be integrated.
Save Into Spectrus Format. By activating this option,
processed chromatograms are saved as separate ﬁles and
become accessible in ACD/MS Workbook Suite for cross-
checking of results, and for additional processing (extraction of
UV and MS data), reporting, and databasing.
Table of Components. The comparative metabolite proﬁling
tool automatically delivers results assembled as a matrix table in
an Excel spreadsheet. Ions intensities below a deﬁned threshold
are represented as a dash, and are treated as 0 (zero) for
statistical analysis (Figure 3).
Data Clustering Using FreeClust (Data Mining Step 2).
A web-application called FreeClust was developed in the R
programming language (free R software package Shiny27). It is
independent from the ACD/Laboratories platform and
provides an interactive and freely accessible environment for
statistical evaluation and data visualization of large data sets
(Figure S-2). Diﬀerent data sets formats (matrix table or text
ﬁles) can be uploaded on FreeClust. Data sets are clustered
within FreeClust using Bayesian, hierarchical, or sparse
hierarchical clustering methods.
Loading Data in FreeClust. Text ﬁles or Excel spreadsheets
exported to CSV ﬁles in Excel are recognized by FreeClust. For
text ﬁles, values should be listed in columns separated by
spaces, commas, or semicolons. Missing values are described in
the input ﬁle as “NA”, “-”, or an empty space. For matrix tables,
feature names and sample names should be listed in ﬁrst
columns and ﬁrst row, respectively. If feature information is
described in more than one column, the concatenation function
in excel should be used.
Group of Data Sets. One data set is deﬁned by
measurement values, also designated as observations or features
(e.g., metabolites deﬁned by RT-m/z) recorded for one sample.
A group of data sets includes, for example, all values obtained
after comparative metabolite proﬁling. This group can be large
in terms of sample size (high number of samples compared to
the total number of observations recorded) or feature size (high
number of features observed compared to the total number of
samples).
Basic Processing. The app oﬀers basic data processing, such
as data trimming, clipping, and rescaling. In data trimming,
outliers are excluded from clustering (values below or above a
threshold are treated as missing values). In data clipping,
outliers are limited but not excluded from clustering (values
below or above the threshold are converted to the threshold
value). Rescaling normalizes features to allow their comparison
in case they were measured on diﬀerent scales or in diﬀerent
units. It is performed independently on every feature (mean
value is subtracted from each individual feature value, and the
diﬀerence is further divided by the standard deviation). Values
treated as missing are not aﬀected by trimming nor clipping.
Hierarchical Clustering. It provides best results with groups
of data sets characterized by large sample size. This method is
considering all features for clustering. It builds hierarchy of
clusters using standard R functions dist and hclust.28 Diﬀerent
metrics (e.g., Euclidean, Maximum, Manhattan), as well as
linkage criteria (e.g., complete-linkage clustering), are used to
calculate pairwise distances or dissimilarities between feature
patterns in samples.
Sparse Hierarchical and Bayesian Clustering. These
methods provide best results when applied on groups of data
sets characterized by a large feature size. Only a selected
number of features are considered here for clustering. Feature
importance is expressed as a score factor. A color-code and
asterisks are used to display the importance of each feature
within the group (below the heatmap). Sparse and Bayesian
clustering algorithms use diﬀerent methods to determine the
importance of features.
Sparse hierarchical clustering builds a hierarchy of clusters
using R package sparcl.29 The algorithm quantiﬁes the
contribution of a particular feature, that is, its importance, to
clustering by giving a weight between 0 an 1 to each feature.
For example, if a feature has the same value across all samples,
its contribution for building clusters will be nil, and its weight
will be assigned to zero.
Bayesian clustering builds clusters using the R package
bclust.30 Feature importance is quantiﬁed here by the log Bayes
factor (log ratio of the likelihood probability). For example, a
negative value of importance implies negative evidence that a
feature participates in the optimal clustering. To apply bclust,
missing values need to be converted to zeroes, and this data
adjustement can be performed in FreeClust.
Figure 2. Schematic representation of relative peak abundances
(shades of blue) in diﬀerent chromatograms (samples). Example
comprising two samples and nine diﬀerent compounds (A). Example
comprising six samples and ten diﬀerent compounds (B).
Figure 3. Example of a table of components obtained after processing
in ACD/MS Workbook Suite. Individual peaks are deﬁned by RT
(column A) and m/z values (column B), and sorted by their RT.
Columns represent the diﬀerent samples. Sample names are reported
in row 1. The matrix elements represent the abundancy of molecular
ions of single compounds in each sample, expressed as AUC.
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Heatmaps. Feature values are visualized as heatmaps by
using diﬀerent color shades (e.g., color darkness is directly
proportional to metabolite abundance). An interactive plot
allows to highlight individual values in the heatmap. A zoom-in
option enables the exploration of large data sets (Figure S-3).
Dendrogram. The cluster tree or dendrogram is presented
on the left-hand-side of the heatmap. It shows how individual
samples are grouped in clusters. For easy read-out, clusters can
be highlighted using distinct colors. The number of clusters to
be highlighted can be modiﬁed accordingly.
Practical Example. The two-step data mining workﬂow
was tested with a set of HPLC-ESIMS chromatograms obtained
from the analysis of 69 honey samples. Data were acquired in a
full scan mode on a triple quadrupole instrument. The
calculation time needed for comparative metabolite proﬁling
on a standard PC was 8.3 h, and results comprising a total of 84
features, were automatically assembled in a matrix table in
Excel. Due to the large variability of honey samples, only the
most abundant metabolites were considered in the comparison
analysis. The number of peaks was arbitrarily set to 5. In
addition, each processed chromatogram was saved as a Spectrus
ﬁle (“Save Into Spectrus Format”) to serve for extraction of
additional spectroscopic data. The Excel table containing the
results was then loaded in FreeClust and presented as a 2D
heatmap after applying Bayesian clustering (Figure 4).
The 2D heatmap provides an overview of the metabolite
distribution within the data sets. By using the interactive
interface, diﬀerent clusters were readily identiﬁed. Distinct
Figure 4. Dendrogram and 2D heatmap of a group of data sets obtained from the comparative metabolite proﬁling of 69 honey samples. The
dendrogram is shown on the left-hand-side of the heatmap, and clusters are highlighted by diﬀerent colors. Color shades of individual cells in the
heatmap correspond to the relative abundance of molecular ions. Sample identity is displayed on the y axis (right-hand-side of the heatmap).
Features (RT and m/z values) are represented on the x-axis. The importance score of each feature is indicated by asterisks and colors (black, green,
yellow, and red). Bayesian clustering was applied, and samples were classiﬁed in 5 (A) and 8 (B) clusters, respectively. Characteristic metabolite
patterns in speciﬁc clusters are highlighted with colored frames. Red and blue arrows are highlighting data sets obtained from same honey type,
namely, orange honeys (in blue) and manuka honeys (in red).
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metabolite patterns for clusters 1−4 can be seen in the heatmap
and are highlighted in Figure 4A with the corresponding cluster
color. Cluster 1 containing samples X15 (cheastnut honey) and
X56 (black locust honey) was characterized by four highly
abundant metabolites. In contrast, cluster 5 did not show
obvious similarities in metabolite patterns. The clustering level
was therefore increased to 8 (Figure 4B). Cluster 5 was thereby
subdivided into three groups (5a to 5c). This level adjustment
also aﬀected cluster 3 which was further subdivided into two
groups (3a and 3b).
Processing of the individual Spectrus ﬁles provided additional
relevant information on single constituents. The four highly
abundant metabolites in cluster 1 (RT 7.4, 8.7, 10.8, and 11.4
min, respectively) were reported as XIC (Figure 5A, 5B).
Supplementary spectroscopic data indicated very similar UV
spectra, and the molecular masses were deduced from the MS+
and MS- spectra as 211.3, 258.3, 239.3, and 188.3, respectively
(Figure 5C). The UV spectra and MS fragmentation pattern
recorded for the four metabolites thus suggested similar
structures.
The metabolite proﬁles of honeys of same ﬂoral origin
(according to labeling by provider) were compared. Interest-
ingly, three samples of orange honey were grouped in 2
diﬀerent clusters, namely 2 and 5 (X25, X44, and X47,
highlighted in Figure 4A). Samples X25 and X44 were
characterized by a rather similar metabolite pattern and were
thus classiﬁed in cluster 2. Sample X47 was classiﬁed in cluster
5, and only one metabolite (RT 12.9 min, m/z 212.9) was
present in all three samples. Three samples of manuka honey
were grouped in the same cluster (5c) suggesting similar
metabolite patterns for these three samples (samples X21-X23
highlighted in Figure 4B). Clustering levels could be further
increased to unravel small diﬀerences between metabolite
patterns.
The step 1 of our workﬂow enabled the extraction of
additional structural information from MS spectra, as shown for
the peak RT 10.5 min with m/z 384.9. A molecular mass of 362
could be deduced from the ions m/z 361.1 [M − H]− and m/z
384.9 [M + Na]+. Fragment ions at m/z 344.9 [M − OH]+, m/
z 327.0 [M − 2OH]+, m/z 308.9 [M − 3OH]+, and m/z 290.9
[M − 4OH]+ suggested the presence of four hydroxy groups
(Figure S-4A). As for peak at RT 13.0 min with m/z 286.9, a
mass of 264 was deduced from the molecular ions m/z 264.9
[M + H]+ and m/z 263.2 [M − H]−. The ion at m/z 286.9 was
identiﬁed as the sodium adduct. The fragment ion at m/z 246.9
[M − OH]− was indicative of a loss of a hydroxy group (Figure
S-4B).
As ACD/MS Workbook Suite is using a deconvolution
algorithm, coeluting peaks can be identiﬁed. In sample 51, a
TIC peak eluting at RT 16.7 min was deconvoluted into three
XIC peaks with m/z 255, m/z 257, and m/z 271 (Figure S-5).
With the support of mass spectra recorded in positive and
negative ionization modes, molecular masses of 254, 256, and
270 were deduced (data obtained from Spectrus ﬁles, not
shown here).
■ CONCLUSIONS
Our proposed two-step data mining workﬂow enables (i)
comparison of metabolite proﬁles of complex LC-MS
chromatograms in an automated and systematic way and (ii)
clustering and visualization of the results in a 2D heatmap for
data interpretation.
Developed within the ACD/Laboratories software platform,
the add-in tool (step 1) provides a simple way to compare large
numbers of LC-MS data sets. Moreover, the comprehensive
results can be fully integrated into a multidisciplinary workﬂow.
Relevant structural information can be obtained from a single
peak in an individual chromatogram for dereplication,
metabolite characterization or databasing work. This tool was
developed to work with ACD/IX. A new version of the
algorithms, ACD/IX2, was released in July 2017, and provides
additional features (e.g., capabilities for processing of HRMS,
Figure 5. Information extracted from individual Spectrus ﬁles in
ACD/MS Workbook Suite. Chromatograms obtained from sample
X15 (chestnut, A) and sample X56 (black locust, B) is shown. The
total ion chromatogram (TIC) is displayed in red, and extracted ion
chromatograms (XIC) are overlaid using diﬀerent colors. Additional
spectroscopic information, such as negative- and positive-ion mass,
molecular mass, and UV spectrum are available in a table (C).
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GC-MS, and APCI data). We are currently modifying the add-
in tool to operate with ACD/IX2.
The web application FreeClust (step 2) can cluster and
display the results in intuitive 2D heatmap graphs for easy and
unbiased data interpretation. The user-friendly design of
FreeClust allows analytical chemists to perform statistical
analysis on their data without the need of expert knowledge in
advanced statistical tools. Moreover, the 2D heatmap has been
designed as an interactive interface that allows users to quickly
identify diﬀerences between clusters. The user can access
speciﬁc values by simply moving the cursor to the cell of
interest. FreeClust was developed as an open-access web
application which is independent from the ACD/Laboratories
environment. It can be used with data sets obtained from
various sources and, therefore, fulﬁlls needs not only in the
ﬁelds of phytochemistry and phenotyping,7 but also in other
areas such as molecular biology.
The proposed two-step data mining workﬂow can be applied
in various ﬁelds of research where metabolite proﬁles of
numerous samples need to be compared. In the ﬁeld of natural
products this includes, for example, the quality control of
botanicals, analysis of chemical traits in plant breeding, or
prioritization/selection of crude extracts in drug discovery.
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Crüsemann, M.; Boudreau, P. D.; Esquenazi, E.; Sandoval-Calderoń,
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ABSTRACT: Plant pollens are strong airborne elicitors of
asthma. Their proteinaceous allergens have been studied
intensively, but little is known about a possible contribution of
pollen secondary metabolites to the nonallergic exacerbation
of asthma. Pollen samples originating from 30 plant species
were analyzed by HPLC coupled to PDA, ESIMS, and ELSD
detectors and oﬀ-line NMR spectroscopy. Polyamine con-
jugates, ﬂavonoids, and sesquiterpene lactones were identiﬁed.
Polyamine conjugates were characteristic of all Asteraceae species. The presence of sesquiterpene lactones in Asteraceae pollen
varied between species and pollen lots. All plant pollen, including those from non-Asteraceae species, contained to some extent
electrophiles as determined by their reaction with N-acetyl-L-cysteine. Selected pollen extracts and pure compounds were tested
in murine aﬀerent neurons and in murine tracheal preparations. Tetrahydrofuran extracts of Ambrosia artemisiifolia and Ambrosia
psilostachya pollen and a mixture of sesquiterpene lactones coronopilin/parthenin increased the intracellular Ca2+ concentration
in 15%, 32%, and 37% of cinnamaldehyde-responsive neurons, respectively. In organ bath experiments, only the sesquiterpene
lactones tested induced a weak dilatation of naiv̈e tracheas and strongly lowered the maximal methacholine-induced tracheal
constriction. A tetrahydrofuran extract of A. psilostachya and coronopilin/parthenin led to a time-dependent relaxation of the
methacholine-preconstricted trachea. These results provide the ﬁrst evidence for a potential role of pollen secondary metabolites
in the modulation of the tracheal tone.
Asthma is a chronic inﬂammatory disorder of the airwaysassociated with airway hyper-responsiveness1 and is one of
the chronic diseases with the highest mortality.2 Two recent
global studies estimated that asthma aﬀects between 200 and
300 million children and adults worldwide.3,4 The incidence
varies considerably between countries and ranges from 1% to
16%.5 Asthma triggers are very diverse in nature and origin and
can be classiﬁed into those nonallergic and allergic. Nonallergic
triggers include exercise, emotional conditions, cigarette smoke,
and a cold temperature. Certain medicines, viral infections,
animal dander, dust mites, molds, and plant pollen are known
allergic triggers, capable of inducing an inﬂammatory process
resulting in hypersensitivity reactions.6 Plant pollens are known
to be strong airborne elicitors of asthma in humans, and the
role of proteinaceous pollen allergens in asthma, as well as their
structures, has been studied extensively.7−10 In contrast, little is
known regarding a potential contribution of pollen secondary
metabolites in the nonallergic exacerbation of asthma
symptoms.
Secondary metabolites in pollen and their role in vegetative
and generative cells have been investigated previously. Besides
the widely studied antioxidative properties of phenolic
substances in bee pollen,11−14 the biosynthesis of free
polyamines and their role in pollen embryogenesis15,16 and in
other developmental functions have been of major interest.17,18
Furthermore, primary and secondary pollen metabolites, such
as carbohydrates, amino acids, lipids, hormones, glutathione,
and polyamines, were found to be directly involved in the
adaptation processes to environmental conditions such as a
high temperature.19
Besides the well-established role of pollen proteins in the
inﬂammatory and allergic airway hyper-responsiveness and tone
modulation, there is so far no evidence for a possible
involvement of pollen phytochemicals in the exacerbation of
nonallergic asthma symptoms. The transient receptor potential
cation channel A1 (TRPA1) is a ubiquitous protein highly
expressed in sensory neurons in skin and airways.20−22 This
Ca2+-selective channel can be activated through covalent (e.g.,
cinnamaldehyde) or noncovalent (e.g., menthol) mechanisms,
rendering it a possible target for structurally diverse
molecules.23 TRPA1 has been associated with activation of
aﬀerent C-ﬁbers and airway hyper-responsiveness.24,25 On the
other hand, contraction of myocytes in the trachea has been
linked to the endogenous free polyamines spermidine and
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spermine directly acting on airway smooth muscle cells.26 The
polyamine-mediated activation of the type I phosphatidylino-
sitol 4-phosphate 5-kinase (PIP5K) gamma isoform induces the
release of sarcoplasmatic Ca2+ to the cytosol, leading to myosin
phosphorylation and contraction of smooth muscle ﬁbers.
Relaxation of trachea has been linked to the activation of bitter
taste receptors (T2Rs) expressed in ciliated epithelial and
smooth muscle cells in the airways.27
To address a possible contribution of pollen secondary
metabolites to the clinical exacerbation of the pollen protein-
mediated allergic response, a phytochemical proﬁling was
performed of plant pollen from species known for their varying
degrees of allergenicity.28 Pollen from species of 11 genera of
the family Asteraceae was selected, including the highly
allergenic Ambrosia artemisiifolia L. and Ambrosia psilostachya
DC., and from eight genera belonging to plant families other
than the Asteraceae. This constituted pollen from a total of 30
plant species. For A. artemisiifolia, six diﬀerent lots of pollen
(Aa1−Aa6), as well as samples from ﬂowers and leaves, were
analyzed, and for A. psilostachya ﬁve lots of pollen (Ap1−Ap5)
were analyzed. All pollen samples were from commercial
suppliers of allergens for the manufacturing of pharmaceutical
products for hyposensitization. Phytochemical proﬁling of
secondary metabolites was performed by means of HPLC-
PDA-ESIMS-ELSD and supported by targeted isolation of
selected compounds and oﬀ-line microprobe NMR analysis.
Sesquiterpene lactones (STLs) and other electrophiles in
pollen extracts were quantiﬁed by reaction with N-acetyl-L-
cysteine. Finally, extracts of the highly allergic A. artemisiifolia
and A. psilostachya pollen, selected STLs, and polyamine
conjugates were tested in murine aﬀerent neurons for their
eﬀect on Ca2+ inﬂux measured by calcium imaging and for
constriction of murine tracheal rings in organ bath experiments.
■ RESULTS AND DISCUSSION
Comparison of HPLC-ESIMS Proﬁles of Pollen Ex-
tracts. Pollen samples originating from 30 plant species (Table
S1, Supporting Information) were defatted with n-hexane and
extracted exhaustively with tetrahydrofuran (THF) and MeOH.
The THF extracts were analyzed by HPLC coupled in series to
PDA, ESIMS (positive- and negative-ion modes), and ELSD
detectors (Figure S1, Supporting Information). HPLC-ESIMS
data were automatically analyzed using ACD/Spectrus
Processor software. The analysis consisted of data deconvolu-
tion followed by a parallel comparative processing. In a second
step, the data table was loaded into a Web application designed
for data clustering and visualization, and data were presented as
a 2D heat map (Figure S2, Supporting Information).29 The
most striking observation from this data set was linked to peaks
eluting between tR 27.0 and 32.4 min (indicated with black
squares in Figure S2 and Table S2, Supporting Information)
that were detected only in pollen from Asteraceae species.
Peaks designated with orange squares showed UV−vis
absorption spectra with λmax 240−350 nm and molecular ions
that were suggestive of phenolic glycosides (Table S3,
Supporting Information). Peaks labeled with blue and green
squares, in contrast, showed a λmax < 240 nm and molecular
ions in the range of m/z 250−300 that were indicative of STLs.
For example, the extract of A. psilostachya pollen showed at tR
25.3 and 25.7 min two major HPLC peaks with molecular ions
m/z [M + H]+ 263.0 and 264.9 (λmax 233 and 230, respectively)
(Figure S2 and Table S3, Supporting Information). Based on
this preliminary comparison, a targeted isolation of metabolites
was conducted. HPLC chromatograms of A. artemisiifolia
(sample Aa1) THF and MeOH extracts (Figure 1) and an A.
psilostachya (sample Ap1) THF extract (Figure S1, Supporting
Information) served as a basis for a targeted small-scale
puriﬁcation of characteristic major compounds.
Figure 1. HPLC proﬁles of extracts from pollen of A. artemisiifolia (lot Aa1). Proﬁles of THF (A) and MeOH (B) extracts were recorded with PDA,
ELSD, and ESIMS in positive- and negative-ion modes. Peak numbering designates unambiguously identiﬁed compounds 1−11, and I−IV designate
peaks for which only partial structural information was obtained.
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Major Phytochemical Observations. THF and MeOH
extracts of A. artemisiifolia pollen aﬀorded 11 compounds that
were identiﬁed by HRESIMS and 1D and 2D NMR data.
The new compound 1 was obtained as an amorphous white
solid, and a molecular formula of C34H38N3O7 was assigned on
the basis of a molecular ion of m/z 600.2400 [M + H]+ in the
HRESIMS (calcd for C34H37N3O7, 600.2409). 1D and 2D
NMR spectra of 1 (Figures S3−S6, Supporting Information)
were similar to those of previously reported N1,N5(Z,Z)-
N10(E)-tri-p-coumaroylspermidine (2).30 However, the six
oleﬁnic protons in 1 (δH 6.47, d, J = 12.6 Hz, H-7′; δH 6.37,
d, J = 12.6 Hz, H-7″; δH 6.47, d, J = 12.6 Hz, H-7‴) exhibited
vinylic coupling constants indicative of a cis conﬁguration.
Furthermore, the HMBC correlations of H-2″ (δH 6.86, br s)
and H-6″ (δH 6.69) with C-3″ (δC 145.5) were indicative of a
caﬀeoyl moiety attached to N-5 (Table 1). Thus, compound 1
was established as N1,N10(Z,Z)-di-p-coumaroyl-N5(Z)-caﬀeoyl-
spermidine.
Compound 9 was obtained as an amorphous yellow solid. A
molecular formula of C24H23O15 was assigned on the basis of a
molecular ion at m/z 551.1071 [M + H]+ in the HRESIMS
spectrum (calcd for C24H22O15, 551.0959). 1D and 2D NMR
spectra (Figures S7−S10, Supporting Information) were
virtually superimposable to those of compound 4 (Table S6,
Supporting Information) and to quercetin-3-O-β-D-glucopyr-
anoside.31 The presence of a malonyl residue was indicated by
HMBC correlations of a methylene (δH 3.34, s) with
quaternary carbons C-1″ (δC 166.9) and C-3″ (δC 168.0). Its
attachment at C-4 of the glucopyranoside moiety was suggested
by a downﬁeld shift of glucose C-4 (δC 72.0 in 9, vs δC 69.9 in
4) and conﬁrmed by the HMBC correlation of Glc-4 (δH 4.64,
dd, J = 9.5, 9.0 Hz) with C-1″ (δC 166.9) (Table 2). Thus,
compound 9 was established as quercetin 3-(4″-O-malonyl)-β-
glucopyranoside (9).
Besides the polyamine conjugate 1, the known polyamine
derivatives N1,N5(Z,Z),N10(E)-tri-p-coumaroylspermidine (2)
and N1,N5,N10,N14(E,E,E,E)-tetra-p-coumaroylspermine (3)
were identiﬁed (Tables S4 and S5, Supporting Information).
Their NMR and MS data were in good agreement with
previously reported values.30,31 Additional HPLC peaks I−IV
(Figure 1) corresponded to isomers of 1 and 2 and were
tentatively assigned by comparison of online spectroscopic data
with those of 1 and 2 (Table 1; Table S2, Supporting
Information). Thus, the peaks with molecular ions m/z 584
(m/z 606 [M + Na]+), m/z 600 (m/z 622 [M + Na]+), and m/
z 787 could be assigned to compounds 1−3 and their isomers
(I−IV). It thus appears that conjugated polyamines occurred in
all Asteraceae pollen, but were absent in pollen from other
plant families (Figure S2, Supporting Information). From the
MeOH extract of A. artemisiifolia several ﬂavonoid glycosides
(4−11) were identiﬁed by comparison of their NMR and MS
data with reported values.32−36 They were determined to be
derivatives of quercetin, kaempferol, and isorhamnetin (Table
S3; Tables S6−S13, Supporting Information). However, STLs
were absent in the THF or MeOH extracts prepared from ﬁve
diﬀerent lots of A. artemisiifolia pollen. From the THF extract
of A. psilostachya pollen (Ap1) the two major peaks (m/z 263.0
[M + H]+; m/z 264.9 [M + H]+) that corresponded to the
dominant peak in the ELSD trace (tR = 25.3 min) were isolated
(Figure S1, Supporting Information). The two compounds
were obtained as a mixture (70:30) and were identiﬁed as the
known sesquiterpene lactones coronopilin (13) and parthenin
(14) (Tables S14 and S15, Supporting Information).37,38 In
addition, the minor kaempferol glycoside 12 (not visible in
Figure S2, Supporting Information) was obtained.33 The
absence of sesquiterpene lactones in A. artemisiifolia was
conﬁrmed by a comparison of HPLC proﬁles of pollen with
those recorded with THF extracts from the aerial parts. The
HPLC-ESIMS proﬁles of ﬂowers and leaves showed peaks with
molecular ions m/z 243.1 [M + H]+, m/z 265.1 [M + H]+, m/z
232.2 [M + H]+, and m/z 234.1 [M + H]+) and UV spectra
(λmax ≈ 230 nm) that were indicative of additional
sesquiterpene lactones (Figures S11 and S13, Supporting
Information).
Non-Asteraceae Pollen Contain Electrophiles. Given
the electrophilic nature of many sesquiterpene lactones
including coronopilin (13) and parthenin (14), electrophiles
in all pollen samples and in leaves and ﬂowers of A.
artemisiifolia were quantiﬁed with the aid of a validated
spectrophotometric assay.39 Electrophilic metabolites in pollen
extracts were covalently trapped with N-acetyl-L-cysteine
(NAC). The excess of NAC was treated with Ellman’s reagent
to form 5-thio-2-nitrobenzoate dianion (TNB2−), which was
quantiﬁed by spectrophotometry at 412 nm. The concentration
of electrophiles was expressed as parthenolide (15) (Figures
S15−S17, Supporting Information). Since phenolic compounds
like curcumin have been shown to form adducts with
cysteine,40 quercetin, quercetin 3-O-β-glucoside, caﬀeic acid,
and 1 as typical representatives of pollen secondary metabolites
were tested for reactivity with NAC. Monitoring of adduct
formation by HPLC-ESIMS showed that only 15 formed an
Table 1. 1H and 13C NMR Spectroscopic Data for
Compound 1 (DMSO-d6, 500 MHz for
1H and 125 MHz for
13C NMR)
position type 1H [ppm] 13C [ppm]a
1 and 10 NH 7.96 and 7.89 (m)b
2 and 9 CH2 3.15 and 3.03 (m)
b 38.0, 37.7, 36.2, 35.7
3, 7,
and 8
CH2 1.27−1.77 (m) 28.0, 26.8, 26.3, 26.0,
25.6, 24.2
4 and 6 CH2 3.19−3.36 (m) 47.3, 45.4, 43.5, 42.0
1′/1‴ C 125.9
2′/2‴ CH 7.58 and 7.60 (each d, J =
8.6 Hz)
131.4
6′/6‴
3′/3‴ CH 6.71 (d, J = 8.6 Hz) 114.4
5′/5‴
4′/4‴ C 157.5
7′/7‴ CH 6.47 (d, J = 12.6 Hz) 135.9
8′/8‴ CH 5.79 (d, J = 12.6 Hz) 120.7
9′/9‴ C 165.8
1″ C 126.6
2″ CH 6.86 (br s) 115.5
3″ C 145.5d
4″ C 144.3d
5″ CH 6.68c 115.0
6″ CH 6.69c 120.2
7″ CH 6.37 and 6.33 (each d,
J = 12.6 Hz)
131.8
8″ CH 5.88 and 5.85 (each d, J =
12.6 Hz)
120.5
9″ C 167.9
a13C NMR chemical shifts were extracted from HSQC and HMBC
spectra. bAssigned by 2D NOESY. cSignals partially overlapped.
dAssigned on the basis of 13C NMR shifts predicted by ACD/
Laboratories software.
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adduct with NAC (Figure S18, Supporting Information).
Extracts of A. artemisiifolia pollen (six lots; Table S16,
Supporting Information), leaves (two lots), and ﬂowers (two
lots), A. psilostachya pollen (ﬁve lots, Table S17, Supporting
Information), and pollen extracts from other Asteraceae and
non-Asteraceae plant species were compared. Concentrations
of electrophiles in A. artemisiifolia leaves and ﬂowers were 10-
to 20-fold higher compared to six diﬀerent lots of pollen (Aa1−
Aa6; Figure S19, Supporting Information). The ﬁve lots of A.
psilostachya pollen (Ap1−Ap5) showed the highest concen-
tration of electrophiles among all pollen samples that were
analyzed. However, concentrations of coronopilin (13) and
parthenin (14) varied considerably between these lots. In
sample Ap1 they were the two dominant compounds of this
type. Ap5 had the highest concentration of electrophiles, but 13
was present only in traces and 14 was not detected. In Ap2,
compounds 13 and 14 were absent (Figure 3, Figure S20,
Supporting Information). Compared to A. psilostachya, pollen
from other Ambrosia and Artemisia species and from other
genera of the Asteraceae showed considerably lower concen-
trations of electrophiles. Interestingly, pollen from Phleum
pratense, Zea mays, Fagus sylvatica, and Urtica dioica (all non-
Asteraceae) contained electrophiles at concentrations com-
parable to some Asteraceae pollen (Figure S19, Supporting
Information). The limited amounts of pollen from these species
precluded a puriﬁcation and structural characterization of
electrophiles.
THF extracts from pollen of A. artemisiifolia (Aa1) and A.
psilostachya (Ap1), the mixture of coronopilin (13) and
parthenin (14), and a mixture of conjugated polyamines (1−
3, and I−IV) were tested in murine aﬀerent neurons and
tracheal ring preparations.
Electrophiles Increase [Ca2+]i in Murine Aﬀerent
Neurons. The intracellular calcium concentration [Ca2+]i was
measured with the aid of calcium imaging after stimulation of
murine aﬀerent neurons with A. artemisiifolia and A. psilostachya
pollen extracts and with a mixture of compounds 13 and 14.
Conjugated polyamines were not soluble under the assay
conditions and were not tested. At the ﬁnal DMSO
concentration (0.1%), which was also used as a vehicle control,
only a low number of cinnamaldehyde-responsive (CA+; 8%, n
= 107) and cinnamaldehyde-unresponsive (CA−; 2%, n = 90)
neurons showed an increase in [Ca2+]i. A. psilostachya extract
and compounds 13 and 14 increased [Ca2+]i in 32% (n = 207)
and 37% (n = 372) of CA+ neurons (p < 0.05 compared to
vehicle control) and only in 7% (n = 197) or 6% (n = 311) of
CA− neurons, respectively (not signiﬁcant compared to vehicle
control). The A. artemisiifolia extract increased [Ca2+]i in only
15% (n = 144) of CA+ neurons (not signiﬁcant compared to
vehicle control and CA− neurons) (Figure 2). For the two
pollen extracts tested, the number of activated neurons
appeared to correlate with the concentration of electrophiles.
Sesquiterpene Lactones Induce Relaxation of Murine
Tracheal Rings. Next, we studied the eﬀect of A. psilostachya
extract, a mixture of coronopilin (13) and parthenin (14), and a
mixture of conjugated polyamines (1−3 and I−IV) on murine
tracheal ring preparations. Tracheal tone in naiv̈e and
methacholine-constricted tracheal rings was recorded in
response to vehicle (0.5% DMSO), extract, and compounds.
In naiv̈e tracheal rings A. psilostachya extract and conjugated
Chart 1
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polyamines had no signiﬁcant eﬀect on tracheal tone (Figures
3A and C, Figure 4A). In contrast, 13/14 induced signiﬁcant
relaxation (p = 0.017; Figure 3B). After washing, the tracheal
rings were constricted with methacholine (muscarinic receptor
agonist known to induce a strong tracheal constriction).
Interestingly, the magnitude of constriction in the 13/14-
pretreated tracheal rings was signiﬁcantly lower compared to
control (p < 0.05). Methacholine-constricted tracheal rings
were treated with either A. psilostachya extract (Figure 3A), 13/
Table 2. 1H and 13C NMR Spectroscopic Data for
Compound 9 (DMSO-d6, 500 MHz for
1H and 125 MHz for
13C NMR)
position type 1H [ppm] 13C [ppm]
2 C 156.7
3 C 133.2
4 C 177.4
5 C 161.2
6 CH 6.21 (br s) 98.8
7 C 164.3
8 CH 6.41 (br s) 93.7
9 C 156.4
10 C 104.0
1′ C 121.1
2′ CH 7.61 (d, J = 2.2 Hz) 116.3
3′ C 144.9
4′ C 148.6
5′ CH 6.87 (d, J = 8.5 Hz) 115.3
6′ CH 7.56 (dd, J = 8.5, 2.2 Hz) 121.5
1″ C 166.9
2″ CH2 3.34 (s) 40.6
3″ C 168.0
Glc-1 CH 5.53 (d, J = 7.6 Hz) 101.1
Glc-2 CH 3.40a 74.4
Glc-3 CH 3.51 (dd, J = 9.0, 9.0 Hz) 74.4
Glc-4 CH 4.64 (dd, J = 9.5, 9.0 Hz) 72.0
Glc-5 CH 3.37a 75.0
Glc-6 CH2 3.43 (dd, J = 11.8, 2.0 Hz) 60.6
3.25 (dd, J = 11.8, 6.0 Hz)
aSignals partially overlapped.
Figure 2. Stimulation of murine dorsal root ganglia neurons with
pollen extracts and sesquiterpene lactones. A. psilostachya THF (lot
Ap1) extract and coronopilin (13)/parthenin (14) increased the
[Ca2+]i in 32% and 37% of CA+ neurons, respectively. A. artemisiifolia
THF (lot Aa1) extract induced an increase of [Ca2+]i in 15% of CA+
neurons. Cinnamaldehyde (CA) was used as positive control. CA+
and CA− designate cinnamaldehyde-responsive and -unresponsive
neurons, respectively. DMSO (0.5% in assay) was used as vehicle
control.
Figure 3. Mean cumulative time-response curves for the constrictive
response of murine tracheal rings in organ bath experiments to A.
psilostachya THF (lot Ap1) extract (A), coronopilin (13)/parthenin
(14) (B), and conjugated polyamines 1−3 and I−IV (C). DMSO
(0.1% in assay) was used as vehicle control, and methacholine was
used to induce constriction of tracheal rings.
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14 (Figure 3B), or conjugated polyamines (Figure 3C).
Conjugated polyamines had no eﬀect on methacholine-
constricted tracheal rings (Figure 3C), while A. psilostachya
extract and 13/14 both caused signiﬁcant relaxation (p < 0.05).
An initial large phytochemical proﬁling of plant pollen was
conducted, with a focus on pollen known to be allergic to
varying degrees. Caﬀeoyl and coumaroyl conjugates of
spermine and spermidine were found to be characteristic of
the family Asteraceae. The compounds coronopilin (13) and
parthenin (14) were detected only in the pollen of A.
psilostachya, albeit at varying concentrations in the diﬀerent
lots. The six lots of A. artemisiifolia pollen that were analyzed
herein did not contain STLs present in the leaves and ﬂowers.
Concentrations of electrophiles were found to be consistently
low among the A. artemisiifolia pollen lots analyzed in our
study, but were 15- to 20-fold higher in ﬂowers and leaves.
These ﬁndings are in contrast to earlier studies reporting a high
concentration of STLs in pollen of A. artemisiifolia collected in
Italy.41 Diﬀering STL proﬁles of A. artemisiifolia collected in the
US and in Europe suggest the occurrence of distinct
chemotypes41,42 that might also comprise accessions with low
concentrations of STLs in pollen. In turn, the concentrations of
electrophiles in pollen of other species in the Asteraceae were
variable but consistently lower than in A. psilostachya.
Interestingly, metabolites with electrophilic properties were
also detected in pollen from non-Asteraceae species, and their
concentrations were comparable to those found in pollen of
most species in the Asteraceae. The nature of these
electrophilic compounds remains to be investigated.
Testing of pollen extracts and pure compounds for increase
of [Ca2+]i in murine aﬀerent neurons and for constriction in
murine tracheal rings led to somewhat conﬂicting results.
TRPA1-mediated Ca2+ inﬂux in aﬀerent neurons was propor-
tional to the concentration of electrophiles in A. artemisiifolia
and A. psilostachya pollen extracts, and the rise of [Ca2+]i would
be expected to induce tracheal constriction.24,43 However, A.
psilostachya and the mixture of coronopilin (13) and parthenin
(14) induced relaxation in both methacholine-constricted and
native tracheal rings. This eﬀect could possibly be due to an
activation of bitter receptors (T2Rs), via a Ca2+-mediated
activation of the large conductance Ca2+-dependent K+ channel
(BKCa) channel and subsequent hyperpolarization and smooth
muscle relaxation.27,44,45 The relaxation of methacholine-
constricted trachea caused by these compounds could possibly
also be linked to the disruptive character of electrophiles on
synaptic or neuromuscular junction proteins (electrophilic
neurotoxicants).46 Further experiments are needed to elucidate
the molecular mechanism behind these biological observations.
Polyamine conjugates did not aﬀect the tracheal tone, in
Figure 4. Eﬀect of pollen extracts and isolated compounds on naiv̈e
and methacholine-constricted murine tracheal rings. All values were
normalized to the maximal response to methacholine (MCh). The
pretreatment of tracheal rings with conjugated polyamines 1−3 and I−
IV (conj. PAs; 30 mM, n = 4) and A. psilostachya THF extract (lot
Ap1; 300 μM, n = 6) did not signiﬁcantly diﬀer from the negative
control (0.1% DMSO). The mixture of coronopilin (13)/parthenin
Figure 4. continued
(14) (100 μM, n = 6) induced weak but signiﬁcant relaxation in naiv̈e
tracheal rings (p = 0.017) (A). The maximal MCh-induced tracheal
constriction remained unaltered after pretreatment with conj. PAs (30
mM, n = 4) and A. psilostachya (300 μM, n = 6), and was comparable
to pretreatment with 0.1% DMSO. In contrast, a signiﬁcant (* = p <
0.05) decrease of the maximal MCh-induced constriction was
observed by pretreatment of naiv̈e tracheal rings with coronopilin
(13)/parthenin (14) (B). The second exposure of MCh-precon-
stricted tracheal rings with A. psilostachya (p = 0.001) and coronopilin
(13)/parthenin (14) (p = 0.004), at time points 3 min (C) and 9 min
(D), resulted in a time-dependent relaxation.
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contrast to the known eﬀects of free polyamines spermidine
and spermine.28,47 Given the high enzymatic activity in airway
epithelial tissue,48 a release of physiologically relevant
concentrations of free polyamines from polyamine conjugates
is conceivable but requires further investigation. Also, the
chemical nature of electrophiles in the pollen of plants other
than in the Asteraceae and their possible activities need to be
explored.
■ EXPERIMENTAL SECTION
General Experimental Procedures. NMR spectra were recorded
on a Bruker AVANCE III 500 MHz spectrometer (Bruker BioSpin)
equipped with a 1 mm TXI microprobe (1H detected experiments) or
a 5 mm BBO probe (for 13C NMR spectra) operating at 500 (1H) and
125 MHz (13C), respectively. All experiments were carried out at
291.15 K. Chemical shifts are reported as δ values (ppm) with the
residual solvent signal as internal reference, J in Hz. Standard pulse
sequences of the software package Topspin 3.0 were used. HPLC-
PDA-MS-ELSD proﬁling was carried out on an HPLC system
consisting of a degasser, binary high-pressure mixing pump, column
thermostat, PDA detector (SDP-M20A) with thermostated UV cell,
and a triple quadrupole LCMS-8030 with ESI interface coupled via T
split (all Shimadzu). Both positive- and negative-ion HPLC-ESIMS
chromatograms were recorded simultaneously in the range of m/z 160
to 1500; capillary voltage: 4.5 V; scan speed: 6000 u/s; event time:
0.150 s. The second line of the T-splitter was connected to a model
3300 ELSD (Alltech). ELSD settings were as follows: nitrogen ﬂow:
2.5 L/min, temperature: 55 °C, detector gain: 8. Data acquisition and
analysis was performed with LabSolutions software (Shimadzu).
HRESIMS were recorded with a micrOTOF ESIMS system (Bruker
Daltonics) connected to a 1100 series HPLC (Agilent). Mass spectra
were recorded in the range m/z 160 to 1500 in the positive-ion mode
with the aid of micrOTOF control software 1.1 (Bruker Daltonics).
Mass calibration was performed with a solution of 0.1% formic acid in
2-propanol−water (1:1) containing 5 mM NaOH. HPLC grade
MeOH, MeCN (Scharlau), and H2O (EASY-pure II, Barnstead,
Dubuque) were used for HPLC separations. A 1100 series instrument
with PDA detector (Agilent) was used for semipreparative isolation
and puriﬁcation. HPLC solvents used for analytical separation
contained 0.1% HCOOH (Scharlau). HPLC samples were dissolved
in DMSO (Scharlau). DMSO-d6 and MeOH-d4 (100 atom %D) for
NMR experiments were purchased from Amar Chemicals. Sephadex
LH-20 (GE Healthcare) column chromatography was performed using
a B-688 pump (Büchi) and a SuperFrac fraction collector (Pharmacia
Biotech). For extraction and column chromatography, technical grade
solvents were used after distillation. Analytical scale extraction of
pollen material was performed by pressurized liquid extraction using
an ASE 200 instrument with attached solvent controller (Dionex).
Preparative scale extraction was performed by maceration. Spectro-
photometric measurements were performed with a Lambda 35
instrument (PerkinElmer). Samples were analyzed in standard 1 cm
cuvettes.
Plant Material. Pollen material was purchased from Allergon AB
(Ängelholm, Sweden) and GREER Laboratories (Lenoir, NC, USA),
and voucher specimens (969−1010) were deposited at the Depart-
ment of Pharmaceutical Biology, University of Basel, Switzerland. A
complete list of pollen and sample-related information are given in
Supporting Information, Tables S1, S16, and S17. A. artemisiifolia
leaves and ﬂowers, collected on the outskirts of Novara (Italy), were
provided by Prof. Giovanni Appendino, Universita ̀ degli Studi del
Piemonte Orientale, Italy. Voucher specimens designated with the
codes 1008, 1009 (ﬂowers), and 1010, 1011 (leaves) are deposited at
the Department of Pharmaceutical Biology, University of Basel.
HPLC Separation. Analytical scale separation was performed at 40
°C on a SunFire C18 (150 × 3.0 mm; 3.5 μm; Waters) column
equipped with a guard column (20 × 3.0 mm) with 0.1% HCOOH in
H2O (solvent A) and 0.1% HCOOH in MeOH (solvent B) as mobile
phase. The following gradient proﬁle was used: 0−2 min 5% B
isocratic, 2−50 min 5−100% B, 52−62 min 100% B. The ﬂow rate was
0.4 mL/min, and sample injection volume was 2 μL. Semipreparative
separations were carried out at 25 °C on a SunFire C18 (150 × 10 mm;
5 μm; Waters) column equipped with a precolumn (10 × 10 mm).
Gradients of water and MeCN were used. The ﬂow rate was 4 mL/
min.
Extraction and Isolation. Dried A. artemisiifolia leaves and ﬂowers
were ground with a ZM 1 ultracentrifugal mill. Aliquots (300 mg) of A.
artemisiifolia pollen, leaves, and ﬂowers, A. psilostachya pollen, and
pollen samples from other species were separately packed into steel
cartridges and extracted by pressurized liquid extraction. Samples were
sequentially extracted with n-hexane, THF, and MeOH (3 × 5 min
cycles per solvent, 120 °C, 70 bar). Extracts were dried on a rotary
evaporator. For preparative scale extraction, A. artemisiifolia pollen
(Aa1) (95 g) was extracted at room temperature sequentially with n-
hexane, THF, and MeOH (3 × 8 h per solvent, 500 mL each). n-
Hexane, THF, and MeOH extracts were dried on a rotary evaporator,
yielding 10.8 g (11.3%), 3.0 g (3.2%), and 17.0 g (17.9%), respectively.
THF (2.8 g) and MeOH (12.0 g) extracts of A. artemisiifolia were both
separated on a Sephadex LH-20 column (7 × 100 cm i.d.) eluted with
MeOH at a ﬂow rate of 1.5 mL/min. Fractions of 15 min were
collected. A total of 10 fractions (1−10) were combined based on
TLC analysis. Fractions T5 (232 mg) and T6 (283 mg) from the THF
extract contained conjugated polyamines, and fractions M4 (441 mg),
M5 (290 mg), and M6 (215 mg) from the MeOH extract consisted
mainly of ﬂavonoids. All fractions were submitted to semipreparative
HPLC. Fraction T5 aﬀorded compound 1 (3.1 mg; tR = 27.0 min),
compound 2 (4.2 mg; tR = 28.4 min), and mixture of polyamine
isomers I−IV (10.4 mg). Compound 3 (2.7 mg; tR = 32.4 min) was
obtained from fraction T6. Compounds 4 (6.5 mg; tR = 26.1 min), 8
(4.0 mg; tR = 29.6 min), and 9 (6.3 mg; tR = 30.1 min) were puriﬁed
from fraction M4, and compounds 5 (4.6 mg; tR = 27.2 min) and 10
(2.1 mg; tR = 30.5 min) from fraction M5. Compound 6 (4.3 mg; tR =
27.7 min), 7 (5.2 mg; tR = 29.1 min), and 11 (4.9 mg; tR = 30.9 min)
were isolated from fraction M6. Compound 12 (0.9 mg; tR = 30.5
min) and a mixture of 13 and 14 (1.5 mg; tR = 25.6 min) were isolated
from the A. psilostachya (Ap1) THF extract (12.4 mg) obtained from
970 mg of pollen. Retention times given for compounds 1−14 refer to
the analytical HPLC conditions given above.
N1,N10(Z,Z)-di-p-Coumaroyl-N5(Z)-caﬀeoylspermidine (1): white,
amorphous solid; [α]22D −37 (c 0.8, DMSO); UV (DMSO) λmax (log
ε) 272 (3.85) nm; 1H NMR (DMSO, 500 MHz) and 13C NMR
(DMSO, 125 MHz), see Table 1; HRESIMS m/z 600.2400 [M + H]+
(calcd for C34H37N3O7, 600.2409).
Quercetin 3-(4″-O-malonyl)-β-glucopyranoside (9): yellow, amor-
phous solid; [α]22D −79 (c 0.7, MeOH); UV (DMSO) λmax (log ε)
260 (3.62), 352 (3.88) nm; 1H NMR (DMSO, 500 MHz) and 13C
NMR (DMSO, 125 MHz), see Table 2; HRESIMS m/z 551.1071 [M
+ H]+ (calcd for C24H22O15, 551.0959).
Spectrophotometric Quantiﬁcation of Electrophiles. N-
Acetyl-L-cysteine and parthenolide were from Sigma-Aldrich, and
5,5′-dithiobis(2-nitrobenzoic acid) (DTNB or Ellman’s reagent),
triethylamine (TEA), and anhydrous sodium phosphate (HNa2PO4)
from Fluka. Sodium dihydrogen phosphate (H2NaPO4) was from
Merck. As a source of cysteine residues, a stock solution of N-acetyl-L-
cysteine in MeOH (0.429 mg/mL) was prepared daily. The stock
solution of Ellman’s reagent was obtained by dissolving 16 mg of
DTNB in 1 mL of sodium phosphate buﬀer (pH 8; 74 mg of
NaH2PO4·H2O and 1.68 g of anhydrous Na2HPO4 in 100 mL of
distilled water). TEA was used undiluted. For the calibration curve, a
stock solution of parthenolide in MeOH was prepared at a
concentration of 1.13 mg/mL. Five diﬀerent concentrations of
parthenolide (15) (ranging from 4.55 to 45.5 μM) were prepared
by mixing 200 μL of cysteine stock solution, 40 μL of TEA, and
incubation of 10, 20, 30, 50, and 100 μL of parthenolide stock solution
for 40 min at room temperature. At the end of the incubation, 30 μL
of Ellman’s reagent was added, and the solution was diluted with
MeOH to 10.0 mL (reaction described in Figure S15, Supporting
Information). A blank solution was prepared by mixing 200 μL of
MeOH, 40 μL of TEA, and 30 μL of Ellman’s reagent and diluted to
10.0 mL with MeOH. The absorbance was measured at 412 nm
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against the blank. The calibration curve y = −0.0047x + 0.8318
showed a correlation coeﬃcient (R2) of 0.9972 (Figure S16,
Supporting Information) and was used for the calculation of %
electrophiles in the extract. For the determination of electrophiles in
pollen extracts, the following procedure was used: n-hexane, THF, and
MeOH extracts were dissolved in DMSO at a concentration of 25 mg/
mL and ﬁltered if needed. The samples were prepared by mixing 200
μL of cysteine stock solution and 40 μL of TEA and incubating 20 μL
of extract (MeOH as control) for 40 min, at room temperature. After
the incubation time, 30 μL of Ellman’s reagent was added, and the
mixture was diluted with MeOH to 10.0 mL. The concentration of
electrophiles in the extracts was calculated with the formula described
in Figure S17, Supporting Information.
Measurement of Intracellular Ca2+ Increase. The intracellular
[Ca2+]i measurements were performed with dissociated jugular/
nodose neurons. The coverslip was loaded with Fura-2 AM (8 μm)
in L-15 medium containing 20% fetal bovine serum and incubated for
30 min at 37 °C. The coverslip was placed in a Bioptechs Delta T
(Butler) that was superfused with Locke’s solution [at 37 °C;
composed of (mM): 136 NaCl, 5.6 KCl, 1.2 MgCl2, 2.2 CaCl2, 1.2
NaH2PO4, 14.3 NaHCO3, and 10 dextrose; pH 7.3−7.4] for 20 min
before the experiment by an infusion pump (8 mL/min). Changes in
intracellular [Ca2+]i were measured by digital microscopy (Leica
DM5000B) equipped with an X-Cite 200DC illumination system
(Waltham) for ratiometric recording of single cells. A ﬁeld of cells was
monitored by sequential dual excitation, 360 and 380 nm, and the
analysis of the image ratios used methods previously described. Ratio
images were acquired every second. Superfused buﬀer was stopped 20
s prior to test material applications. In each experiment, the cells on
the coverslip were exposed to vehicle (0.1% DMSO or EtOH),
cinnamaldehyde (100 μM), capsaicin (1 μM), and KCl (80 mM) for 1
min each. Between each stimulus, the cells were washed with fresh
buﬀer for at least 2 min for the cells to recover prior to the addition of
the second stimulus. Each set of images for the Ca2+ measurements
also included a bright ﬁeld image of the ﬁeld of cells under study. Cells
that had an average diameter (long and short axis) of over 15 μm were
analyzed. Those cells that failed to respond to capsaicin were
considered healthy neurons only if they responded to KCl with a rapid
rise in Ca2+.
Assessment of Tracheal Ring Constriction. Tracheal rings were
isolated from male and female C57BL/6 mice (age range: 10 to 16
weeks), respectively. Until use, the segments were stored at +4 °C in
MEM gassed with a 95% O2−5% CO2 gas mixture. Stainless steel wire
hooks were inserted from each side into the tracheal segments,
connected to an isometric force transducer (Hugo Basile), placed in an
isolated organ bath ﬁlled with 15 mL of MEM, and oxygenated with a
95% O2−5% CO2 gas mixture at 37 °C. Tension due to isometric
changes in airway tone was recorded, processed, and analyzed by
LabChart 7 software (AD Instruments). The experiment started after
equilibrating the tracheas for at least 30 min in the bath at a tension of
0.5 g. Airway constriction was measured after application of DMSO
(vehicle, 0.5%), A. psilostachya THF extract (300 μM), 1−3, and I−IV
(30 mM), or a mixture of compounds 13 and 14 (100 μM),
respectively, which were allowed to incubate for at least 20 min. After
washing, methacholine (100 μM) was added. After maximal
constriction was reached, DMSO (vehicle, 0.5%), A. psilostachya
THF extract (300 μM), 1−3, and I−IV (30 mM), or the mixture of 13
and 14 (100 μM), respectively, was added again, and the smooth
muscle contraction was measured.
All animal experiments were performed in accordance with the
German animal welfare law and had been declared to the Animal
Welfare Oﬃcer of the University of Giessen (Registration No.
426_M). The animal housing facility was licensed by the local
authorities. The methods used to euthanize the animals humanely
were consistent with the recommendations of the AVMA Guidelines
for the Euthanasia of Animals.
Statistical Analysis. Values in the text and ﬁgures are expressed as
the arithmetic means ± the standard error of the mean (SEM) from
experiments with tracheas from 4 to 10 independent mice. Increasing
isometric smooth muscle tone corresponds to increasing isometric
force expressed as force expressed in grams (g) and converted to %.
Data were evaluated statistically in an analysis of variance and the
Kruskal−Wallis or Mann−Whitney−U post-test, depending on the
number of groups that were compared. Diﬀerences in the abundance
of neurons responding to cinnamaldehyde or pollen extracts,
respectively, were calculated by using the chi-square test. A diﬀerence
was considered statistically signiﬁcant when the probability value p was
below 0.05 (p < 0.05).
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Figure S1. Comparative HPLC-PDA-ESIMS-ELSD analysis of THF extracts from pollen of 30 plant species. 
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Figure S1. (continued). 
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Figure S1. (continued). 
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Figure S2. 2D heat map of HPLC-ESIMS+ metabolite profiles of THF extracts from A. artemisiifolia (lot Aa1), 
A. psilostachya (lot Ap1), and pollen from other Asteraceae and non-Asteraceae species. The x-axis represents 
the Rt-m/z of molecular ions. Botanical origins of pollen are listed to the right of the y-axis, and clustering is 
provided on the left side of the y-axis. The color-coded matrix elements represent the relative intensity of each 
ion. Asterisks with Rt-m/z represent the importance of each ion in the construction of clusters: no asterisk – 
weighting equals zero (present in a restricted number of samples), “*” – weighting factor within 0 and 0.1, “**” - 
weighting factor within 0.1 and 0.5, “***” – weighting factor within 0.5 and 1.0 (present in many samples). 
Colored squares below RT-m/z indicate known or only partially identified metabolites. Black: conjugated 
polyamines; blue: coronopilin (13)/parthenin (14); green: unidentified sesquiterpene lactones; orange: partially 
characterized polyphenols. 
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Figure S3. 1H-NMR spectrum of compound 1 (500 MHz, DMSO-d6). 
 
 
Figure S4. 1H-1H COSY spectrum of compound 1 (500 MHz, DMSO-d6). 
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Figure S5. Overlay of HSQC (blue/green) and HMBC (red) spectra of compound 1 (500/125 MHz, DMSO-d6). 
 
 
 
Figure S6. 2D 1H-1H ROESY spectrum of compound 1 (500 MHz, DMSO-d6). 
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Figure S7. 1H-NMR spectrum of compound 9 (500 MHz, DMSO-d6). 
 
 
Figure S8. 1H-1H COSY spectrum of compound 9 (500 MHz, DMSO-d6). 
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Figure S9. Overlay of HSQC (blue/green) and HMBC (red) spectra of compound 9 (500/125 MHz, DMSO-d6). 
 
 
Figure S10. DEPTq spectrum of compounds 9 (500 MHz, DMSO-d6). 
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Figure S11. HPLC-PDA-ESIMS-ELSD analysis of THF extract from A. artemisiifolia flowers. 
 
 
 
 
 
 
Figure S12. HPLC-PDA-ESIMS-ELSD analysis of MeOH extract from A. artemisiifolia flowers. 
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Figure S13. HPLC-PDA-ESIMS-ELSD analysis of THF extract from A. artemisiifolia leaves. 
 
 
 
 
 
 
Figure S14. HPLC-PDA-ESIMS-ELSD analysis of MeOH extract from A. artemisiifolia leaves. 
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Figure S15. Spectrophotometric quantification of electrophiles with N-acetyl-L-cysteine and Ellman’s reagent. 
Electrophiles (15) react with sulfhydryl groups (N-acetyl-L-cysteine) to form adducts (adduct 1) (1). Excess N-
acetyl-L-cysteine reacts with Ellman’s reagent to form the yellow TNB2- ion, which can be quantified at 412 nm 
(2).  
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Figure S16. Calibration curve for parthenolide (15). 
 
 
 
 
𝑦 = −0.0047𝑥 + 0.8318 
𝑦 = 𝐴 = 𝐴2 − 𝐴1 
% 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑝ℎ𝑖𝑙𝑒𝑠𝑒𝑥𝑡𝑟. =
𝑥 ∙ 248.3
500
 
Figure S17. Calculation of the % of electrophiles in extract, quantified as parthenolide (15). y = -0.0047x + 
0.8318 is the equation obtained from the calibration curve (Figure S11). A is the absorbance (A2 – A1), where A2 
is the absorbance after the entire N-acetyl-L-cysteine reacted with Ellman’s reagent producing the fluorescent 
TNB2-; excess of N-acetyl-L-cysteine is incubated with extracts and the absorbance related to the unreacted 
fraction of sulfhydryl groups is represented as A1; 248.3 is the molecular weight of parthenolide. 500 correspond 
to 500 μg of extract present in 10 mL of sample (measuring concentration); all measurements were performed at 
412 nm. 
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Figure S18. Adduct formation of N-acetyl-L-cysteine and selected phytochemicals in plant pollen, monitored by 
HPLC-ESIMS (positive ion mode). (A) Triethylamine, Ellman’s reagent, N-acetyl-L-cysteine (reagents); caffeic 
acid, quercetin 3-O-β-glucoside, p-coumaroylspermidine, quercetin (negative controls); parthenolide (positive 
control) were first injected individually to determine their retention time and molecular ions. (B) HPLC-ESIMS 
(positive ion mode) chromatograms measured after incubating N-acetyl-L-cysteine with negative and positive 
controls, respectively. Only parthenolide reacted with N-acetyl-L-cysteine forming adduct 1. The unreacted 
fraction of N-acetyl-L-cysteine formed adduct 2 with Ellman’s reagent. Trimethylamine was used as N-acetyl-L-
cysteine activator.  
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Figure S19. HPLC-ESIMS detection of 13 and 14 in THF extracts prepared from five different lots of A. 
psilostachya pollen. 
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Table S1. Commercially available pollen included in the study. 
 
 plant species lot # supplier 
1. Baccharis halimifolia (Asteraceae) P2195277 Greer 
2. Hymenoclea salsola (Asteraceae) P3618767 Greer 
3. Xanthium strumarium (Asteraceae) P3766835-2 Greer 
4. Eupatorium capillifolium (Asteraceae) P3401503 Greer 
5. Iva annua (Asteraceae) P3787377-1 Greer 
6. Iva angustifolia (Asteraceae) 94443 Greer 
7. Artemisia ludoviciana (Asteraceae) P3397739 Greer 
8. Ambrosia deltoidea (Asteraceae) P3557881-2 Greer 
9. Ambrosia dumosa (Asteraceae) P3408578 Greer 
10. Ambrosia trifida (Asteraceae) P3685399-6 Greer 
11. Ambrosia confertiflora (Asteraceae) P3670198 Greer 
12. Ambrosia bidentata (Asteraceae) P3743121 Greer 
13. Ambrosia psilostachya (Asteraceae) P3406293-1 Greer 
14. Ambrosia acanthicarpa (Asteraceae) P3760470 Greer 
15. Artemisia frigida (Asteraceae) 115587 Greer 
16. Artemisia tridentata (Asteraceae) P3771025-1 Greer 
17. Leucanthemum vulgare (Asteraceae) 254739 Greer 
18. Helianthus annuus (Asteraceae) P3716774 Greer 
19. Ambrosia artemisiifolia (Asteraceae) 020512201 Allergon AB 
20. Artemisa vulgaris (Asteraceae) 101112101 Allergon AB 
21. Solidago virgaurea (Asteraceae) 025912101 Allergon AB 
22. Taraxacum officinale (Asteraceae) 010711101 Allergon AB 
23 Betula pendula (Betulaceae) 012510101 Allergon AB 
24. Carpinus betulus (Betulaceae) 027309702 Allergon AB 
25. Corylus avellana (Corylaceae) 012713701 Allergon AB 
26. Fagus sylvatica (Fagaceae) 012813101 Allergon AB 
27. Olea europea (Oleaceae) 032511201 Allergon AB 
28. Phleum pretense (Poaceae) 011312102 Allergon AB 
29. Zea mays (Poaceae) 012013101 Allergon AB 
30. Urtica dioica (Urticaceae) 014812101 Allergon AB 
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Table S2. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 1 (DMSO-d6, 500 MHz for 
1H, and 125 MHz for 13C NMR) 
N1,N10(Z,Z)-di-p-coumaroyl-N5(Z)-caffeoylspermidine                  
accurate mass found 600.2400 [M+H]+ 
accurate mass calculated 600.2409 [M+H]+ 
molecular formula C34H37N3O7 
 
 
 
 
 
 
 
 
 
NMR data  
position 1H [ppm] 13Ca[ppm] 
1 and 10 7.96 and 7.89 (m) b - 
2 and 9 3.15 and 3.03 (m) b 38.0, 37.7, 36.2, 35.7 
3, 7 and 8 1.27-1.77 (m) 28.0, 26.8, 26.3, 26.0, 25.6, 24.2 
4 and 6 3.19-3.36 (m) 47.3, 45.4, 43.5, 42.0 
1ʹ/1ʹʹʹ - 125.9 
2ʹ/2ʹʹʹ 
6ʹ/6ʹʹʹ 
7.58 and 7.60 (each d, J=8.6 
Hz) 
131.4 
3ʹ/3ʹʹʹ 
5ʹ/5ʹʹʹ 
6.71 (d, J=8.6 Hz) 114.4 
4ʹ/4ʹʹʹ - 157.5 
7ʹ/7ʹʹʹ 6.47 (d, J=12.6 Hz) 135.9 
8ʹ/8ʹʹʹ 5.79 (d, J=12.6 Hz) 120.7 
9ʹ/9ʹʹʹ - 165.8 
1ʹʹ - 126.6 
2ʹʹ 6.86 (br s) 115.5 
3ʹʹ - 145.5d 
4ʹʹ - 144.3d 
5ʹʹ 6.68 c 115.0 
6ʹʹ 6.69 c 120.2 
7ʹʹ 6.37 and 6.33 (each d, 
J=12.6 Hz) 
131.8 
8ʹʹ 5.88 and 5.85 (each d, 
J=12.6 Hz) 
120.5 
9ʹʹ - 167.9 
a 13C NMR chemical shifts were extracted from HSQC and HMBC spectra. 
b Assigned by 2D NOESY. 
c Signal partially overlapped. 
d  Assigned on the basis of 13C NMR shifts predicted by ACD/Labs software. 
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Table S3. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 9 (DMSO-d6, 500 MHz for 
1H, and 125 MHz for 13C NMR) 
quercetin 3-O-(4ˮ-O-malonyl)-β-glucopyranoside 
accurate mass found 551.1071 [M+H]+ 
accurate mass calculated 551.0959 [M+H]+ 
 
molecular formula C24H22O15 
 
 
 
 
 
 
 
 
 
 
 
 
NMR data  
position 1H [ppm] 13Ca[ppm] 
2 - 156.7 
3 - 133.2 
4 - 177.4 
5 - 161.2 
6 6.21 (br s) 98.8 
7 - 164.3 
8 6.41 (br s) 93.7 
9 - 156.4 
10 - 104.0 
1ʹ - 121.1 
2ʹ 7.61 (d, J=2.2 Hz) 116.3 
3ʹ  144.9 
4ʹ - 148.6 
5ʹ 6.87 (d, J=8.5 Hz) 115.3 
6ʹ 7.56 (dd, J=8.5, 2.2 Hz) 121.5 
1ʹʹ - 166.9 
2ʹʹ 3.34 (s) 40.6 
3ʹʹ - 168.0 
Glc-1 5.53 (d, J=7.6 Hz) 101.1 
Glc-2 3.40b 74.4 
Glc-3 3.51 (dd, J=9.0, 9.0 Hz) 74.4 
Glc-4 4.64 (dd, J=9.5, 9.0 Hz) 72.0 
Glc-5 3.37b 75.0 
Glc-6 3.43 (dd, J=11.8, 2.0 Hz) 
3.25 (dd, J=11.8, 6.0 Hz) 
60.6 
a Signal partially overlapped. 
b Signal partially overlapped.  
c  Not detected. 
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Table S4. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 2 (DMSO-d6, 500 MHz for 
1H, and 125 MHz for 13C NMR) 
N1N5(Z,Z),N10(E)-tri-p-coumaroylspermidine                
accurate mass found 584.1311 [M+H]+ 
accurate mass calculated 584.1340 [M+H]+ 
molecular formula C34H37N3O6 
 
 
 
 
 
 
 
 
 
NMR data  
position 1H [ppm] 13Ca[ppm] 
1  7.99 (m) b - 
2 and 9 3.16 and 3.06 (m) b 38.0, 37.8, 36.4, 36.0 
3, 7 and 8 1.28-1.81 (m) 28.3, 27.0, 26.5, 26.0, 25.4, 24.1 
4 and 6 3.40-3.20 (m) 47.2, 45.4, 43.5, 42.0 
10 7.91 (m) b  
1ʹ - 126.0 
2ʹ/6ʹ 7.58 and 7.60 (each d, J=8.0 
Hz) 
131.1 
3ʹ/5ʹ 6.74c  114.5 
4ʹ - 157.0 
7ʹ 6.50 (d, J=12.0 Hz) 135.8 
8ʹ 5.82/5.79 (d, J=12.0 Hz) 120.5 
9ʹ - 166.0 
1ʹʹ - 126.0 
2ʹʹ/6ʹʹ 7.25 and 7.23 (each d, J=8.0 
Hz) 
129.7 
3ʹʹ/5ʹʹ 6.74c  115.1 
4ʹʹ - 157.3 
7ʹʹ 6.45c 131.6 
8ʹʹ 5.95/5.91 (each d, J=12.0 
Hz) 
120.6 
9ʹʹ - 167.0 
1ʹʹʹ - 125.6 
2ʹʹʹ/6ʹʹʹ 7.40 c 128.6 
3ʹʹʹ/5ʹʹʹ 6.81c  115.3 
4ʹʹʹ - 158.6 
7ʹʹʹ 7.37c 138.4 
8ʹʹʹ 6.43c 118.4 
9ʹʹʹ - 165.4 
a 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
b Assigned by NOESY spectra.  
c Signal partially overlapped. 
 
 
 
 
 
 
S22 
 
Table S5. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 3 (DMSO-d6, 500 MHz for 
1H, and 125 MHz for 13C NMR) 
N1,N5,N10,N14(E,E,E,E)-tetra-p-coumaroylspermine               
accurate mass found 787.3611 [M+H]+ 
accurate mass calculated 787.3629 [M+H]+ 
molecular formula C46H50N4O8 
 
 
 
 
 
 
 
 
 
 
 
 
NMR data  
position 1H [ppm] 13Ca[ppm] 
1 and 14 8.05 and 7.93 (br m) - 
2, 4, 6, 9, 11, and 13 3.55-3.15b  46.6, 45.0, 44.7, 43.5, 36.3,36.0 
3, 7, 8 and 12 1.86-1.45b 29.5, 27.7, 26.5, 24.8 
1ʹ - 125.5 
2ʹ/6ʹ 
 
7.50-7.45b 129.3 
3ʹ/5ʹ 
 
6.74b  115.2 
4ʹ/4ʹʹʹ - c 
7ʹ 7.45 b,d 141.2 
8ʹ 6.90 b,d 114.4 
9ʹ - c 
1ʹʹ - 125.5 
2ʹʹ/6ʹʹ 
 
7.39 (d, J=8.0 Hz) 128.7 
3ʹ/5ʹ 
 
6.80 (d, J=8.0 Hz)  115.4 
4ʹ/4ʹʹʹ - 158.1 
7ʹʹ 7.36b,d 138.3 
8ʹʹ 6.44b,d 118.4 
9ʹʹ - c 
a 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
b Signal partially overlapped. 
c Not detected. 
d Assigned on the basis of 13C NMR shifts predicted by ACD/Labs software. 
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Table S6. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 4 (DMSO-d6, 500 MHz for 
1H, and 125 MHz for 13C NMR) 
quercetin 3-O-β-glucoside 
accurate mass found 465.0943 [M+H]+ 
accurate mass calculated 465.0955 [M+H]+ 
molecular formula C21H20O12 
 
 
 
 
 
 
 
 
 
 
 
NMR data  
Position 1H [ppm] 13Ca[ppm] 
2 - 156.1 
3 - 133.3 
4 - 177.4 
5 - 161.3 
6 6.20 (br s) 98.7 
7 - 164.3 
8 6.41 (br s) 93.5 
9 - 156.4 
10 - 103.9 
1ʹ - 121.2 
2ʹ 7.58 (br s) 116.2 
3ʹ - 144.8 
4ʹ - 148.5 
5ʹ 6.86 (d, J=8.6 Hz) 115.2 
6ʹ 7.58 (dd, J=8.6, 2.6 Hz) 121.6 
Glc-1 5.47 (d, J=7.0 Hz) 100.8 
Glc-2 3.23b 74.1 
Glc-3 3.22 b 76.5 
Glc-4 3.09 b 69.9 
Glc-5 3.09 b 77.6 
Glc-6 3.33 b 
3.60 (br d, J=11.6) 
61.0 
a 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
b Signal partially overlapped. 
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Table S7. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 5 (DMSO-d6, 500 MHz for 
1H, and 125 MHz for 13C NMR) 
isorhamnetin 3-O-(6ˮ-O-acetyl)-β-glucopyranoside 
accurate mass found 521.1201 [M+H]+ 
accurate mass calculated 521.1217 [M+H]+ 
 
molecular formula C24H24O13 
 
 
 
 
 
 
 
 
 
 
 
 
NMR data  
position 1H [ppm] 13Ca[ppm] 
2 - 156.8 
3 - c 
4 - c 
5 - 161.2 
6 6.22 (d, J=2.0 Hz) 98.5 
7 - 164.8 
8 6.46 (d, J=2.0 Hz) 93.4 
9 - 156.8 
10 - 103.8 
1ʹ - 120.9 
2ʹ 7.83 (d, J=2.0 Hz) 113.0 
3ʹ - 147.1 
4ʹ - 149.2 
5ʹ 6.92 (d, J=8.2 Hz) 114.9 
6ʹ 7.45 (dd, J=8.2, 2.0 Hz) 122.0 
7ʹ 3.86 (s) 55.5 
1ʹʹ - 170.0 
2ʹʹ 1.74 (s) 19.8 
Glc-1 5.42 (d, J=8.0 Hz) 100.9 
Glc-2 3.27 b 73.8 
Glc-3 3.27 b 76.0 
Glc-4 3.15 (m) 69.7 
Glc-5 3.34 (m)  73.9 
Glc-6 4.02 (dd, J=12.0, 6.0 Hz) 
4.09 (dd, J=12.0, 2.0 Hz) 
62.5 
a 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
b Signal partially overlapped. 
c  Not detected. 
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Table S8. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 6 (MeOH-d4, 500 MHz for 
1H, and 125 MHz for 13C NMR) 
kaempferol -3-O-β-glucopyranoside 
accurate mass found 449.1203 [M+H]+ 
accurate mass calculated 449.1176 [M+H]+  
 
molecular formula C21H20O11 
 
 
 
 
 
 
 
 
 
 
NMR data  
position 1H [ppm] 13Ca[ppm] 
2 - 157.8 
3 - 133.6 
4 - c 
5 - 161.6 
6 6.33 (d, J=2.0 Hz) 94.3 
7 - 164.5 
8 6.16 (d, J=2.0 Hz) 99.3 
9 - 156.9 
10 - 104.1 
1ʹ - 122.3 
2ʹ/6ʹ 8.01 (pseudo d, J=8.7, 2.0 Hz) 131.7 
3ʹ/5ʹ 6.87 (pseudo d, J=8.7, 2.0 Hz) 115.5 
4ʹ - 160.0 
Glc-1 5.17 (d, J=7.0 Hz) 103.8 
Glc-2 3.46b 75.2 
Glc-3 3.44b 77.5 
Glc-4 3.33 (dd, J=9.5, 9.0 Hz) 70.9 
Glc-5 3.23 (ddd, J=9.0, 6.0, 2.0 Hz) 77.8 
Glc-6 3.69 (ddd, J=12.0, 2.0 Hz) 
3.54 (ddd, J=12.0, 6.0 Hz) 
62.4 
a 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
b Signal partially overlapped. 
c  Not detected. 
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Table S9. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 7 (DMSO-d6, 500 MHz for 
1H, and 125 MHz for 13C NMR) 
isorhamnetin 3-O-β-glucopyranoside 
accurate mass found 478.0987 [M+H]+ 
accurate mass calculated 478.1011 [M+H]+ 
 
molecular formula C22H22O12 
 
 
 
 
 
 
 
 
 
 
 
 
NMR data  
position 1H [ppm] 13Ca[ppm] 
2 - 155.9 
3 - 133.0 
4 - c 
5 - 160.9 
6 6.22 (d, J=2.0 Hz) 98.5 
7 - 163.9 
8 6.45 (d, J=2.0 Hz) 93.5 
9 - 156.2 
10 - 103.5 
1ʹ - 120.6 
2ʹ 7.93 (d, J=2.0 Hz) 113.4 
3ʹ - 146.6 
4ʹ - 148.3 
5ʹ 6.93 (d, J=8.4 Hz) 114.9 
6ʹ 7.52 (dd, J=8.4, 2.0 Hz) 121.8 
7ʹ 3.86 (s) 55.5 
Glc-1 5.55 (d, J=7.0 Hz) 100.6 
Glc-2 3.26b 74.0 
Glc-3 3.28 b 76.2 
Glc-4 3.14 b 69.6 
Glc-5 3.14 b 77.1 
Glc-6 3.41 (dd, J=12.0, 4.0 Hz) 
3.61 (dd, J=12.0, 2.0 Hz) 
60.4 
a 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
b Signal partially overlapped. 
c Not detected. 
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Table S10. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 8 (DMSO-d6, 500 MHz for 
1H, and 125 MHz for 13C NMR) 
quercetin 3-O-(6ˮ-O-malonyl)-β-glucopyranoside 
accurate mass found 551.0857 [M+H]+ 
accurate mass calculated 551.0959 [M+H]+ 
 
molecular formula C24H22O15 
 
 
 
 
 
 
 
 
 
 
 
NMR data 
position 1H [ppm] 13C[ppm] 
2 - 156.7 
3 - 133.2 
4 - 177.4 
5 - 161.3 
6 6.21 (br s) 98.8 
7 - 164.3 
8 6.41 (br s) 93.7 
9 - 156.5 
10 - 104.0 
1ʹ - 121.2 
2ʹ 7.54 (d, J=2.2 Hz) 116.3 
3ʹ - 144.9 
4ʹ - 148.6 
5ʹ 6.85 (d, J=8.8 Hz) 115.3 
6ʹ 7.53 (dd, J=8.8, 2.2 Hz) 121.7 
1ʹʹ - 166.7 
2ʹʹ 3.11 (s) 40.2 
3ʹʹ - 167.9 
Glc-1 5.38 (d, J=7.3 Hz) 101.1 
Glc-2 3.30a 74.0 
Glc-3 3.30a 76.3 
Glc-4 3.18 (dd, J=9.0, 9.0 Hz) 69.7 
Glc-5 3.35a 74.0 
Glc-6 4.22 (dd, J=11.8, 2.0 Hz) 
4.01 (dd, J=11.8, 6.0 Hz) 
63.7 
a Signal partially overlapped. 
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Table S11. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 10 (DMSO-d6, 500 MHz 
for 1H, and 125 MHz for 13C NMR) 
kaempferol 3-O-(6ʹʹ-O-malonyl)-β-glucopyranoside 
accurate mass found 535.1251 [M+H]+ 
accurate mass calculated 535.1110 [M+H]+ 
 
molecular formula C24H22O14 
 
 
 
 
 
 
 
 
 
 
NMR data  
position 1H [ppm] 13Ca[ppm] 
2 - 156.2 
3 - c 
4 - c 
5 - 160.7 
6 6.21 (br s) 98.4 
7 - 163.5 
8 6.42 (br s) 93.3 
9 - c 
10 - 104.3 
1ʹ - c 
2ʹ/6ʹ 7.98 (pseudo d, J=8.7,2.0 Hz) 130.5 
3ʹ/5ʹ 6.89 (pseudo d, J=8.7,2.0 Hz) 114.8 
4ʹ - 159.0 
1ʹʹ - c 
2ʹʹ 3.02 (s) 43.0 
3ʹʹ - 167.5 
Glc-1 5.33 (d, J=7.1 Hz) 101.0 
Glc-2 3.23b  73.8 
Glc-3 3.25 b 75.8 
Glc-4 3.16 (m) 69.2 
Glc-5 3.34 (m) 73.6 
Glc-6 4.15 (dd, J=11.8, 2.0 Hz) 
4.00 (dd, J=11.8, 6.0 Hz) 
62.6 
a 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
b Signal partially overlapped. 
c Not detected. 
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Table S12. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 11 (DMSO-d6, 500 MHz 
for 1H, and 125 MHz for 13C NMR) 
isorhamnetin 3-O-(6ʹʹ-O-malonyl)-β-glucopyranoside 
accurate mass found 565.1019 [M+H]+ 
accurate mass calculated 565.1052 [M+H]+ 
 
molecular formula C25H24O15 
 
 
 
 
 
 
 
 
 
 
 
 
NMR data  
Position 1H [ppm] 13Ca[ppm] 
2 - 156.7 
3 - 133.3 
4 - c 
5 - 161.6 
6 6.21 (d, J=2.0 Hz) 98.4 
7 - 164.8 
8 6.45 (d, J=2.0 Hz) 93.5 
9 - 156.7 
10 - 104.4 
1ʹ - 122.3 
2ʹ 7.82 (d, J=2.0 Hz) 113.2 
3ʹ - 147.3 
4ʹ - 149.3 
5ʹ 6.92 (d, J=8.4 Hz) 114.9 
6ʹ 7.54 (dd, J=8.4, 2.0 Hz) 121.8 
7ʹ 3.86 (s) 55.7 
1ʹʹ - 166.8 
2ʹʹ 3.09 (s) 41.0 
3ʹʹ - 168.0 
Glc-1 5.44 (d, J=7.0 Hz) 101.1 
Glc-2 3.28 (dd, J=8.5, 7.0 Hz) 74.0 
Glc-3 3.31 (dd, J=9.0, 8.5 Hz) 76.0 
Glc-4 3.17 (dd, J=9.0, 9.0 Hz) 69.5 
Glc-5 3.39 (ddd, J=9.0, 6.0, 2.0 Hz) 73.7 
Glc-6 4.18 (dd, J=12.0, 2.0 Hz) 
4.09 (dd, J=12.0, 6.0 Hz) 
63.4 
a 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
b Signal partially overlapped. 
c  Not detected. 
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Table S13. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 12 (DMSO-d6, 500 MHz 
for 1H, and 125 MHz for 13C NMR) 
kaempferol 3-O-(6ʹʹ-(E)-p-coumaroyl)-β-glucopyranoside 
accurate mass found 595.1360 [M+H]+ 
accurate mass calculated 595.1373 [M+H]+ 
 
molecular formula C34H37N3O6 
 
 
 
 
 
 
 
 
 
 
 
NMR data  
position 1H [ppm] 13Ca[ppm] 
2 - 156.6 
3 - 132.8 
4 - c 
5 - 161.3 
6 6.14 (d, J=1.8 Hz) 98.7 
7 - 164.2 
8 6.37 (d, J=1.8 Hz) 93.2 
9 - 156.6 
10 - 103.6 
1ʹ - 120.6 
2ʹ/6ʹ 7.97 (pseudo dd, J=8.7, 2.0 Hz) 130.3 
3ʹ/5ʹ 6.86 (pseudo dd, J=8.7, 2.0 Hz) 114.7 
4ʹ - 159.9 
1ʹʹ - 124.9 
2ʹʹ/6ʹʹ 7.34 (pseudo dd, J=8.5, 2.0 Hz) 129.8 
3ʹʹ/5ʹʹ 6.79 (pseudo dd, J=8.5, 2.0 Hz) 115.3 
4ʹʹ - 159.8 
7ʹʹ 7.33 (d, J=16.0 Hz) 144.1 
8ʹʹ 6.09 (d, J=16.0 Hz) 113.4 
9ʹʹ - 166.1 
Glc-1 5.43 (d, J=7.5 Hz) 100.7 
Glc-2 3.25 (dd, J=8.5, 7.5 Hz) 73.9 
Glc-3 3.29 (dd, J=9.0, 8.5 Hz) 76.1 
Glc-4 3.19 (dd, J=9.0, 9.0 Hz) 69.8 
Glc-5 3.40 (ddd, J=9.0, 6.0, 2.0 Hz) 74.0 
Glc-6 4.28 (dd, J=12.0, 2.0 Hz) 
4.04 (dd, J=12.0, 6.0 Hz) 
62.7 
a 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
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Table S14. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 13 (DMSO-d6, 500 MHz 
for 1H, and 125 MHz for 13C NMR) 
coronopilin  
accurate mass found 265.1344 [M+H]+ 
accurate mass calculated 265.1362 [M+H]+ 
molecular formula C15H20O4 
                               
 
 
 
 
 
 
NMR data a  
Position 1H [ppm] 13C [ppm]b 
1 - 83.2 
2 2.34 and 2.25 (m) 31.6 
3 2.51 and 1.65 (m) 30.6 
4 - 218.0 
5 - 58.6 
6 4.76 (d, J=8.2 Hz) 79.0 
7 3.31 (m) 43.5 
8 1.89 (m) 
1.71 (m) 
26.5 
9 2.16 (m) 
1.49 (m) 
29.3 
10 2.09 (m) 41.1 
11 - 140.4 
12 - 170.2 
13 6.05 (dd, J=2.6 Hz) 
5.69 (dd, J=2.0 Hz) 
120.3 
14 1.11 (d, J=7.6 Hz) 17.5 
15 0.97 (s) 13.5 
a NMR chemical shifts recorded in a mixture of coronopilin (13) and parthenin (14) (70:30). 
b 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
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Table S15. HRESIMS and 1H and 13C NMR Spectroscopic Data for Compound 14 (DMSO-d6, 500 MHz 
for 1H, and 125 MHz for 13C NMR) 
parthenin 
accurate mass found 263.1247 [M+H]+ 
accurate mass calculated 263.1271 [M+H]+ 
 
molecular formula C13H20O4 
                       
 
 
 
 
 
NMR data a  
Position 1H [ppm] 13C [ppm]b 
1 - 83.0 
2 7.63(d, J=6.0 Hz) 165.0 
3 7.09(d, J=6.0 Hz) 130.9 
4 - 210.4 
5 - 58.0 
6 4.85 (d, J=8.2 Hz) 78.0 
7 3.44 (m) 43.3 
8 1.83 (m) 
2.09 (m) 
27.4 
9 2.13 (m) 
1.54 (m) 
29.1 
10 2.10 (m) 39.3 
11 - 140.8 
12 - 170.2 
13 6.09 (dd, J=2.8 Hz) 
5.71 (dd, J=2.3 Hz) 
120.3 
14 1.02 (d, J=7.6 Hz) 16.7 
15 1.10 (s) 17.4 
a NMR chemical shifts recorded in a mixture of coronopilin (13) and parthenin (14) (70:30). 
b 13C NMR chemical shifts extracted from HSQC and HMBC spectra. 
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Table S16. A. artemisiifolia pollen lots. 
sample pollen lot # collection date collection area plant origin supplier 
Aa1 020512201 2012 Missouri, USA cultivated Allergon 
Aa2 P3024704-3 28.08.2012 Missouri, USA wild Greer Labs 
Aa3 P3744652-9 29.08.2012 Czech Republic wild Greer Labs 
Aa4 P3396120-3 27.08.2013 Missouri, USA wild Greer Labs 
Aa5 P335440-18 01.08.2008 Illinois, USA wild Greer Labs 
Aa6 P3392522-19 20.08.2013 Illinois, USA cultivated Greer Labs 
 
Table S17. A. psilostachya pollen lots. 
sample pollen lot# collection date collection area plant origin supplier 
Ap1 P3406293-1 16.08.2013 California, USA wild Greer Labs 
Ap2 P3801393 27.09.2013 Texas, USA wild Greer Labs 
Ap3 P3757208 19.08.2014 Oklahoma, USA wild Greer Labs 
Ap4 P3701938-2 06.08.2013 Arizona, USA wild Greer Labs 
Ap5 P4129072-1 05.08.2014 Arizona, USA wild Greer Labs 
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Asthma is a global burden mostly affecting developed and industrialized countries, worldwide. 
The variety and complexity of biological mechanisms causing asthma symptoms is considerably 
high and diverse, and is making the diseases still nowadays difficult to predict and to fully 
understand.  
We investigated the role of plant pollen secondary metabolites as potential factors involved in the 
exacerbation of allergen-mediated asthma. This study didn’t give direct answers to the question 
whether pollen secondary metabolites are involved in the worsening of asthma symptoms. 
However, we obtained relevant results regarding the modulation of airways by pollen secondary 
metabolites in mouse. A first aspect which still needs to be clarified is the exact pathway 
involved in the pollen-mediated increase of intracellular Ca2+-influx. The application of 
cinnamaldehyde as positive control in the Ca2+-imaging experiments is still not enough to 
discriminate the TRPA1-controlled Ca2+ influx from other Ca2+ regulating pathways (e.g. L-type 
calcium channels). To answer this intriguing question, in-vitro knock-out models of murine 
afferent neurons should be used in order to clarify this point. Another valid but certainly less 
exclusive approach would be the chemical inhibition of specific channels. Nevertheless, the 
caveat of this cheaper and straightforward strategy could be identified in the selection of 
inhibitors that are not selective enough and thus leading to undesired inhibition, or activation, of 
other proteins. The second aspect which calls for further experimental work are the effects 
induced by pollen extracts and purified compounds on a higher biological system, like murine 
trachea. In the specific case, it was possible to observe that the pre-treatment with sesquiterpene 
lactones (STLs) mixture coronopilin/parthenin was able to significantly reduce the maximal 
methacholine-induced constriction of tracheal preparations, indicating a possible synergistic 
effect of STLs on the muscarinic or other receptors. This partial relaxation was not observed 
when pre-treating tracheal rings with the A. psilostachya THF extract, containing other 
metabolites besides the sesquiterpene lactones coronopilin and parthenin. On the other hand, both 
A. psilostachya THF extract and the STLs mixture coronopilin/parthenin induced the relaxation 
of the methacholine pre-constricted trachea. These partial results are of valuable importance for 
developing ad hoc murine tracheal models, which should clarify the role of coronopilin and 
parthenin and identify other metabolites in the A. psilostachya THF extract possibly involved in 
the modulation of the tracheal tone.  
From the phytochemical perspective, there is still need to further explore the pollen metabolome 
originating from different plant species. On one side, we observed strong discrepancies in the 
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electrophiles concentration between the pollen and the rest of the plant (leaves and flowers) in 
Ambrosia artemisiifolia. On the other side, it was interesting to observe the presence of 
metabolites with electrophilic properties in non-Asteraceae pollen originating from e.g. Phleum 
pretense (Poaceae) or Urtica dioica (Urticaceae). These are only few reasons for natural products 
chemists to further investigate in this area. Unfortunately, the limiting factor in the pollen 
phytochemical study is the availability and the stockpiling of the raw material. This aspect calls 
for further development and investigations on two levels: (i) development and optimization of 
electrophiles trapping methods for enrichment of electrophilic metabolites in limited amounts of 
pollen extracts; (ii) HPLC-based activity profiling of pollen extracts on cellular and/or tissue 
assays. These strategies would on one side facilitate the characterization of electrophiles in 
Asteraceae and non-Asteraceae pollen, and on the other side would help to determine if non-
electrophilic secondary metabolites are involved in the modulation of specific proteins.  
 
Our new comparative metabolite profiling tool in ACD/MS Workbook Suite is now fully 
operative for data obtained from low resolution LC-ESIMS systems (Shimadzu, Waters, and 
Agilent). The utility of this recently developed tool was demonstrated in few projects (Chapter 
3.3; bioactivity profiling on Daphne giraldii, lymphogenesis project - Maria Teresa Faleschini). 
The next developmental steps will be focused to further increase the versatility of the tool, by 
making it usable with LC-HRMS, GC-MS, and APCI. By achieving this goal, users will be able 
to process large amounts of LC-MS/HRMS datasets in an automated, systematic, and 
comprehensive way, and simultaneously store, analyze, and database the results in a flexible 
computational platform like ACD/Labs.  
 
The newly developed web application FreeClust is freely accessible on-line and can read data 
from text files or Excel spread sheets. This makes our application highly versatile, enabling the 
clustering of data originating from various instruments, (not necessarily related to LC-MS) and 
thus broadening its application possibilities.  
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